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 Every cell responds to external stimuli. Many 
of these stimuli act through receptors situated at 
the plasma-membrane that transduce the signal in 
the cytosol. After receptor activation, the signal 
propagates via so-called second messengers to 
cellular responses varying from regulation of gene 
expression to actomyosin contraction. These 
second messengers may be proteins, small 
molecules or ions. An example of the latter is 
calcium (Ca2+), a universal second messenger in all 
cells. Other ionic species, e.g. Magnesium (Mg2+) 
are also important because they regulate the 
activity of enzymes. 
 Because various cellular processes depend on 
the abundance of ions (be it as second messengers 
or as regulators of enzymes) the cell maintains 
gradients of ions over the plasma-membrane that 
are tightly regulated. Potassium (K+) and Sodium 
(Na+) are the main ions controlling the membrane 
potential of cells: the cell interior is usually 
negatively charged with regard to the extracellular 
side. Calcium (Ca2+) and Magnesium (Mg2+) play 
pivotal roles in the regulation of many cellular 
reactions and enzymatic activities. The lipid 
bilayer of the plasma-membrane itself cannot let 
ions pass through due to its lipophylic nature. 
Therefore, cells have adapted various mechanisms 
to control the distribution of ions over the plasma-




 The concentration of free cytosolic Ca2+ is 
maintained at extremely low concentrations of 60-
100 nM, whereas the concentrations extracellularly 
and in the endoplasmatic reticulum are higher (~1 
and ~3 mM, respectively). Combined with the 
electrical gradient, there is thus a steep gradient 
that tends to drive extracellular Ca2+ into the cells. 
Under these conditions, any increase in Ca2+ 
permeability of the membranes (either through 
release from the ER or through influx via ion 
channels at the plasma-membrane) causes a sharp 
rise in intracellular Ca2+ (Berridge et al., 2000) 
Thus, Ca2+ is ideally suited to act as a second 
messenger and many proteins and processes are 
triggered by local increases in Ca2+ concentrations. 
For these reasons, a strict regulation of 
intracellular Ca2+ is necessary. Cellular Ca2+ 
regulation or Ca2+ homeostasis is achieved by 
various mechanisms that act at the level of the 
plasma-membrane as well as at cellular organelles 
such as the endoplasmatic reticulum (ER) and 
mitochondria (See Figure 1). 
 
Raising Cytosolic Ca2+ Levels 
 Since the lipid bilayer itself functions as a 
barrier for ions, passive transmembrane transport 
is handled by various ion channels with widely 
different properties. Based on the mode of 
activation, Ca2+ entry through channels can be 
divided into 4 major classes: receptor-operated 
(ionotropic) (Shuttleworth, 2004), second-
messenger-operated (metabotropic) (Kaupp and 
Seifert, 2002), voltage-operated (Felix, 2005) and 
store-operated Ca2+ channels (Bolotina, 2004) 
(Figure 1). Voltage-operated Ca2+ channels in 
excitable cells are best characterized. These 
channels are capable of generating very fast Ca2+ 
elevations upon membrane depolarization and 
control fast cellular responses such as exocytosis 
and muscle contraction. Ionotropic channels are 
also fast because they are directly controlled 
through binding of extracellular ligands that open 
the channels, while gating of metabotropic 
channels is constrained by cytosolic second-
messengers generated upon receptor activation. 
Yet other Ca2+ channels respond to a diverse array 
of stimuli including emptying of Ca2+ stores, 
temperature and mechanical stress (Voets et al., 
2005; Pedersen et al., 2005). Most of these 
channels belong to the large family of transient 
receptor potential (TRP) ion channels that will be 
described in more detail in the sections on TRP ion 
channels and mammalian TRP channels. 
 Next to Ca2+ entry from the extracellular 
medium (influx), Ca2+ can also be raised by release 
from intracellular stores (Figure 1), which are 
primarily located at the ER or in muscle cells at the 
sarcoplasmic reticulum (SR). Both the ER and SR 
posses second messenger activated Ca2+ channels, 
the inostol-1,4,5-triphosphate receptors (IP3-R) and 
ryanodine receptors (RYR) respectively. These 
channels are activated by IP3 and cADPribose/ 
NAADP respectively and are controlled by 
intracellular Ca2+ ([Ca2+]i) (Yoshida and Imai, 
1997; Guerrero-Hernandez et al., 2002). 
 Whenever IP3 binds to the IP3-R, it increases 
the sensitivity of the receptor for Ca2+, which has a 
biphasic characteristic. At slightly elevated levels, 
Ca2+ acts synergistically with IP3 to open the IP3-R 
channel, whereas at high concentrations, for 
example after full Ca2+ release, it inhibits the IP3-
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R, either directly or indirectly via calmodulin 
(CaM) (Taylor, 2002). 
 
Cytosolic Ca2+ Removal Mechanisms 
 Cells prevent Ca2+ overload and terminate 
cytosolic Ca2+ signals in several ways. First of all, 
free Ca2+ is effectively buffered by different Ca2+ 
binding proteins like parvalbumin, calbindin D-28, 
calretinin and, to a lesser extent, by Ca2+-effector 
proteins such as CaM, protein kinase C etc. During 
Ca2+ elevations, these proteins will buffer Ca2+, 
and subsequently, after termination of the Ca2+ 
signals, the buffers will be regenerated. In this 
way, the binding kinetics of these buffering 
proteins helps shaping Ca2+ transients in their 
amplitude and recovery time (John et al., 2001). 
Secondly, activated Ca2+ channels, at the plasma-
membrane or internal stores, are closed by various 
regulatory mechanisms, such as phosphorylation, 
ionic inhibition, (de-)polarization of the plasma-
membrane, or via inhibitory regulators of these 
channels (Hering et al., 2000). Alternatively, Ca2+-
pumps and exchangers located at the plasma-
membrane and internal organelles lower elevated 
cytosolic Ca2+ levels to resting levels and ensure 
that internal stores are refilled with Ca2+ 
(Belkacemi et al., 2005).  
Figure 1: Schematic representation of cellular Ca2+
homeostasis.  
After receptor activation intracellular Ca2+ can be 
raised from IP3-sensitive and/or Ryanodine-sensitive
stores. Also mitochondria may release Ca2+ into the 
cytosol via the uniporter. At the plasma-membrane 
various ion channels, non-selective cation or Ca2+-
specific, can elevate cellular Ca2+ levels after activation 
by receptors (ROCC), ligand binding (LOCC) or by 
membrane depolarization (VOCC). Elevated cytosolic 
Ca2+ levels are lowered to resting conditions by Ca2+
ATPases located at the plasma-membrane (PMCA) and 
the endoplasmic reticulum (SERCA). Furthermore, at 
very high Ca2+i elevations mitochondria will 
accumulate cytosolic Ca2+ and Na+/Ca2+ exchangers at 
the plasma-membrane are activated (not shown). 
 Ca2+-pumps and exchangers can be 
categorized into 4 classes: plasma-membrane Ca2+-
ATPases (PMCA), Na+/Ca2+ exchangers (NCX), 
endo(sarco)plasmatic Ca2+ ATPases (SERCA) and 
the mitochondrial uniporter. Since PMCAs and 
SERCAs have a high affinity for Ca2+, they detect 
and respond to even modest changes in cytosolic 
Ca2+. These proteins have rather low transport 
rates but are most important to set basal Ca2+ 
levels. In contrast, NCX and the mitochondrial 
uniporter have a higher transport rate and a wider 
dynamic range, but they only act optimally at μM 
Ca2+ concentrations (“high capacity, low affinity” 
pumps). 
 
Kinetics  and  Spatial  Distribution  of 
Ca2+ Signals 
 Ca2+ is a very versatile second messenger. The 
shape and duration of the Ca2+ elevation is tailor-
suited to fit the spatial and temporal requirements 
of specific downstream Ca2+-dependent signaling 
complexes. For example, proteins involved in 
rapid responses, such as exocytosis, are highly 
organized and all the downstream effectors are 
closely associated into a signal complex. These 
fast responses rely on rapid voltage operated Ca2+ 
channel gating and are spatially restricted to tens 
of nanometers (Sorensen, 2004). In contrast, 
muscular actomyosin contractions, as well as other 
processes, require Ca2+ elevations that last from 
seconds to many minutes (Ebashi and Ogawa, 
1988; Fields et al., 2005). Ca2+ signals often 
propagate as waves or oscillations throughout the 
cell. During prolonged stimulation, the Ca2+ 
concentration may also show repeated oscillations 
and this phenomenon has been implicated in 
physiological processes such as growth cone 
migration and turning, axonal outgrowth and 
oocyte activation (Berridge et al., 2000). These 
Ca2+-regulated processes do not require the highly 
organized, preexisting signaling complex that 
controls e.g. exocytosis. Cells can interpret Ca2+ 
oscillations using highly sophisticated 
mechanisms. To date, a number of Ca2+ effectors 
that can decode Ca2+ oscillations have been 
identified, such as Nuclear Factor of Activated T 
cells (NFAT) (Tomida et al., 2003), Protein Kinase 
C (PKC) (Oancea and Meyer, 1998) and 
Calmodulin Kinase II (De Koninck and Schulman, 
1998). These decoder proteins use frequency-
encoded Ca2+ signals to regulate gene 
transcription, exocytosis and the redox state of 
mitochondria (Dolmetsch et al., 1997; Li et al., 




Replenishment  of  Intracellular  Stores 
through Store‐Operated Calcium Entry 
 Responses to stimulation of GPCR or tyrosine 
receptors often are characterized by an initial, 
rapid Ca2+ release from IP3- or ryanodine-sensitive 
intracellular stores that is not dependent on the 
presence of extracellular Ca2+, followed by a 
second, smaller and more sustained phase that does 
rely on extracellular Ca2+. Emptying of the 
intracellular stores is the trigger for this Ca2+ influx 
that is known as Store-Operated Calcium Entry 
(SOCE). The SOCE conductance is not purely 
selective for Ca2+, for example Mn2+ can also enter 
the cytosol, as is evident from Fura-2 quenching 
essays (Jacob, 1990). Thus, depletion of 
intracellular stores somehow causes opening of a 
Ca2+ entry pathway in the plasma-membrane that is 
thought to be important for replenishment of 
intracellular stores. SOCE is proposed to continue 
as long as the IP3-sensitive stores are not 
adequately refilled (Putney, Jr., 1986; Clapham, 
1995). This event is observed in many different 
cell-types but the underlying molecular mechanism 
is still not understood and under scientific debate. 
 A major tool to investigate regulation of 
SOCE is thapsigargin, a naturally occurring 
sesquiterpene lactone isolated from the 
umbelliferous plant Thapsia garganica 
(Rasmussen et al., 1978). Thapsigargin specifically 
binds to and inhibits Ca2+ pumps (SERCA) located 
at the membranes of intracellular stores and 
thereby prevents Ca2+ to be pumped back into the 
lumen of the store (Thastrup et al., 1990). Under 
these conditions, basic leakage of Ca2+ through the 
intrinsic IP3 receptor channels causes depletion of 
the stores. The rate of store depletion and 
consequently Ca2+ influx via SOCE is highly 
variable between cell-types, but it may be quite 
rapid (within 5 s for rat mast cells (Hoth and 
Penner, 1993)). This indicates that there is high 
basal Ca2+ turnover across the membranes of the 
Ca2+ stores.  
 The first indications for SOCE were obtained 
by Fura-2 measurements (Jacob, 1990). Hoth and 
Penner used electrophysiological recordings to 
identify ionic currents responsible for SOCE. 
Using mast cells in whole-cell recordings, they 
observed ionic currents induced by depletion of 
intracellular stores as a result of inclusion of IP3 in 
the pipette solution (Hoth and Penner, 1992). 
These store-depletion-mediated currents were 
described as Calcium Release Activated Current 
(ICRAC). In most cells, the current amplitude of 
ICRAC is much smaller than background currents 
during patch-clamp, but it can be revealed by 
increasing extracellular Ca2+ to 10mM while 
intracellular Ca2+ is strongly buffered with EGTA 
or BAPTA. ICRAC selectively permeates Ca2+ over 
monovalent ions, but surprisingly almost no Mn2+ 
entry through CRAC channels was observed (Hoth 
and Penner, 1992), notwithstanding the fact that 
Mn2+ can efficiently replace Ca2+ in SOCE assays 
with Fura-2 (Jacob, 1990). The amplitude of 
ICRAC flowing through one channel is very low, a 
single channel conductance of only ~ 24 fS, which 
is far below the conductance of any ion channel 
identified to date (Zweifach and Lewis, 1993). 
ICRAC can only be measured in a limited number 
of cells, due to the low current amplitude and the 
incapability of discriminating between background 
currents for technical reasons (Zitt et al., 2002). It 
has not been convincingly demonstrated that 
SOCE and ICRAC reflect the same process. Until 
now, the ion channel(s) responsible for conducting 
ICRAC has remained illusive and scientists all over 
the world are eager to identify the channel. 
 
Mg2+ Homeostasis 
 Magnesium ions have an undisputable role in 
regulation of tissue and cell functions. Mg2+ is 
indispensable for the activity of numerous 
enzymes, e.g. kinases, DNA/RNA polymerases, 
various ATPases, small and heteromeric G-
proteins. In addition, Mg2+ might alter 
transcription by binding to the transcription factor 
DREAM. Furthermore, regulation of several ion 
channels, like the IP3 receptor, TRPM6 and 
TRPM7, L-type Ca2+ channels and ATP-sensitive 
K+ channels is mediated by Mg2+. 
 Given all of these functions, it is not 
surprising that Mg2+ is found in abundance 
intracellularly. The Mg2+ content in cells varies 
from 17-20 mM (Romani et al., 1995) and it is 
more or less homogenously distributed over the 
nucleus, mitochondria, endo(sarco)plasmatic 
reticulum and cytosol (Griswold and Pace, 1956; 
Gunther, 1986). Approximately 95% of the cellular 
Mg2+ ions is bound or sequestered. A considerable 
amount of Mg2+ (4-5 mM) found in the cytosol is 
bound to ATP or other phosphometabolites 
(Garfinkel et al., 1986) and as a result, in the 
cytosol only 0.5-1.0 mM ionized Mg2+ is free (see 
table I in Romani and Scarpa, 1992). In 
mitochondria the free Mg2+ levels are estimated to 
be between 0.5-1.0 mM (Jung et al., 1997) and in 
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the endo(sarco)plasmatic reticulum ~1mM 
(Sugiyama and Goldman, 1995). 
 Because both in the cytosol and the 
extracellular fluid Mg2+ is kept at (sub)millimolar 
concentrations, the transmembrane Mg2+ gradient 
is small, usually a factor of 2 or less. Therefore, 
influx or efflux of Mg2+ usually results in only 
small changes in free [Mg2+]i. Despite this small 
gradient, Mg2+ levels in the cells are under control 
of hormonal signaling: Mg2+ can be actively 
removed and accumulated into the cytosol after 
hormonal stimulation with e.g. epinephrine, 
phenylephrine and vasopressin. For details I refer 




 Data from Mg2+ flux-studies indicate the 
presence of several membrane transporters for 
Mg2+. An electroneutral, extracellular Na+-
dependent Mg2+/Na+ exchanger in the plasma-
membrane of chicken and turkey erythrocytes was 
the first characterized Mg2+ extruder (Gunther et 
al., 1984). Over the years, this Mg2+/Na+ 
exchanger has been identified in many other cell 
types (Gunther and Vormann, 1990; Handy et al., 
1996; Tashiro and Konishi, 1997; Gunther et al., 
1997). This exchanger can be stimulated by 
receptor-mediated increases in cyclic AMP 
(cAMP) and is dependent on extracellular Na+. 
Removing Na+ from the extracellular fluid 
(Romani et al., 1993b) or blocking Na+ transport 
(Gunther et al., 1984; Feray and Garay, 1986) 
inhibits extrusion of Mg2+. However, the data 
indicate that the mode of activation differs 
between cell types. Apart from its activation by 
cAMP (Gunther and Vormann, 1992), the 
Na+/Mg2+ exchanger can also be turned on by 
increasing amounts of free cytosolic Mg2+ 
(Gaussin et al., 1997) and Ca2+ (Romani et al., 
2000). Further more, the exchange stoichiometry 
varies between cell-types, e.g. in human red blood 
cells the exchange of Mg2+ for Na+ has a 
stoichiometry of 1:3 (Ludi and Schatzmann, 1987; 
Schatzmann, 1993).  
 In addition, several laboratories have reported 
a Na+-independent Mg2+ extrusion pathway that 
exchanges extracellular Ca2+ (Romani et al., 
1993a), Mn2+ (Feray 1987), Cl- (Gunther et al., 
1990) or HCO3- (Gunther and Hollriegl, 1993) for 
Mg2+. Extrusion appears to occur at a one-to-one 
ratio when Mn2+ is used as counter-ion and the 
exchanger can operate in reverse mode. In line 
with the presence of a Ca2+/Mg2+ exchanger, 
inhibition of Ca2+ channels with nifedipine or 
verapamil prevents Mg2+ extrusion (Romani et al., 
1993a). 
 Both Mg2+ extrusion mechanisms may coexist 
in a single cell. For example, results from the lab 
of Romani and Scarpa indicate that phenylephrine 
extrudes Mg2+ via a Ca2+-dependent mechanism 
(accounting for 10-15% of the total Mg2+ 
extrusion) and via a Ca2+-activated Na+-dependent 
mechanism that accounts for the majority of 
extrusion (Romani et al., 2000). 
 Recently, two channels implicated in Mg2+ 
homeostasis have been cloned and characterized 
(Runnels et al., 2001; Nadler et al., 2001; 
Schlingmann et al., 2002; Walder et al., 2002). 
These highly related channels belong to the TRP 
family of ion channels and are known as TRPM6 
and TRPM7 respectively. Both channels conduct 
Mg2+ and permeability appears to be regulated by 
the intracellular Mg2+ concentration: lowering of 
intracellular [Mg2+] by washout with Mg2+-free 
patch pipette solution causes the channels to open, 
leading to Mg2+ influx (Nadler et al., 2001; Voets 
et al., 2004b). Whereas TRPM6 expression is 
restricted to the distal tubules of kidney and the 
intestinal tract (Schlingmann et al., 2002; Walder 
et al., 2002), TRPM7 is ubiquitously expressed 
(Runnels et al., 2001; Nadler et al., 2001). 
Therefore it has been proposed that TRPM7 is the 
first identified ion channel responsible for cellular 
Mg2+ handling in all cell types (Schmitz et al., 
2003). Several mutations in TRPM6 are associated 
with hypomagnesia with secondary 
hypocalcaemia, an autosomal-recessive Mg2+ 
handling disorder (Schlingmann et al., 2002; 
Walder et al., 2002). A more detailed description 
of both channels can be found in sections on 









 Stimulation of cardiac (Vormann and 
Gunther, 1987; Romani et al., 1993b; Howarth 
et al., 1994) and liver cells (Romani and 
Scarpa, 1990; Gunther and Vormann, 1991; 
Keenan et al., 1996) with β-adrenergic receptor 
agonists results in a marked extrusion of Mg2+ 
evident within 1 minute after application and 
reaching its maximum after 5-6 minutes. 
Subsequently, Mg2+ levels return towards basal 
levels, independent of the persistence of the 
agonist (Keenan et al., 1996; Romani et al., 
2000). β-adrenergic receptor agonists act via 
adenylyl cyclases to increase cAMP levels, 
which in turn activates Protein Kinase A 
(PKA) (Huang et al., 1982; Wolf et al., 1997; 
Rothermel and Parker Botelho, 1988). Besides 
β-adrenergic receptor mediated extrusion, 
Cittadini’s lab observed Mg2+ extrusion in 
spleen lymphocytes and Ehrlich cells after 
prostaglandin (PGE1 or PGE2) or arachidonic 
acid stimulation that is mediated by 
intracellular cAMP increase (Wolf et al., 1994; 
Wolf et al., 1996). Mg2+ extrusion over the 
plasma-membrane requires the presence of 
physiological levels of extracellular Na+ and 
Ca2+. 
 Stimulation with α-adrenergic agonists, 
such as phenylephrine revealed a second 
pathway involved in cellular Mg2+ regulation 
(Jakob et al., 1989). Pretreatment of cells with 
insulin allows discrimination between α- and 
β-adrenergic receptor-activated Mg2+ 
extrusion. Insulin inactivates β-adrenergic 
receptors through tyrosine phosphorylation and 
interferes with intracellular cAMP levels 
through inhibition of the adenylyl cyclase 
(Karoor et al., 1995) or activation of phospho-
diesterases (Smoake et al., 1995), and thereby 
prevents Mg2+ efflux (Keenan et al., 1996; 
Romani et al., 2000). In contrast, α-adrenergic 
receptors are coupled to small G-proteins that 
activate PhosphoLipase C (PLC) and result in 
release of Ca2+ from IP3-sensitive stores 
(Minneman, 1988). Therefore insulin 
pretreatment does not prevent Mg2+ extrusion
after α-adrenergic receptor stimulation 
(Keenan et al., 1996). The release of 
intracellular Ca2+ could directly activate a 
Ca2+-dependent Mg2+ transporter or act as a 
counter-ion for Mg2+ extrusion. 
 Cellular ATP is the most abundant 
chelator of Mg2+ present in the cytosol. 
Chemicals that decrease the cellular ATP 
content, like cyanide, mitocondrial uncouplers 
(Wolf et al., 1994; Romani and Scarpa, 2000), 
fructose (Gaussin et al., 1997) or ethanol 
(Tessman and Romani, 1998), increase the 
amount of free cytosolic Mg2+ that is extruded 
in a Na+-dependent fashion. Since there is no 
evidence that cAMP mediates this extrusion 
(Tessman and Romani, 1998), it is possible 
that the elevation of free cytosolic Mg2+ due to 
decreased cellular ATP content is sufficient to 
activate the Mg2+ transporter. 
 
Accumulation of Cellular Mg2+
 The Mg2+ content of blood plasma and the 
body is mainly controlled by cells in the renal 
apparatus and in the intestine. Mg2+ uptake 
from the intestine and reabsorption in the 
kidney is under hormonal control, although 
many details of this are still unclear. For a 
more exhaustive description I refer to reviews 
of Quamme (Quamme and de Rouffignac, 
2000) and Hoenderop (Hoenderop and Bindels, 
2005). Here I will focus on Mg2+ handling by 
other cells in the body.  
 As mentioned before, in liver and cardiac 
cells adrenergic receptors stimulate Mg2+ 
extrusion, a process that is sensitive to insulin. 
In contrast, in 3T3 fibroblasts and other cell 
types insulin causes accumulation of Mg2+ 
(Gylfe, 1990; Ishijima and Tatibana, 1994). 
Agonists such as vasopressin and angiotensin 
II also cause accumulation of Mg2+ (Okada et 
al., 1992; Touyz and Schiffrin, 1996; Dai et al., 
1998). In hepatocytes, vasopressin-induced 
Mg2+ accumulation is Na+-dependent and 
mediated by PKC and Ca2+ (Romani et al., 





 TRP channels were identified in 1970 in the 
phototransduction cascade of Drosophila 
melanogaster. In wildtype fruit flies, continuous 
illumination of the compound eye produces a long 
lasting depolarization of photoreceptor cells (Pak 
et al., 1970). In the Drosophila trp mutant, the 
initial onset of the response to prolonged 
illumination is identical to wildtype but the 
depolarization is transiently decaying towards 
baseline within seconds despite the continuous 
illumination. This results in a functional loss of 
sight in bright light (Minke et al., 1975).  
Figure 2: Schematic overview of phosphoinositide 
signaling cascade.  
 Upon binding of ligand to G-protein receptors 
(GPCR), the receptor is activated which in turn 
activates a heteromeric G-protein. Specific heteromeric 
G-proteins will activate phospholipase C at the plasma-
membrane that catalyzes the hydrolysis of 
phosphatidylinositol 4,5-biphosphate (PIP2) into the 
soluble second messenger inositol 1,4,5-triphosphate 
(IP3) and the membrane bound diacylglycerol (DAG). 
The IP3 binds to IP3 receptors (IP3-R) at the 
endoplasmasmatic reticulum, which has an internal 
Ca2+ channel that subsequently opens and releases Ca2+
into the cytosol. At the plasma-membrane, DAG 
activates protein kinase C (PKC) which initiates a 
phosphorylation cascade. DAG can be converted into 2 
other potential second messengers: DAG lipases
convert DAG to polyunsaturated fatty acids (PUFA) or 
phosphorylation of DAG by DAG kinases (DGK)  it is
transformed to phosphatidic acid (PA). Resynthesis of 
PIP is dependent on the formation of PA that is furthe2 r 
processed to CDP-DAG via CD-synthase (not shown). 
After conversion to PI at the endoplasmatic reticulum, 
PI is presumably transferred to plasma-membrane by a 
PI transfer protein (PITP) where 2 sequential 
phosphorylation steps by PI-kinases and PIP-kinases 
respectively is converted to PIP . 2
 Members of the mammalian TRP channel 
family are involved in a variety of functions, e.g. 
cation homeostasis and detection of sensory 
stimuli. I will briefly introduce the activation 
pathway of Drosophila TRP channels and its 
multiprotein signal complex as it has been 
extensively studied and is likely to be relevant for 
regulation of mammalian TRP channels.  
 
TRP  Channels  in  the Drosophila’s  Eye 
and Light Perception 
 Phototransduction in the compound eye of 
Drosophila is a complex signaling cascade that 
involves G-Protein Coupled Receptors (GPCR), G-
proteins, Phospholipase C (PLC), and at least 2 
types of channels, TRP and TRPL (Minke and 
Cook, 2002). Incoming photons isomerize 
rhodopsin, the light-sensitive GPCR, to the active 
form metarhodopsin. Metarhodopsin subsequently 
transduces the signal to a heterotrimeric G-protein 
(transducin) that activates PLC (norpA). 
Consequently, PLC activation leads to TRP and 
TRPL channel opening resulting in a light-induced 
current (LIC) via an as yet unknown pathway. 
Resolving this pathway is difficult and results are 
controversial, but the key role for PLC is 
undisputed: in a temperature-sensitive allele of 
PLC, ts-norpA, flies can be rendered fully blind by 
rapidly switching to the non-responsive 
temperature, and vice versa (Deland and Pak, 
1973). Interestingly, gating of TRP and TRPL 
channels has long been associated with various 
PLC-related second messengers, including IP3, 
DAG and PIP2 (Figure 2). As gating of TRPM7 
channels by these messengers is the subject of 
Chapters 2 and 3, I will here review the literature 




 In the horseshoe crab Limulus polyphemus 
there is strong evidence that light induces release 
of Ca2+ from intracellular stores via IP3 receptors 
localized in the submicrovillar cisternae (Payne et 
al., 1986). The release of Ca2+ precedes LIC by a 
few milliseconds. Not only PLC activation is 
required to evoke TRP opening but also the 
presence of extracellular Ca2+ is crucial. When 
photoreceptor cells are deprived from extracellular 
Ca2+ for prolonged time, this reversibly eliminates 
excitation (Hardie and Minke, 1992; Cook and 
Minke, 1999). Nevertheless, photolysis of caged 
Ca2+ , raising intracellular Ca2+ from the patch 
pipette or application of Ca2+ ionophores such as 
ionomycin all fail to activate TRP channels 
(Hardie, 1996). It has to be emphasized that these 
14 
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experimental procedures do not mimic the locally 
very high Ca2+ increases found near the pore of IP3 
channels or plasma-membrane channels. This 
suggests that for example Calmodulin (CaM) may 
not be activated under these conditions. In Ca2+ 
free conditions, Ca2+ release from intracellular 
stores upon exposure to light was similar in trp 
mutant as in wildtype Drosophila. However, 
genetic elimination of the IP3 receptor in 
Drosophila surprisingly abolished neither the light 
responses nor the Ca2+ release (Acharya et al., 
1997). Furthermore, both caged IP3 (Raghu et al., 
2000) and caged GTPγS (Hardie, 1995) failed to 
activate phototransduction in Drosophila. This 
may reflect a diffusion barrier that prevents the 
chemicals from reaching the signaling membrane 
in the ommatidia. On the other hand, biochemical 
labeling studies with [3H]-inositol convincingly 
showed that illumination caused accumulation of 
IP3 and IP2 resulting from PLC activation (Devary 
et al., 1987). Furthermore, addition of 2,3-
diphosphoglycerate (DPG), which prevents 
hydrolysis of IP3, prolonged the light response in 
Lucillia cuprina and Musca domestica (Devary et 
al., 1987; Suss et al., 1989). Thus, IP3 itself can 
also not be excluded as a second messenger.  
 
Activation by DAG Signaling 
 Diacylglycerol (DAG) forms the other signal 
generated by PLC. It is well established that 
formation of DAG inactivates TRP channels by 
phosphorylation through PKC (Drosophila 
homolog is called inaC). Application of 
phorbolesters to activate PKC suppresses the light-
induced Ca2+ release and photon response in 
Limulus (Dabdoub and Payne, 1999). To make 
things more complicated, a signaling pathway 
downstream of DAG may lead to TRP and TRPL 
activation. DAG is a precursor for the generation 
of polyunsaturated fatty acids (PUFA), although 
no activity of DAG lipases has been demonstrated 
in Drosophila. However, impaired downstream 
DAG signaling caused by a mutation in rdgA (a 
Drosophila homolog of diacylglycerol kinase) 
causes light-independent degeneration (Masai et 
al., 1993; Masai et al., 1997). Thus, it was 
proposed that accumulation of DAG leads to 
increased formation of PUFAs that triggers 
opening of TRP and TRPL channels, leading to 
toxic intracellular Ca2+ levels and retinal 
degeneration. Exogenous application of PUFA to 
ommatidia in inside-out patches caused TRP and 
TRPL channel opening, making PUFA a potential 
candidate for TRP channel activation in 
Drosophila phototransduction. In line with this 
notion, a rdgA/trp double mutant prevented to a 
large extend the retinal degeneration (Chyb et al., 
1999; Raghu et al., 2000).  
 
PIP2 Regulating TRP Channel Activity  
 Finally, it has been suggested that PIP2 itself 
could have a role as second messenger in TRP 
channel activation. Two independent mutations 
(rdgB, a Phospho-Inositide (PI) transfer protein, 
and cds, an enzyme involved in PI resynthesis) in 
the PIP2 recycling pathway prevent recovery of 
TRP channel activity from inactivation (Wu et al., 
1995; Hardie et al., 2001). Furthermore, Ca2+ 
influx after illumination is required to maintain 
PIP2 levels possibly through termination of PLC 
activity and/or facilitation of PIP2 recycling. 
Hence, removal of extracellular Ca2+ results in 
sustained TRP channel opening after termination 
of the light exposure (Hardie et al., 2001). 
Recombinant expressed TRPL channels are 
activated by application of exogenous PLCβ and 
are suppressed by PIP2 application in inside-out 
patches (Estacion et al., 2001). On the other hand, 
in in vivo experiments in Drosophila trp mutants 
prolonged illumination leads to PIP2 depletion and 
closure of TRPL channels, which remain 
inactivated until PIP2 is resynthesized (Hardie et 
al., 2001).  
Since DAG/PUFA can activate TRP and PIP2 
regulates these channels, the interesting hypothesis 
arises that simultaneous generation of DAG and 
depletion of PIP2 might trigger TRP channel 
opening. This suggests that TRP channels may 
possess domains for DAG/PUFA binding, 
stabilizing the open state of the channels, as well 




 Following the identification of TRP and 
TRPL channels as Ca2+ conducting channels in 
Drosophila, 28 mammalian genes encoding TRP 
channels have been cloned and their functions are 
now beginning to be understood. TRP channels are 
involved in many different responses such as 
perception of temperature, touch and pain, 
smelling odorants and pheromones, but also in 
regulation of cellular ion homeostasis and uptake 
of ions in the kidney and intestine. Similarly, 
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regulation of TRP channels shows a perplexing 
variety of different mechanisms.  
 The mammalian TRP channel family can be 
grouped into 6 subfamilies (Figure 3, Clapham et 
al., 2003): canonical (TRPC), vanilloid receptor 
(TRPV) and melastatin-related (TRPM) channels, 
and the smaller subfamilies mucolipins (TRPML), 
polycystins (TRPP) and TRPA (an anchorin-repeat 
containing channel). Whereas the focus of this 
thesis is on TRPM7, I will here present a brief 
overview of the current literature on the major 
subfamilies to provide a background for 
understanding the regulation and biophysical 
properties of TRPM7. Emphasis will be on the 
modes of activation, regulation and the proposed 
gating mechanisms of TRPC, TRPV and TRPM 
channels. Information on TRPA, and its 
Drosophila homologue NompC, which have both 
been implicated in mechanosensation, will be 
presented in the paragraph on mechanosensation 
by ion channels.  
 
TRPC Subfamily 
 The mammalian TRPC subfamily consists of 
7 channels, named TRPC1-7. Of all mammalian 
TRP channels, this subfamily shares the highest 
homology with Drosophila TRP and TRPL 
channels. TRPC channels can be divided in 3 
groups based on phylogeny: first, TRPC1, TRPC4 
and TRPC5, second, TRPC3, TRPC6 and TRPC7, 
and third TRPC2 (Clapham, 2003). All these 
channels share a structural feature, a so-called TRP 
box consisting of an invariant amino acid sequence 
EWKFAR juxtamembrane to the 6th 
transmembrane domain. Furthermore, these 
channels possess N-terminal ankyrin repeats and 
are non-selective cation channels, which selectivity 
ratio PCa2+/PNa+ varies from 1.1 for TRPC4 to 9 for 
TRPC5 (Schaefer et al., 2000). Gating of all TRPC 
channels is downstream of GPCR- or tyrosine-
kinase receptor-mediated PLC activation. In all 
cases, the exact gating mechanism is still unclear 
and subject to debate: both store-dependent and -
independent mechanisms have been proposed. For 
example, both TRPC1 and TRPC7 were shown to 
be activated in a store-dependent manner (Zitt et 
al., 1996), whereas others have suggested a store-
independent mechanism (Lintschinger et al., 
2000). Adding to the confusion, a recent paper 
shows that expression of TRPC1 did not induce 




 Channels of the first TRPC group regulate a 
variety of cellular responses. TRPC1, which is 
expressed in various tissues, is involved in 
regulating vascular permeability (Bergdahl et al., 
2003; Kunichika et al., 2004) and axonal turning 
upon chemotropic stimulation (Wang and Poo, 
2005). The first TRP channel knocked out in mice 
was TRPC4. These TRPC4-deficient mice 
revealed that this channel is involved in agonist-
induced relaxation of blood vessels and lung 
microvascular permeability (Freichel et al., 2001; 
Tiruppathi et al., 2002). TRPC5 is predominantly 
expressed in the central nervous system and is 
abundantly present in hippocampal neurons, where 
it might be an important determinant of axonal 
growth and growth cone morphology (Greka et al., 
2003).  
 Members of the second group are relatively 
highly expressed in cardiac and smooth muscle 
cells. TRPC3 and TRPC6 are shown to be 
involved in vasoregulation and regulation of 
tracheal contractility. TRPC3 and TRPC7 are 
proposed candidates for non-selective cation 
channels that may regulate Ca2+-dependent 
contractility. TRPC2 was reported to be a 
pseudogene in humans, but not in other mammal 
species (Vannier et al., 1999). This channel is 
expressed in the vomeronasal organ of the rat 
(Liman et al., 1999), where it most likely involves 
pheromone signaling, since TRPC2 deficient mice 
display abnormal mating behavior (Stowers et al., 
2002). Besides, expression of TRPC2 in the head 
of mouse sperm is involved in the release of 
hydrolytic enzymes upon egg fertilization 
(Jungnickel et al., 2001).  
 
Signaling Complex of TRPC Channels 
 The signaling complex associated with 
Drosophila TRP channels is known as the 
transducisome or signalplex (Li and Montell, 
2000). This protein complex, which consists of 
TRP channels, the InaD scaffold protein and 
regulatory proteins, has served as a model for 
possible signaling complexes of TRPC channels. 
By analogy to this signaling complex, a human 
homologue of InaD protein was cloned that has at 
least 5 protein-interacting PDZ domains (Philipp 
and Flockerzi, 1997). Unfortunately, no binding 
partners have yet been identified. However, several 
TRPC channels are linked to possible regulatory 
proteins. For example, TRPC4 and PLCβ1 form a 
protein complex with the protein NHERF 
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(regulatory factor of the Na+/H+ exchanger) that 
contains 2 PDZ domains and is also linked to the 
cytoskeleton. To date, still no experimental data 
are present on the impact of the cytoskeletal 
interaction on channel functioning (Tang et al., 
2000). Like the Drosophila TRP channels, all 
TRPC family members can bind directly to both 
calmodulin and the IP3-receptor, suggesting that 
both these proteins are involved in regulation of 
the channels. As the binding sites of CaM and the 
IP3-R in TRP channels partially overlap, 
competition between both proteins may occur 
(Tang et al., 2001).  
 Interestingly, PLCs are also involved in 
trafficking of TRPC channels. TRPC3 contains a 
partial PH-domain that is complemented by the C-
terminal split PH-domain of PLCγ1. The 
interaction of both domains forms a complete PH-
domain capable of interacting with PIP2 and is 
required for proper trafficking of TRPC3 to the 
plasma-membrane (Van Rossum et al., 2005) 
Figure 3: Phylogenetic tree of the mammalian TRP 
family.  
 The evolutionary distance is shown by the total 
branch lengths in point accepted mutations (PAM) units, 
which is the mean number of substitutions per 100 
residues. Adapted by permission from Macmillan 
Publishers Ltd: Nature, (Clapham 2003) 2003 
 
Hetero‐tetramerization of TRPC Channels 
 TRPC channels are expressed in virtually all 
tissues, cell types and cell lines and it seems likely 
that they can co-assemble in hetero-tetrameric 
complex (Garcia and Schilling, 1997; Hofmann et 
al., 2000; Riccio et al., 2002). However, to date 
most data on multimerization of TRPC channels 
are from heterologous expression studies 
performed in cancer cell lines. A major drawback 
of this approach is that overexpression favors 
formation of TRPC homo-tetramers and cell may 
lack (sufficient) additional factors that may be 
involved in channel functioning and regulation. Do 
these channels exist and function as homo-
tetramers in vivo?  
 Increasing evidence suggests that the TRPC 
channel functioning is far more complex than 
thought before. Several TRPC family members can 
bind to each other and form hetero-tetrameric 
channels with properties different from the 
individually expressed TRPC channels. Co-
immunoprecipitation revealed that TRPC1 can 
form a hetero-tetrameric channel with TRPC3 
(Lintschinger et al., 2000), TRPC4 (Strubing et al., 
2003) and TRPC5 (Strubing et al., 2001). Co-
expression of TRPC1 with TRPC3 (Lintschinger et 
al., 2000), TRPC4 or TRPC5 (Strubing et al., 
2001) resulted in currents with properties different 
of those of individually expressed channels. From 
studies that use various different approaches such 
as electrophysiological recording, co-
immunoprecipitation and FRET assays, the picture 
emerges that TRPC1, TRPC4 and TRPC5 can co-
assemble together, and that TRPC3, TRPC6 and 
TRPC7 can interact with each other in both 
overexpression studies (Hofmann et al., 2002) as 
well as in native tissues (Goel et al., 2002). In 
contrast, in both studies, members of one group 
were unable to cross interact with members of the 
other group.  
 The domain responsible for interaction 
between TRPC proteins has not yet been defined, 
although recent studies suggest that a conserved 
coiled-coil domain at the C-terminus of all TRPC 
channels may be involved (Engelke et al., 2002). 
Strikingly, alignment of this conserved coiled-coil 
region reveals that it displays an offset in TRPC3, 
TRPC6 and TRPC7 compared to TRPC1, TRPC4 
and TRPC5, which is consistent with the selective 









 TRP ion channels possess 6 
transmembrane domains and cytosolic N- and 
C-terminus reside in the cytosol. In analogy to 
the pore-forming subunits of voltage-gated 
Ca2+, Na+ and K+ channels, which consist of 
either 4 subunits (Shaker K+ and IRK 
channels) or internal 4-fold repeats (Ca2+ and 
Na+ channels), it is reasonable to assume that 
TRP channels also consist of 4 subunits.  
 
The TRP Pore Region and Ion Selectivity 
 A short hydrophobic stretch of amino 
acids between transmembrane domain 5 and 6 
is predicted to be the pore-forming region in 
analogy to the K+ channel KscA (Yool and 
Schwarz, 1991; Yellen et al., 1991). In a 
tetramer, 4 pore-forming regions together form 
the channel pore that is a often negatively 
charged ring that determines the ion selectivity 
of the channel (Doyle et al., 1998). Overall, the 
architecture of the selectivity filter of TRP 
channels is poorly defined. Mutational studies 
showed that replacing aspartate residues by 
neutral amino acids in the pore region alters 
the selectivity for Ca2+, but also the sensitivity 
for intracellular Mg2+, voltage-dependent 
gating and sensitivity to channel blockers 
(Owsianik et al., 2006). The aspartate residues 
in the proposed selectivity filter of TRPV4, 
TRPV5 and TRPV6 form a negatively charged 
 ring that to some extent determines
 Ca2+ selectivity of the channel, analogous to 
voltage-gated Ca2+ channels (Voets et al., 
2003). The amino acids involved in cation 
selectivity in the pore of the other monovalent-
selective and non-specific TRP channels have 
not been identified yet. Alignment of the pore 
region shows that TRPC and TRPM channels 
have a relatively high degree of conservation 
within the subfamilies (Owsianik et al., 2006). 
There is only marginal homology within the 
TRPV pore region, and in the absence of 
further mutational studies, identification of 
amino acids involved in the selectivity of these 
channel pores are merely an educated guess.  
 
Proposed Gating Mechanism of TRP Channels 
 All these channels are involved in sensing 
and responding to a variety of stimuli. The 
cytosolic end of the 6th transmembrane domain 
is suggested to form the gating lever that is 
situated in line with the selectivity filter of the 
channel. Upon stimulation, opening and 
closure of the channel is probably managed by 
movement of the 4th transmembrane domain. 
This assumption is based on voltage-gated 
channels, where this region is positively 
charged and moves in the extracellular 
direction in response to cell depolarization, 







 TRPV channels, which are also widely 
expressed, share a high homology with the Osm9 
channel in Caenorhabditis elegans. Behavioral 
studies with Osm9-deficient C. elegans showed its 
involvement in response to odorants, osmotic 
strength and mechanical stimulation (Colbert et al., 
1997). The founding member TRPV1 was 
identified by expression cloning with the hot 
pepper-derived vanilloid compound capsaicin 
(Caterina et al., 1997). Like TRPC channels, 
TRPV family members have a TRP box after the 
6th transmembrane domain and N-terminal ankyrin 
repeats. TRPV channels non-specifically conduct 
cations and the Ca2+ selectively is set by a single 
aspartic acid residue in the channel pore (Garcia-
Martinez et al., 2000; Voets et al., 2003). The 
TRPV protein family can be divided in 2 groups 
based on phylogeny, biophysical properties and 
cellular function: first, TRPV1-4 and second 
TRPV5 and TRPV6. Typically, the first group of 
TRPV channels can be activated and regulated by 






 TRPV1 is activated by temperatures above 
43°C and in addition by the chemical compounds 
2-APB (Hu et al., 2004), capsaicin and endogenous 
cannabinoid receptor ligands like anandamide. The 
binding domain for both ligands is located to an 
intracellular domain adjacent to the 3rd 
transmembrane domain (Jordt and Julius, 2002). 
Heterologous expression of TRPV1 channels 
displays an outward rectifying current-voltage 
relationship and reveals anomalous mole fraction 
behavior as apparent from linearization of the I/V 
in divalent free medium. TRPV1 currents are 
activated as well as potentiated by a low pH (< 
5.9) (Caterina et al., 1997) and inhibited by PIP2 
(Chuang et al., 2001). Release from PIP2 inhibition 
by receptor mediated PLC activation increases 
heat-activated TRPV1 currents (Chuang et al., 
2001). Furthermore, TRPV1 current are sensitized 
by PKC and PKA activity, however the 
mechanisms of action remains to be clarified. A 
TRPV1 knock-out mouse implicated the 
involvement of this channel in nociception, 
inflammation and in the hypothermic effects of 
vanilloid compounds (Caterina et al., 2000). 
Moreover this channel is implicated in pancreatitis 
(Nathan et al., 2002) and asthma (Hwang and Oh, 
2002). 
 TRPV2 shares 50% homology with TRPV1 
and is activated by noxious heat (> 52°C) and 2-
APB, rather than capsaicin or pH (Caterina et al., 
1999; Jordt and Julius, 2002; Hu et al., 2004). 
Activated TRPV2 channels display moderately 
outward rectifying I/V characteristics. Activation 
by growth factors like Insulin Growth Factor-1 
(IGF-1) translocates functional TRPV2 channels to 
the plasma-membrane by incorporation of 
intracellular vesicles that contain preassembled 
channels (Kanzaki et al., 1999). Stretch forces can 
similarly lead to incorporation of the channel in the 
plasma-membrane in vascular smooth muscle cells 
(Muraki et al., 2003).  
 TRPV3 and TRPV4 channels are also 
activated by heat, but in a more moderate 
temperature range: raising temperature above 25°C 
will activate TRPV4 channels (Guler et al., 2002) 
whereas above 31°C TRPV3 currents are activated 
(Peier et al., 2002; Smith et al., 2002; Xu et al., 
2002). Moreover, TRPV3 channels can be 
activated by 2-APB while TRPV4 channels are 
unaffected (Hu et al., 2004). TRPV3 displays an 
outward rectifying I/V-relationship (Xu et al., 
2002) and the I/V-plot of TRPV4 is linear 
(Watanabe et al., 2002). Unlike TRPV3, TRPV4 
currents are enlarged upon osmotic cell swelling 
cells (Liedtke et al., 2000; Strotmann et al., 2000). 
This effect is mediated by phosphorylation of 
TRPV4 channels, reportedly downstream of the 
tyrosine kinase Src (Xu et al., 2003). Subsequent 




 In contrast to the temperature regulated TRPV 
channels, TRPV5 and TRPV6 can not be activated 
by temperature changes. Heterologous expression 
in HEK293 cells showed that both channels are 
constitutive active (Vennekens et al., 2001) and are 
highly selective for Ca2+ (PCa2+/PNa+ > 100). The 
I/V-relationships of both channels are inward 
rectifying, with hardly any outward currents at 
positive voltages (Vennekens et al., 2000; 
Vennekens et al., 2001). The aspartic residue in the 
pore defining Ca2+ selectivity also influences the 
Mg2+ sensitivity (Nilius et al., 2001). Mg2+ ions 
cause a voltage-dependent block of TRPV5 and 
TRPV6 currents. TRPV5 channels function as the 
main gatekeeper of apical Ca2+ influx pathway in 
kidney and TRPV6 fulfils this role in intestine (den 
Dekker et al., 2003; Nijenhuis et al., 2003) 
 TRPV5 as well as TRPV6 are controlled by 
intracellular Ca2+ levels through a negative 
feedback loop with apparent affinity of ~100 nM 
(Vennekens et al., 2001). The precise mechanism 
of this feedback loop is still unclear. Interestingly, 
CaM binds Ca2+-dependently to human TRPV6 
and this interaction is regulated by PKC-mediated 
phosphorylation of the TRPV6 CaM binding 
domain. Phosphorylation of a threonine residue 
inhibits CaM binding and thereby attenuates 
inactivation of human TRPV6 channels (Niemeyer 
et al., 2001). The CaM-binding domain is poorly 
conserved between mouse and human, and this 
mode of regulation thus seems to be restricted to 
human TRPV6 channels. The human TRPV5 
amino-acid sequence also shows poor homology in 
this binding domain and therefore it is doubtful 
whether the same Ca2+ dependent regulation of 
TRPV5 channels exists. 
 
Heteromultimeric TRPV Complexes 
 As covered in the previous paragraph, based 
on phylogeny, functional and biophysical 
properties, the TRPV channel family can be 
divided into 2 subgroups. All TRPV channels do 
form homo-tetramers (Hellwig et al., 2005) but are 
they also capable to form hetero-tetramers?  
 Data from FRET and co-immunoprecipitation 
assays show that TRPV1 and TRPV2 can interact 
with each other, although, TRPV2 preferably 
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associates with other TRPV2 subunits and only to 
a minor extent with TRPV1 (Hellwig et al., 2005). 
Smith et. al found that TRPV1 can also co-
assemble with TRPV3, based on responses to 
capsaicin and on immunoprecipitation assays 
(Smith et al., 2002). In contrast, a very recent 
study failed to detect functional or physical 
interactions between these TRPV family members 
(Hellwig et al., 2005). For this reason, it still 
remains unclear whether TRPV1 and TRPV3 can 
form hetero-tetrameric channels. The remaining 
member of this subgroup, TRPV4 is not able to 
form hetero-tetrameric channels upon co-
expression with all other TRPV family members 
(Hellwig et al., 2005). 
 TRPV5 and TRPV6 are endogenously 
expressed in various epithelial tissues and their co-
expression levels affect renal and intestinal Ca2+ 
absorption (van Abel et al., 2005). By various 
biochemical assays it was shown that TRPV5 and 
TRPV6 can co-assemble in hetero-tetramers 
(Hoenderop et al., 2003). In summary, formation 
of heteromultimeric TRPV channels may occur 
with some specificity, although the complete 
picture has not yet emerged. 
 
TRPM Subfamily 
 TRPM channels show a large variety in cell-
biological and biophysical properties. For 
convenience, members of this subfamily will here 
be loosely subdivided in 3 groups: TRPM4 and 
TRPM5, which share significant similarities in 
both functional and biophysical properties, 
TRPM6, TRPM7 and TRPM2, which are 
remarkable combinations of an ion channel and an 
enzyme, and the remaining channels.  
 
TRPM1, TRPM3 and TRPM8 
 Melastatin (TRPM1), the founder of the 
TRPM family, was identified in a screen of human 
melanoma-correlated mRNAs. In melanocytes, 
short and full-length TRPM1 mRNA transcripts 
are present. Decreased expression of the short 
transcript of TRPM1 correlates with increased 
invasiveness of malignant melanomas and it is 
therefore used as a diagnostic marker (Duncan et 
al., 1998). TRPM1 is widely expressed in different 
tissues, but functional and electrophysiological 
properties have not been studied extensively so far. 
Untill now, the only ion known to be conducted by 
full-length TRPM1 is Ca2+ (Xu et al., 2001). While 
the precise function of TRPM1 remains unclear, a 
putative role in cellular differentiation and 
proliferation was suggested by Fang et al. (Fang 
and Setaluri, 2000). The short, cytosolic isoform of 
TRPM1 may be responsible for correct trafficking 
of the full length TRPM1 protein to the plasma-
membrane (Xu et al., 2001) 
 The closest relative of TRPM1 is TRPM3, 
which is primarily expressed in human kidney and 
brain but not in mouse kidney (Grimm et al., 2003; 
Lee et al., 2003). Heterologous expression of 
TRPM3 results in formation of constitutive active, 
non-selective cation channels. Recently, 5 
alternatively spliced TRPM3 variants have been 
characterized (α1-5). Interestingly, 2 isoforms, 
TRPM3α1 and TRPM3α2, differ only in their pore 
region (Oberwinkler et al., 2005). Whereas the 
TRPM3 was originally reported to have linear I/V 
characteristics (Grimm et al., 2003), both α1 and 
α2 splice variants revealed outward rectifying ion 
currents regulated by intracellular Mg2+ 
(Oberwinkler et al., 2005). However, their ion 
selectivity is remarkably different: TRPM3α1 
channels are poorly permeable for divalent ions 
whereas TRPM3α2 conduct Ca2+ and Mg2+ rather 
well. Furthermore, TRPM3α2 channels are 
inhibited by extracellular monovalent ions whereas 
TRPM3α1 mediated currents are unaffected. 
 TRPM3 is reported to be regulated by 
osmolarity: in a hypotonic medium, the 
conductance of TRPM3 increased in amplitude 
(Grimm et al., 2003). In addition, activation of 
TRPM3 by store depletion (Lee et al., 2003) and 
by D-erythro-sphingosin (Grimm et al., 2005) was 
also reported.  
 The TRPM8 gene was identified as a prostate-
specific gene and it appears to be upregulated in 
prostate as well as other cancers (Tsavaler et al., 
2001). Heterologously expressed TRPM8 channels 
are activated by low temperatures (8 - 24°C) and 
by cooling agents such as menthol and icillin 
(McKemy et al., 2002; Peier et al., 2002; Nealen et 
al., 2003), which is consistent with a role in 
thermosensation and nociception. TRPM8 
channels permeate both monovalent and divalent 
ions and they are responsible for the intracellular 
Ca2+ elevations induced by menthol and icillin. 
TRPM8 currents display strong outward 
rectification and reverse around 0 mV. 
 Reponses to cold temperature and icillin 
depend on a physiological intracellular H+ 
concentration: lowering the pH inhibits TRPM8 
opening by these stimuli, but menthol-induced 
activation is unaffected (Andersson et al., 2004). 












 The PH-domain of PLCδ1 fused to Green 
Fluorescent Protein (GFP) detects PIP2 at the 
plasma-membrane and is widely used to study 
PIP2 kinetics in living cells by confocal laser 
scanning microscopy (Figure box 3A, (Stauffer 
et al., 1998; Varnai and Balla, 1998). 
Unstimulated cells have high PIP2 levels and 
GFP-PHd1 is bound to the membrane (Figure 
box 3A, inset 2). Receptor-activated PLCs 
hydrolyse PIP2 causing translocation of the 
PIP2 probe into the cytosol (Figure box 3A, 
inset 2). During resynthesis of PIP2, the 




 The principle of measuring PIP2 kinetics 
by Frequency Resonance Energy Transfer 
(FRET) is similar as described above. In stead 
of GFP, the color variants cyan (CFP) or 
yellow (YFP) are fused to PHδ1 and 
simultaneously expressed in living cells 
(Figure box 3B, (van der Wal et al., 2001)). 
Because the emission spectrum of CFP (donor) 
overlaps with the excitation spectrum of YFP 
(acceptor) radiationless transfer of energy 
occurs. Because of the high plasma-membrane 
PIP2 levels, the donor and acceptor are in close 
proximity (< 10 nM) and FRET appears as 
quenching of the donor and as gain of acceptor 
fluorescence (Figure box 3B). Upon hydrolysis 
of PIP2, CFP- and YFP-PHδ1 translocate to the 
cytosol. Consequently the distance increases 
between both fluorophores (> 10 nM) and 
FRET decreases. This leads to a decline in 
YFP emission and an increased CFP 
fluorescence (Figure box 3B, graph). When 
PIP2 levels are recovering, the FRET values 
increases. 
Figure box 3: Principles of imaging PIP2 kinetics in living cells 
 Cells transfected with FP-PHd1 and PIP2 dynamics are followed in time by either confocal laser 
scanning or bright field microscopy. During confocal experiments GFP is excited at 488 nM and GFP 
fluorescence detected at 525 nM. In FRET experiments, excitation occurs at 430 nM and fluorescence CFP 
and YFP are simultaneously recorded. 
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shift in voltage-dependence: low temperatures and 
cooling agents shift the voltage-dependence of 
TRPM8 negatively towards the physiological 
range (Voets et al., 2004a). Activity of TRPM8 
channels depends on the presence of PIP2 at the 
plasma-membrane that binds to the TRP-domain 
(Rohacs et al., 2005). Whole-cell and inside-out 
patch experiments produce rundown of TRPM8 
channels because of PIP2 depletion at the plasma-





 TRPM4 and TRPM5 are the only TRP 
channels impermeable to divalent ions: these 
channels selectively conduct monovalent ions and 
thereby depolarize the plasma-membrane (Launay 
et al., 2002; Hofmann et al., 2003; Prawitt et al., 
2003). Signaling of GPCRs via PLC and release of 
Ca2+ from the ER will activate these channels, 
although the precise mechanism is unclear. For 
activation of the channels relatively high Ca2+i 
levels are necessary, > 0.3μM for TRPM4 (Launay 
et al., 2002) and TRPM5 requires over 1μM of 
Ca2+i (Hofmann et al., 2003), suggesting that both 
channels may be in close proximity to Ca2+ release 
sites of the ER. The I/V plots of both TRPM4 and 
TRPM5 are non-linear as a result of an intrinsic 
voltage-sensing mechanism that is independent of 
divalent cation binding (Launay et al., 2002; 
Hofmann et al., 2003). Sustained exposure to Ca2+ 
desensitizes both channels, but administration of 
PIP2 reverses desensitization partially for TRPM5 
(Liu and Liman, 2003) and restores TRPM4 
currents fully (Zhang et al., 2005) 
 TRPM4 is ubiquitously expressed and 
possibly serves as a negative feedback regulator of 
Ca2+ oscillations (Launay et al., 2002): high Ca2+ 
levels during Ca2+ oscillations activate TRPM4, 
which subsequently depolarizes the plasma-
membrane and decreases the driving force for Ca2+ 
entry in non-excitable cells. In addition, in 
excitable cells TRPM4-mediated depolarization 
may be important in regulation of Ca2+ entry 
through voltage-gated Ca2+ channels, consequently 
shaping action potential duration and frequency. 
The TRPM5 gene was originally identified in a 
chromosomal region that is associated with several 
tumors (Enklaar et al., 2000), but a later study 
showed that TRPM5 is primarily found in taste 
receptor cells (Perez et al., 2002). The taste 
receptors T1R and T2R both signal via PLCβ2 to 
TRPM5. This signaling pathway mediates taste 
sensation of sweet, bitter and amino acid (Perez et 
al., 2002; Zhang et al., 2003).  
 
TRPM Channels with Intrinsic Enzymatic Activity 
 A separate group of TRPM channels is 
formed by TRPM2, TRPM6 and TRPM7. These 
three channels are characterized by a C-terminal 
enzyme moiety. TRPM2 channels posses a 
NUDT9 Nudix hydrolase motif (Perraud et al., 
2001), whereas TRPM6 (Schlingmann et al., 2002; 
Walder et al., 2002) and TRPM7 (Runnels et al., 
2001) both have a serine/threonine kinase at their 
C-terminus. Physiological and biophysical 
properties of TRPM7 will be discussed in detail in 
the following section.  
 TRPM2 forms a Ca2+ permeant non-selective 
ion channel that also conducts K+, Na+ and Cs+. It 
has linear I/V properties and reversal potential 
around 0 mV (Perraud et al., 2001). The channel is 
activated by binding of ADP-ribose (~100 μM), 
cADP-ribose (> 100μM) or NAD (> 1mM) to the 
Nudix motif, which is an inefficient hydrolase 
(Perraud et al., 2001; Sano et al., 2001; Kolisek et 
al., 2005). Interestingly, cADP-ribose (< 10μM) 
potentiates ADP-ribose-mediated TRPM2 
activation to nM concentrations (Kolisek et al., 
2005). Opening of TRPM2 channels is facilitated 
by intracellular Ca2+, but by itself Ca2+ can not 
activate the channel (Perraud et al., 2001; McHugh 
et al., 2003).  
 Furthermore, oxidative stress (hydrogen-
peroxide) and tumor necrosis factor α also regulate 
TRPM2 channel opening. Therefore, Hara and 
collaborators suggest that TRPM2 may act as an 
intracellular oxidation-reduction sensor (Hara et 
al., 2002). Prolonged exposure to oxidative stress 
concurrently results in increased Ca2+ levels and 
apoptosis of cardiac myocytes and hematopoietic 
cells (Zhang et al., 2005; Yang et al., 2005).  
 TRPM6 (also known as ChaK2) channel 
currents are carried by mono- and divalent cations. 
TRPM6 currents reverse around 0 mV and their 
I/V-plot is outward rectifying. Moreover, the 
current is strongly regulated by internal Mg2+ ions 
(Voets et al., 2004b). TRPM6 expression is 
predominantly expressed in intestinal epithelia and 
kidney tubules, and this has lead to the hypothesis 
that it is involved in uptake of Mg2+ in the gut and 
renal reabsorption of Mg2+ and Ca2+. Indeed, 
several mutations in TRPM6 are linked to a 
disorder in renal and intestinal Mg2+ and Ca2+ 
absorption that is known as familial 
hypomagnesemia with secondary hypocalcemia 
(FHSH,  Schlingmann et al., 2002; Walder et al., 
2002). Transport of TRPM6 to the plasma-
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membrane and subsequent incorporation is 
dependent on hetero-tetramerization with TRPM7. 
A missense mutation in TRPM6 abrogated 
oligomerization with TRPM7, providing a possible 
explanation for the impaired epithelial Mg2+ 
reabsorption in patients diagnosed with FHSH 




 TRPM7 (also kown as ChaK1, LTRPC7 and 
TRP-PLIK) shares many properties with TRPM6 
but it has been studied much more extensively. 
Like TRPM6, the TRPM7 currents are carried by 
cations and, at least in whole-cells, they display an 
outward rectifying I/V-plot (Runnels et al., 2001; 
Nadler et al., 2001). Monovalent TRPM7 currents 
are inhibited by internal Mg2+ ions, i.e. the 
channels display an anomalous mole fraction 
behavior that has also been termed ‘divalent 
permeation block’. In accordance, the I/V 
relationship linearizes in divalent-free solutions. 
 In addition, it was reported that depletion of 
intracellular Mg2+ (Prakriya and Lewis, 2002; 
Kozak and Cahalan, 2003) or Mg-nucleotides 
(Nadler et al., 2001; Demeuse et al., 2006) causes 
full activation of TRPM7 by a mechanism 
independent of Mg2+ permeation block (Kozak and 
Cahalan, 2003). A current with similar properties 
had been previously described as Mg-Nucleotide-
regulated Metal (MagNuM) ion current (Nadler et 
al., 2001) or Magnesium Inhibited Current (MIC) 
(Kerschbaum and Cahalan, 1998). Subsequent 
inhibitor studies demonstrated that TRPM7 is the 
carrier of this current (Kerschbaum et al., 2003).  
 Besides Ca2+ and Mg2+, TRPM7 provides a 
mechanism for entry of trace metal ions as Ni2+, 




 Whereas it was originally suggested that 
TRPM7 would be a good candidate to conduct 
ICRAC (Cahalan, 2001), detailed follow-up studies 
have now dismissed this idea. It was shown that 
biophysical and pharmacological properties of 
TRPM7 differ from those of ICRAC. For example, 
ICRAC is strongly selective for Ca2+ while TRPM7 
conducts both Mg2+ and Ca2+ (Runnels et al., 2001; 
Nadler et al., 2001). Unlike TRPM7, ICRAC is also 
impermeant to Mn2+ ions and has low Cs+ 
permeability. Furthermore, ICRAC displays a rapid 
desensitization in divalent-free media that is not 
seen in TRPM7. Inhibitor profiles of ICRAC and 
TRPM7 show distinct differences as well. In 
divalent free media, the aspecific Ca2+ entry 
blocker SKF 96365 fully inhibits ICRAC whereas 
TRPM7 currents are unaffected. Moreover, 
TRPM7 currents are insensitive to low 2-APB 
concentrations, while ICRAC is potentiated by this 
compound (Prakriya and Lewis, 2002).  
 The TRPM7 protein is ubiquitously expressed 
and TRPM7 knockout cells are not viable due to 
Mg2+ deficiencies. Therefore this channel was the 
first protein hypothesized to be directly involved in 
Mg2+ homeostasis (Schmitz et al., 2003). Knocking 
out the TRPM7 gene in mice is embryonically 
lethal at a very early stage (E6.5), showing the 
importance of the channel during development 
(Kim et al., 2005). A rare point mutation in 
TRPM7 was identified that increases the 
sensitivity of the channel to Mg2+ inhibition and 
that may contribute to the pathogenesis of 2 types 
of neurodegenerative disorders (Hermosura et al., 
2005). However, alternative functions for TRPM7 
have also been proposed, e.g. in proliferation of 
retinoblastoma cells (Hanano et al., 2004), anoxic 
cell death (Aarts et al., 2003) and in zebrafish 




 Since the cloning of TRPM7 it has been 
debated whether the kinase domain is involved in 
regulation of the channel gating. Initially it was 
reported that TRPM7 channel gating requires a 
functional kinase domain (Runnels et al., 2001). 
However, subsequent studies and our own data 
show that the channel gating can be dissociated 
from kinase activity and TRPM7 
autophosphorylation. Whole-cell currents and Ca 2+ 
influx through kinase-dead point mutants were 
indistinguishable from those of wild-type TRPM7 
(Schmitz et al., 2003; Matsushita et al., 2005; 
Clark et al., 2006). Complete deletion of the kinase 
domain caused a significant, but not complete, 
decrease in both Ca2+ influx and whole-cell 
currents. According to Matsushita, impaired 
trafficking to the plasma membrane or assembly of 
tetramers can not be excluded, since the expression 
levels of the deletion mutant were similar to the 
full-length construct (Matsushita et al., 2005). In 
contrast with observations made by Matsushita, 
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Schmitz and coworkers found that kinase-dead 
TRPM7 channels are less sensitive to inhibition by 
intracellular Mg2+. In their hands, the kinase-
deletion mutant did not affect channel conductance 
but it was more potently inhibited by Mg2+i 
(Schmitz et al., 2003). Overall, these reports 
support the view that the kinase domain is neither 
required for activation of the TRPM7 channel nor 
that it contains the internal Mg2+ sensor. 
 
TRPM7 Interacts with PLC Isozymes 
 The available evidence suggests that TRPM7 
contains a number of domains that are involved in 
PLC-mediated signaling. The channel was 
originally cloned in the lab of Dr. D. Clapham in a 
yeast-two-hybrid screen for interactors with 
PLCβ1. Analysis showed that this interaction 
involves the kinase domain of TRPM7 and the C2-
domain of PLCβ1  (Runnels et al., 2001). Later, it 
was shown that the kinase domain can also bind to 
the PLC isoforms β2, β3 and γ1 (Runnels et al., 
2002). As PLCγ1 was shown to contain a split PH 
domain that interacts with a complementary split 
PH domain in TRPC3 (Van Rossum et al., 2005), 
Figure 3: Putative domain structures of Drosophila TRP channels and the mammalian TRPM7 channel.  
 The protein sequence for both TRP (A) and TRPM7 (B) channels encodes for 6 hydrophobic transmembrane 
domains (red) and a pore region between the 5th and 6th domain. Downstream of the 6th transmembrane helix the TRP 
domain is located (orange), characteristic for all TRP channels. In TRP there is one putative Calmodulin-binding motif 
(green) directly downstream of the TRP domain. In silico analysis of the TRPM7 sequences revealed 5 putative CaM
motifs and one is topological similar to the one located in TRP. At the end of C-terminus, the TRP channel has an InaD 
binding and other features of TRP are a PEST sequence, proline-rich region with the dipeptide lysine-proline (KP) 
repeating 27 times. The TRP domain has a unique and curious hydrophylic sequence (8x9) near the C-terminus. The 
TRPM7 gene at the C-terminus encodes a unique α-kinase (yellow) with embedded a split PH domain (light green).
TRPM7 contains 2 putative PIP2 binding sites at the C-terminal side of the TRP domain (blue, see text for details), which
is followed by a coiled-coil region (purple). Amino acid analysis revealed several potential phosphorylation sites for 
PKA, PKC, CaM kinase II and tyrosine kinases. 
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we analyzed TRPM7 for the presence of such a 
split PH domain (van der.Krogt, unpublished). We 
used a search algorithm that was programmed in 
our lab to identify split PH domains similar to that 
of TRPC3. Interestingly, a partial PH-domain 
complementing the C-terminal half of the PLCγ1 
split PH-domain is located in the TRPM7 kinase 
(see Figure 3). Therefore we anticipate that the 
PLCγ1 interaction with TRPM7 mediates 
trafficking to the plasma-membrane  
 
TRPM7 Functioning is Dependent on PIP2
 The function of many TRP channels, 
including TRPM4, TRPM5 and TRPM8, depend 
on the presence of PIP2 at the plasma-membrane. 
A role for PIP2 in regulating TRPM7 has also been 
claimed (Runnels et al., 2002). Runnels observed 
that when TRPM7 channels were pre-activated by 
depletion of intracellular Mg2+ in whole-cells or 
inside-out patches, agonist-induced PIP2 
hydrolysis potently closed the channels. 
Subsequent addition of PIP2 to the intracellular 
leaflet of the plasma membrane restored the 
conductance (Runnels et al., 2002).  
 This report has been the source of much 
confusion. First, an inhibitory role for PLC 
signaling contradicts observations that we had 
obtained earlier (Chapter 2 & 3, Clark et al., 2006). 
We found that activation of PLC activates TRPM7 
channels, as detected by morphological and 
electrophysiological methods as well as using Ca2+ 
fluorometry. In Chapter 2 and 3, this issue is 
addressed in detail.  
 Second, the results of Runnels were also 
challenged by Takezawa and colleagues 
(Takezawa et al., 2004). They observed that upon 
pretreatment with the “specific” PLC inhibitor 
U73122 endogenous PLC-activating receptors 
were still able to inhibit TRPM7 currents and 
concluded that PLC signaling is not involved. 
However, Takezawas’ data do not justify such as 
strong conclusion (see Chapter 3) because U73122 
is NOT a specific inhibitor for PLC. Rather, it 
interferes with several GPCR-effector interactions 
(Balla, 2001) thereby additionally blocking e.g. 
phospholipase A2 and phospholipase D signaling 
pathways. U73122 is quite unstable and it rapidly 
looses its inhibitory potential in solution. 
Furthermore, in our lab we observed that 
application of freshly prepared U73122 solution to 
cells caused a rapid drop in membrane [PIP2], 
thereby inactivating Mg2+ depletion-induced 
TRPM7 currents (Chapter 3). Horowitz and Hille 
recently reached a similar conclusion for the 
effects of U73122 on M-type K+ channels 
(Horowitz et al., 2005).  
 A further interesting twist was recently added 
by Kozak and coauthors (Kozak et al., 2005). 
These authors reported that cytosolic acidification 
inhibits both TRPM7 currents and endogenous 
MIC currents, and they showed that both can be 
rescued by application of PIP2 in inside-out 
patches (Kozak et al., 2005). As a mechanism, they 
proposed that protons might exert this regulatory 
action by charge-screening of the negatively 
charged PIP2 moieties. Taken together, most 
results point out that PIP2 at the plasma-membrane 
is essential for keeping TRPM7 channels in an 
open conformation.  
 
Putative Mechanisms of TRPM7 Regulation by PIP2
  PIP2 may be important for TRPM7 currents 
through an interaction with the intermolecular 
(split) PH-domain, or via interactions independent 
of this domain. Indeed, sequence analysis 
identified 2 other putative PIP2 interaction sites in 
TRPM7 (Dr. T. Balla, NIH, Bethesda, personal 
communication). Downstream of the TRP domain 
a short stretch of positively charged amino acids 
(1147 to 1153) is likely to interact with negatively 
charged inositol headgroups of PIP2, and at amino 
acids 1196 to 1218, a stretch including positive 
residues may form a modular PIP2 binding pocket 
that is analogous to a PIP2-binding stretch in 
TRPV1 (Prescott and Julius, 2003). In several 
other PIP2-regulated TRP channels including 
TRPM8, TRPM5 and TRPV5, the TRP-domain 
was reported to be responsible for PIP2 binding 
and for maintaining the channel in an activated 
state (Rohacs et al., 2005); this TRP consensus 
sequence is an additional candidate site of PIP2 
interactions in TRPM7. The interaction between 
PIP2 and TRPM7 at the plasma-membrane most 
likely reflects an electrostatic interaction (Kozak et 
al., 2005) rather than the ‘key-and-lock’ binding 
observed in PH domains. In conclusion, loss of 
PIP2 binding to TRPM7 may underlay both cation 
interferences and PLC-mediated closure of 
TRPM7 channels.  
 
Regulation of TRPM7 by cAMP Levels 
 As mentioned above, Takezawa and 
colleagues challenged a role for PIP2 in regulating 
TRPM7 based predominantly on inhibitor studies 
using U73122. Instead, they observed that a 
decrease in intracellular cAMP levels after 
muscarinic receptor activation is responsible for 
TRPM7 current inhibition and that this effect 
depends on a functional TRPM7 kinase domain. 
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On the other hand, a raise in intracellular cAMP 
levels increased Mg2+-depletion-activated TRPM7 
currents. Inhibition of PKA prevented carbachol-
mediated inhibition of TRPM7 currents (Takezawa 
2004). Hence, alterations in cytosolic cAMP levels 
effects PKA activity and by this means regulate 
TRPM7 currents. Our in silico analysis of the 
TRPM7 amino acid sequence revealed that it 
contains several putative PKA phosphorylation 
sites that may be involved in regulation of TRPM7 





 A final possible mechanism of TRPM7 
current/channel activation must also be mentioned 
here. By analogy to TRPC3 (Singh et al., 2004) 
and TRPC5 (Bezzerides et al., 2004), it is 
conceivable that TRPM7 currents may be activated 
by fusion of vesicles that contain pre-assembled 
TRPM7 channels with the plasma-membrane. 
Whereas the precise signaling steps involved in 
such regulation are unclear, it is possible that PIP2-
recognizing sequences (including the split PH 
domain) are involved in this process. Interestingly, 
Oancea et al (Oancea 2006) recently showed that 
shear force induced by fluid flow gave rise to some 
incorporation of native TRPM7 channels in the 
plasma membrane in vascular smooth mucle cells. 
How significant the increase is, and whether it is a 
general mechanism that is also effective in other 




 If the TRPM7 kinase domain does not 
regulate channel gating, what role does it fulfill in 
living cells? The majority of the eukaryotic protein 
kinases belong either the serine/threonine kinase 
family or to the tyrosine kinase family that 
together comprise the so-called “conventional 
protein kinases” or CPKs (Taylor et al., 1992). The 
human genome further encodes kinases that share 
sequence homology to this group and are distantly 
related to CPKs, for example the phosphoinositol-
3-kinases (Hunter, 1995). In addition there are 
kinase known that have no sequence homology to 
CPKs, although they are structurally similar. The 
TRPM7 kinase is an example of this group 
(Yamaguchi et al., 2001). These kinases are known 
as α-kinases and the name refers to the capability 
of these kinases to phosphorylate amino acids 
located within an α-helix (Ryazanov et al., 1999). 
The TRPM7 kinase domain shares 28% homology 
to the myosin heavy chain kinase A of 
Dictyostelium, a member of the α-kinase family 
involved in regulation of myosin stability (Kolman 
et al., 1996). 
 
Substrates of the TRPM7‐Kinase 
 In vitro characterization of the catalytic 
domain of TRPM7 showed that it is subject to 
autophosphorylation and shows kinase activity 
towards myelin basic protein (MBP), a 
promiscuous substrate used as a control in many in 
vitro kinase assays. The kinase domain specifically 
uses ATP as substrate and is unable to use GTP, 
and it depends on the presence of Mg2+ (optimum 
at 4-10 mM). Importantly, increased Ca2+ 
concentrations up to 1 mM did not alter kinase 
activity (Ryazanova et al., 2004).  
 A follow-up study by the group of Ryazanov 
identified an intriguing substrate for TRPM7-
kinase, namely annexin-1, an anti-inflammatory 
protein that is regulated by Ca2+ and can bind actin 
filaments (Dorovkov and Ryazanov, 2004). An 
evolutionary conserved serine located in α-helix at 
the N-terminus of annexin-1 is phosphorylated by 
the TRPM7 kinase. Phosphorylation of annexin-1 
depends on the presence of Ca2+ (500μM) and 
EGTA almost completely prevents annexin-1 
phosphorylation.  
 We have identified non-muscle myosin IIA 
heavy chain (MHC IIA) as an additional substrate 
for TRPM7 kinase (chapter 4, Clark et al., 2006). 
Like all myosin II isoforms, MHC IIA organizes 
into homo-dimers consisting of a long α-helical 
domain and a short head domain that interacts with 
actin filaments. Starting point for this study was 
the observation of F. van Leeuwen that bradykinin 
causes MHC IIA phosphorylation in N1E-115 
cells, which leads to dissociation of actin filaments 
from MHC IIA, and consequent loss of 
contractility that is apparent as a marked cell 




 The actin cytoskeleton controls many cellular 
functions, such as intracellular transport, and 
phagocytosis but also cell adhesion and migration. 
Actin is organized into filaments, held together by 
a number of actin bunding proteins. Membrane 
protrusive activity (force) can be generated by 
26 
Introduction 
actin polymerization, which occurs at the leading 
edge of migrating cells, for instance in response to 
a chemotactic stimulus (Small, 1981; Burridge et 
al., 1988; Small et al., 1995). In addition, actin 
filaments can generate intracellular forces 
(tension) by associating with myosins. Similar to 
muscle, also in non-muscle cells myosin II 
isoforms are the major motor proteins responsible 
for force generation (Redowicz, 2001). However, 
important differences exist between muscle and 
non-muscle myosin II isforms. Whereas in muscle 
cells, myosin II is assembled in stable, regularly-
patterned myofibrils, in non-muscle cells myosin II 
is part of the dynamic actomyosin cytoskeleton 
that undergoes continuous remodeling in order to 
accommodate changes in cell adhesion and cell 
shape, for instance during cell migration (Burridge 
and Chrzanowska-Wodnicka, 1996). 
 As mentioned previously, we find that 
TRPM7 affects actomyosin function by Ca2+- and 
kinase-dependent phosphorylation of MHC IIA. 
Activation of TRPM7 by GPCRs results in 
cytoskeletal relaxation, leading to increased cell 
spreading. Simultaneously, cells increase their 
adhesion to the extracellular matrix accompanied 
by the formation of large integrin-containing 
adhesions (Chapter 4, Clark et al., 2006). 
 We have proposed that TRPM7 may, at least 
in part, affect actomyosin function by 
phosphorylation of the myosin II heavy chain. 
However, additional (kinase-dependent and -
independent mechanisms) may contribute to 
TRPM7-induced cytoskeletal remodeling. For 
instance, it was shown by Dorokov et al that 
TRPM7 can phosphorylate annexin-1 (Dorovkov 
and Ryazanov, 2004), a protein known to bundle 
actin filaments independent of Ca2+ (Campos-
Gonzalez et al., 1990; Kusumawati et al., 2000). 
Furthermore, annexin-1 can interact with profilin 
and plasma-membrane lipids PIP2 and 
phosphatidylserine (Alvarez-Martinez et al., 1996). 
This suggests that TRPM7-mediated 
phosphorylation of annexin-1 may regulate 
cytoskeletal structures. Additionally, we find that 
some of the effects of TRPM7 on cell spreading 
appear to be independent of kinase activity 
(Chapter 4, Clark et al., 2006). 
 Altogether, the picture emerges that TRPM7 
plays a pivotal role in the regulation of the 
cytoskeleton and that regulation occurs at multiple 
levels (Chapter 4, Clark et al., 2006). 
Actomyosin Regulation by Rho 
and Rac Proteins 
 Actomyosin regulation in response to cell 
surface receptors is controlled by GTP binding 
proteins of the Rho family. Of particular relevance 
to this thesis are the small GTPases RhoA and 
Rac1. Activation of RhoA increases actomyosin 
contractility by increasing phosphorylation of the 
myosin II regulatory light chain (MLC) 
(Chrzanowska-Wodnicka and Burridge, 1996). 
Increased phosphorylation of the MLC can be 
achieved via 2 separate Rho signaling pathways; 
first, activated Rho stimulates MLC kinase and 
Rho-kinases (ROCK, ROK) to phosphorylate 
MLC (Amano et al., 1996), and secondly, Rho-like 
GTPases are also able to inhibit MLC 
phosphatases (Kimura et al., 1996). 
 The effects of Rac1 on actomyosin function 
are often opposite to that of Rho. Rac activation by 
stimulation of growth factor receptors causes 
lamellipod formation and membrane ruffling 
(Ridley et al., 1992). The driving force for 
lamellipodia formation and membrane ruffling is 
Rac-induced actin polymerization. Rac can 
accomplish this through activation of the Arp2/3 
complex which associates with members of the 
conserved WASP family (Miki et al., 2000; Eden 
et al., 2002). While Rho activity is the major 
determinant of actomyosin contraction, the small 
GTPase Rac1 promotes actomyosin relaxation by 
antagonizing RhoA (van Leeuwen et al., 1997; 
Kozma et al., 1997). A similar Rho/Rac 
antagonism was shown to be important during the 
formation and maintenance of focal adhesions 
(Rottner et al., 1999). As all of these studies show, 




 In common with other small GTPases, Rho 
and Rac act as molecular switches. Inactive small 
GTPases are in a GDP-bound state, and receptor 
stimulation causes activation by stimulating 
exchange of GDP for GTP. Hydrolysis of GTP by 
the intrinsic, low GTPase activity of these proteins 
terminates the activated state. Three types of 
regulatory proteins influence this balance: Guanine 
Nucleotide exchange Factors (GEFs) that speed up 
the exchange of GDP for GTP, GTPase Activating 
Proteins (GAPs) that dramatically enhance the low 
intrinsic GTPase activity, and GTPase Dissociation 
Inhibitors (GDIs) that stabilize small GTPases in 
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their inactive conformation (Nobes and Hall, 
1995). It is the active conformation of the small 
GTPases that is located primarily at membranes 
and that interacts with the target proteins. 
 The mode of activation of Rho and Rac is 
complex and involves several signaling pathways. 
Gα12/13-coupled receptors such as those for LPA 
and thrombin can trigger Rho via GAPs (Jalink et 
al., 1994; Hart et al., 1998; Kozasa et al., 1998). In 
addition, we found a new PKC mediated signaling 
pathway that leads to increased Rac activity at the 
plasma-membrane: elevation of cytosolic Ca2+, 
originating either from intracellular stores or 
extracellular Ca2+ entry, sufficed to activate a Ca2+-
sensitive PKC that in turn enhanced Rac 
translocation to the plasma-membrane (Chapter 5, 
(Price et al., 2003). 
 To add to the regulatory complexity, Rac can 
bind to and activate both PI(4,5)-kinase and PI(3)-
kinase (Tolias et al., 1995). Inhibition of PI(3)-
kinase, the kinase that produces PIP3 from PIP2 at 
the membrane, prevented growth factor induced 
membrane ruffling but could not block ruffling 
induced by expression of activated Rac (Nobes and 
Hall, 1995). Many RacGEFs are capable of 
binding to PIP2 and PIP3 with their PH-domain, 
and recruit Rac GTPases to the plasma-membrane 
to activate them (Schmidt and Hall, 2002; Mertens 
et al., 2003). In addition to phosphoinositide 
dependent activation, binding of the p85 subunit of 
PI(3)-kinase to RacGEFs also results in activation 





 Both Rho and Rac are involved in formation 
and maturation of focal adhesion structures. Focal 
adhesions are large multi-protein complexes that 
anchor cells to the extracellular matrix and 
function as attachment for stress fibers. Cells can 
sense mechanical forces through focal adhesions, 
and the cytoskeleton is strongly influenced by 
these mechanical forces. I will here review some 
of the literature on this topic to provide a 
background for the work presented in Chapter 4 & 
5. 
 Focal complexes arise from nascent integrin 
containing adhesive contacts that form at the 
leading edge of migrating cells and can grow out 
to focal adhesions. The formation of focal 
complexes depends on Rac, but not Rho (Rottner 
et al., 1999), but what triggers their formation is 
not well understood. When cells attach to the 
extracellular matrix, translocation of Rac to the 
plasma-membrane (del Pozo et al., 2000) may 
trigger the formation of focal complexes by 
inducing actin polymerization and branching 
followed by integrin clustering (Kraynov et al., 
2000). Different Rac effectors may mediate these 
effects. Activation of PI(5)P-kinases mediated by 
Rac increases PIP2 levels, which results in 
uncapping of actin filaments (Tolias et al., 2000). 
Other effectors implicated in focal complex 
formation are the WAVE/Scar complex 
(Machesky et al., 1999) and the serine-threonine 
kinase PAK (Edwards et al., 1999). 
 The maturation of focal complexes to focal 
adhesions requires activation of RhoA, although 
again, the exact mechanism is still poorly 
understood. It has been shown that the combined 
action of 2 Rho effectors, Rho kinase ROCK and 
diaphanous protein Dia1, can substitute for active 
Rho in the process of focal adhesion assembly 
(Watanabe et al., 1999). It was suggested, on the 
based on rather indirect evidence, that Dia 
promotes actin polymerization by targeting profilin 
and possibly by enhancing its function (Watanabe 
et al., 1997). Furthermore, similar to WASP, Dia 
may directly activate Arp2/3 (Alberts, 2001). On 
the other hand, formation of focal adhesions relies 
on increased myosin II-mediated contractility 
which is due to increased myosin light chain 
phosphorylation by inactivation of MLC 
phosphatases and/or activation of MLC kinases 
(Amano et al., 2000).  
 Podosomes are a third type of cell-matrix 
adhesion relevant for this thesis. Podosomes are 
integrin containing adhesions, clearly distinct from 
focal adhesions, which are a characteristic feature 
of cells that have the capacity to cross tissue 
boundaries. Examples are monocyte-derived cells 
(Marchisio et al., 1984) but also carcinoma-derived 
epithelial cells (Spinardi et al., 2004). Podosomes 
are anchored to the extracellular matrix through 
integrins and can develop from existing focal 
adhesions (Moreau et al., 2006) or are de novo 
synthesized by attachment to the matrix (Gaidano 
et al., 1990). Podosomes have a distinct dense core 
of F-actin and each podosome is surrounded by 
ring structure enriched proteins such as vinculin, 
α-actinin (David-Pfeuty et al., 1980) and 
regulators of contractility, e.g. myosin II isoforms 
and TRPM7 (Clark et al., 2006). Podosome 
structures share similarities with focal adhesion but 
contrast on several points. First of all, the actin 
core of podosomes contains proteins that regulate 
28 
Introduction 
actin polymerization, such as WASP, Arp2/3 and 
gelsolin that are absent in focal adhesions 
(Marchisio et al., 1988). Second, formation of 
podosomes frequently occurs from rapid and 
dynamic turnover of pre-existing podosomes 
(Stickel and Wang, 1987), while focal adhesions 
are less dynamic and formation requires 
continuous protein synthesis. At last, podosomes 
may remodel and tubulate the plasma-membrane 
(Burgstaller and Gimona, 2005). Furthermore 
ECM-degrading metalloproteases localize to 
podosomes (Sato et al. 1997; Delaisse et al. 2000). 
These observations point out that podosomes are 




 Cells and their cytoskeleton are continuously 
subjected to mechanical forces due to both 
physical interactions with the extracellular matrix 
and their own contractile machinery. Sensing 
mechanical forces induced by the cells’ 
environment is critical for processes such as 
motility, adhesion, proliferation and apoptosis 
(Geiger et al., 2001; Burridge and Wennerberg, 
2004). Therefore, cells have developed “force 
receptors” for mechanosensing that are still poorly 
characterized. Two types of protein complexes 
have been proposed to sense these forces, namely 
focal adhesions and ion channels. As we speculate 
(Chapter 4) that TRPM7 may act as a 
mechanosensor, or is involved in mechano-





 Several lines of evidence indicate that 
integrin-mediated adhesion is involved in sensing 
mechanical stress. Application of forces to cells 
causes strengthening of their anchorage to the 
extracellular matrix. This depends on both 
clustering and occupancy of the integrins that link 
the cytoskeleton to the extracellular matrix at the 
adhesion sites (Wang et al., 1993; Choquet et al., 
1997; Geiger et al., 2001). Focal adhesions are 
capable of adjusting their size to the degree of 
mechanical force applied. Application of force to 
either the cell (Riveline et al., 2001) or to the 
(flexible) matrix (Wang et al., 2001) transforms 
the focal complexes into mature focal adhesions. 
The tension that focal adhesions “sense” regulates 
both their maintenance and growth. Relieve of this 
tension, by inhibition of myosin-driven 
contractility, causes rapid disassembly of focal 
adhesions (Geiger et al., 2001). Furthermore, 
applied tension also determines the vinculin 
content in focal adhesions (Opazo et al., 2004). 
These local effects of force-induced changes in 
integrin-mediated adhesion indicate that focal 
adhesions can act as sensors for detection of 
internal or external forces.  
 How exactly focal adhesions detect forces is 
still poorly understood. One possibility is that 
tension reorganizes the molecular structure of focal 
adhesions, thus allowing additional cytosolic 
components to be incorporated. Force-driven 
maturation of focal complexes to focal adhesions 
is accompanied by an increase in αvβ3 integrins 
(Ballestrem et al., 2001). Furthermore, β3 integrins 
can move into individual focal adhesions in an 
energy- and myosin II-dependent manner (Tsuruta 
et al., 2002)). Another possible mechanism relies 
on intrinsic properties of some of the molecules of 
the focal adhesion complex. Focal adhesion 
associated proteins like vinculin, fibronectin and 
possibly αβ integrin dimers exist in an active 
(open) or inactive (closed) conformation (Alberts, 
2001; DeMali et al., 2002). Normally, the 
transition between active and inactive 
conformation results from signaling involving 
kinases, phosphatases and changes in membrane 
lipid composition, but Geiger hypothesized that 
mechanical forces may similarly expose previously 
hidden interaction sites (Geiger et al., 2001).  
 
Mechanosensation by Ion Channels 
 Membrane tension caused by mechanical 
forces can also be sensed by specialized ion 
channels (Gustin et al., 1988; Martinac, 2004). A 
wide variety of mechanosensitive or stretch-
activated channels (SAC) are found in all 
prokaryotic and eukaryotic cells. In eukaryotic 
cells, 4 different families of ion channels have 
been implicated in sensing mechanical forces: the 
mechano-sensitive K+ channels TREK and 
TRAAK, Na+-selective MEC/DEG (for 
mechanosensory abnormal/degenerins) channels, 
ClC Cl- channels and TRP channels.  
 Other ion channels potentially involved in 
sensing mechanical forces are linked to the actin 
cytoskeleton and protein complexes within focal 
adhesions. In flies it has been demonstrated that 
the TRP family member TRPN1 (NOMPC), which 
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binds to actin via the channels N-terminal ankyrin 
repeats, contributes to bristle mechanosensation 
(Walker et al., 2000) and the zebrafish homologue 
mediates mechanoreception in hair cells (Sidi et 
al., 2003). Mammals do not have a TRPN1 
homologue, but recently the TRPA1 channel was 
implicated in mammalian nociception and hair cell 
transduction (Nagata et al., 2005).  
 Two modes of force detection by ion channels 
have been suggested. First, changes in intrinsic 
forces (lateral pressure) generated by lipid bilayer 
composition may regulate channel opening and 
closure (Kung, 2005). Secondly, mechanical 
tension may be transduced via either intracellular 
linkers (mainly the actin cytoskeleton) or external 
anchors to the channel pore to modulate the 
intracellular ion concentration (Gillespie, 2002). In 
this view, Howard hypothesized that the repetitive 
ankyrin repeats of TRPN1 form a helical turn that 
can act as a gating spring for channel opening 
(Howard and Bechstedt, 2004). Mechanosensation 
is not limited to specialized cells in sensory 
organs, but all adherent cells can sense mechanical 
forces. The external environment is probed by cells 
by applying actomyosin-driven forces to cell-
matrix or cell-cell adhesion sites. In turn, the 
adhesion sites respond to these forces by changes 
in size, dynamic behavior and by signaling events 
(Geiger et al., 2001).  
 In view of the above, it is tempting to 
speculate that TRPM7 may act as a 
mechanosensory channel. Interestingly, in 
endothelial cells it was recently shown that 
TRPM7 ion channels become embedded into the 
plasma-membrane in response to fluid flow shear 
forces (Oancea et al., 2006). This may cause local 
Ca2+ influx at the plasma-membrane through 
TRPM7 channels located around focal adhesions. 
Subsequent Ca2+-dependent myosin II 
phosphorylation or other TRPM7-mediated effects 
on MHC IIA activity, may induce the 
transformation of focal adhesions into podosomes 
as well as contribute to de novo formation of 
podosomal-like adhesions (Clark et al., 2006). 
Similarly, a recent report of Su et. al. has also 
implicated  TRPM7 in regulation of cell adhesion 
(Su et al., 2006) 
 
Overview of This Thesis 
 In this thesis, we address the regulation of 
TRPM7 channels by receptor-mediated signals and 
the effects of the ensuing ionic signals on the 
cytoskeleton. In Chapter 2 signaling pathways 
were investigated that activate TRPM7 channel 
opening. We show that PLC-activating receptors 
open TRPM7 channels, leading to influx of 
extracellular Ca2+. The results presented in this 
chapter contrast markedly with a report by Runnels 
et al that appeared during our studies who showed 
inhibition of TRPM7, rather than activation, by 
PLC. In Chapter 3 we present experiments that 
explain these discrepancies: we explored the 
differences in PIP2-mediated regulation of TRPM7 
measured in perforated-patch and whole-cell 
configuration after intracellular Mg2+ depletion. 
This leads us to propose that the effects of PLC 
activation on TRPM7 currents as detected in whole 
cells can best be viewed as ‘accelerated rundown’ 
rather than as bona fide signal transduction.  
 In Chapter 4 we examine how agonist-
induced TRPM7 activation and subsequent Ca2+ 
influx affect the cytoskeleton. It is shown that 
TRPM7 phosphorylates the myosin II heavy chain 
to promote cytoskeletal relaxation and the 
conversion of focal adhesions to podosomes. Ca2+ 
influx appears crucial for the in vivo function of 
the TRPM7-kinase by triggering the association 
between the kinase and its substrate. In Chapter 5, 
we report that receptor-mediated Ca2+ influx can 
affect the cytoskeleton by translocating Rac in a 
PKC-dependent manner to the plasma-membrane, 
where it induces extensive membrane ruffling.  
 In conclusion, intracellular Ca2+ elevations 
agonist-induced due to channel activation affects 
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 TRPM7 is an ubiquitously expressed non-
specific cation channel that has been implicated 
in cellular Mg2+ homeostasis. We recently 
showed that moderate overexpression of 
TRMP7 in neuroblastoma N1E-115 cells 
elevates Ca2+ levels and markedly increases cell-
matrix adhesion. We also found that activation 
of TRPM7 by phospholipase C (PLC)-coupled 
receptors further increased Ca2+ levels and 
augmented cell adhesion and spreading in a 
Ca2+-dependent manner (Clark et al., 2006). 
 Regulation of the TRMP7 channel is not 
well understood, although it has been reported 
that PIP2 hydrolysis closes the channel. We here 
addressed TRPM7 regulation by GPCR 
agonists. Using FRET assays for second 
messengers we show that TRPM7-dependent 
Ca2+ increases correlate with PLC activation, 
but not with other GPCR signaling cascades. In 
non-invasive “perforated-patch clamp” 
recordings TRPM7 currents are also activated 
by PLC agonists. Whereas we could confirm 
that, under whole-cell conditions, the channels 
were significantly inhibited by PLC-activating 
agonists, TRPM7 current inhibition by PIP2 
hydrolysis was only observed when [Mg2+]i was 
reduced below physiological levels. Thus, under 
physiological [Mg2+]i conditions, TRPM7 




 TRPM7 is an ubiquitously expressed non-
specific cation channel that, intriguingly, contains 
a C-terminal serine-threonine kinase domain. It 
belongs to the TRPM (Melastatin-related) 
subfamily of Transient Receptor Potential (TRP) 
channels that transduce sensory signals (Clapham, 
2003). TRPM7 appears essential for life in that 
knock-out or overexpression of the channels 
caused growth arrest, loss of adhesion and rapid 
cell death (Nadler et al., 2001; Schmitz et al., 
2003; Su et al., 2006). We recently discovered that 
low-level overexpression of TRMP7 induces cell 
spreading and adhesion and that its´ activation by 
PIP2-hydrolyzing receptor agonists leads to the 
formation of adhesion complexes in a kinase-
dependent manner (Clark et al., 2006). 
 Currents of TRPM7 channels exogenously 
expressed in mammalian cells have been analysed 
by several groups. In physiological solutions, the 
channel conducts mainly Ca2+ and Mg2+ (Runnels 
et al., 2001), but in the absence of these divalents 
K+ and Na+ (Nadler et al., 2001; Runnels et al., 
2001) are passed efficiently. A characteristic 
feature is the inhibition of this current by 
physiological intracellular Mg2+ levels: in whole-
cell patch clamp experiments, large outward 
rectifying TRPM7 currents (Runnels et al., 2001; 
Nadler et al., 2001; Kerschbaum et al., 2003) are 
revealed by perfusion with Mg2+-free pipette 
solutions. Furthermore, MgATP and MgGTP also 
inhibit the channels (Nadler et al., 2001; Demeuse 
et al., 2006) although some controversy was raised 
on this topic (Kozak et al., 2002). TRPM7 currents 
have been termed MagNuM (for Mg2+-Nucleotide 
sensitive Metal ion (Nadler et al., 2001)) or MIC 
(for Mg2+-Inhibited Cation (Kozak et al., 2002)) 
currents. These terms will here be used 
interchangeably to reflect whole-cell currents 
evoked by internal Mg2+ depletion. MagNuM/MIC 
currents revert around 0 mV; the inward currents 
are predominantly carried by divalent cations, 
whereas outward currents consist mainly of 
monovalent cations (at low [Mg2+]i). TRPM7 
currents lack voltage- and time-dependent 
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activation (Nadler et al., 2001; Runnels et al., 
2001), and outward rectification is most likely due 
to divalent permeation block of inward currents at 
negative potentials (Nadler et al., 2001). 
Accordingly, perfusion with divalent-free 
extracellular solutions augments inward currents 
and causes the I/V relationship to become linear. 
The activation of TRPM7 by internal perfusion 
with Mg2+-free solutions does not rely on 
permeation block, but the precise mechanism of 
action has not been solved yet (Kozak et al., 2002). 
Several reports document that the setpoint for 
[Mg2+]i sensitivity is governed by the kinase 
domain; however, constructs lacking the entire 
kinase domain can still be activated by internal 
Mg2+ depletion (Schmitz et al., 2003; Schmitz et 
al., 2005; Matsushita et al., 2005). Thus, the 
interactions of TRPM7 with Mg2+ are complex: 
Mg2+ is conducted through the channel pore, 
causes voltage-dependent permeation block, and 
influences gating at the cytosolic surface. 
 The exact mechanisms by which receptor 
agonists regulate TRPM7 are less well 
characterized and the published data are, at least 
partly, conflicting. An initially claimed 
indispensable role for the kinase domain (Runnels 
et al., 2001) was challenged in subsequent studies 
(Schmitz et al., 2003; Takezawa et al., 2004; 
Matsushita et al., 2005; Schmitz et al., 2005). 
Rather, we recently showed that the TRPM7 α-
kinase specifically phosphorylates the heavy chain 
of myosin-II (Clark et al., 2006) thereby strongly 
influencing cell adhesion. Importantly, association 
with- and subsequent phosphorylation of myosin-II 
depend on prior activation of the channel by PLC-
coupled receptors, and influx of extracellular Ca2+ 
constitutes an essential step in this process (Clark 
et al., 2006). In accordance, TRPM7 binds directly 
to several PLC isoforms, including PLCγ and 
PLCβ (Runnels et al., 2002). The stimulatory 
effect of PLC on TRPM7 observed in intact cells 
by biochemical-, cell-biological- and live-cell 
imaging studies contrasts markedly with a report 
by Runnels et al (Runnels et al., 2002) that in 
HEK-293 cells whole-cell TRPM7 currents are 
potently inhibited by carbachol-induced PIP2 
hydrolysis. PIP2-dependent gating also occurs in 
other TRP family members, including TRPV1 
(Prescott and Julius, 2003), TRPM5 (Liu and 
Liman, 2003) and TRPM8 (Liu and Qin, 2005; 
Rohacs et al., 2005). Finally, in a recent study 
Takezawa and colleagues (Takezawa et al., 2004) 
reported that in HEK-293 cells (expressing only 
endogenous muscarinic receptors) carbachol 
attenuated TRPM7 currents via the Gs-cAMP 
signalling pathway, whereas PLC activation was 
not involved. 
 As thus regulation of TRPM7 detected in 
whole-cell experiments appears to differ from our 
cell-biological studies, we here address the effects 
of GPCR stimulation by non-invasive techniques 
in cells retrovirally transduced to overexpress 
TRPM7 at very low level. We combine FRET 
assays for second messengers with Ca2+ 
fluorometry and perforated-patch experiments to 
show that opening of TRPM7 correlates well with 
PLC, but not with cAMP or cGMP signaling. We 
also address why in our observations the effect of 
PLC activation appears opposite to that obtained in 
whole-cell by comparing both approaches under 
various ionic conditions. Strikingly, in perforated 
patches TRPM7 currents can be evoked by 
treatment with the membrane-permeable Mg2+ 
chelator EDTA-AM, and these currents are 
inhibited, rather than augmented, by PLC-
activating agonists. We conclude that in intact cells 
TRPM7 currents are enhanced, rather than 




 Amphotericin B, MgATP, bradykinin, 
lysophosphatidic acid, spermin, La(NO3)3, 
Gd2(CO3)3, sodium nitroprusside, prostaglandin 
E1, and niflumic acid were from Sigma-Aldrich 
Co. (St. Louis, MO). Oregon Green 488 BAPTA-1 
AM, Fura Red AM, Indo-1 AM, o-nitrophenyl-
EGTA AM, pluronic F127 and BAPTA-AM were 
from Molecular Probes Inc. (Eugene, OR). 
Ionomycin, 2-APB, SKF 96365, IBMX, forskolin, 
neurokinin A (NKA) and thapsigargin were from 
Calbiochem-Novabiochem Corp. (La Jolla, CA). 
Salts were from Merck (Darmstadt, Germany). 
Dulbecco’s MEM, foetal calf serum, penicillin and 
streptomycin were obtained from Gibco BRL 
(Paisley, Scotland). Neomycin was purchased from 
Invitrogen-Life technologies (Breda, the 
Netherlands). FuGene 6 transfection reagent was 




 Mouse TRPM7 in pTracer-CMV2 was a kind 
gift from Dr. D. Clapham (Harvard, Boston, Ma). 
To generate retroviral expression vectors, the 




fragment into the LZRS-ires-neomycin vector. For 
production of recombinant protein in bacteria a pcr 
product encoding amino acids 1748 to 1862 of 
TRPM7 was cloned in frame in pGEX-1N using 
BamHI and EcoRI sites. All constructs were 
verified by sequencing. The PIP2 FRET sensor 
(eCFP-PHδ1 and eYFP-PHδ1) was previously 
generated in our lab as described (van der Wal et 
al., 2001). The genetically encoded cAMP sensor 
was a kind gift from Dr. M. Zaccolo (University of 
Padova, Padova, Italy), the cGMP sensor Cygnet 
2.1 was kindly provided by Dr. W. Dostmann 
(University of Vermont, Burlington, VT), and the 
Ca2+ indicator Yellow Cameleon 2.1 was a gift 
from Dr. R. Tsien (UCSD, La Jolla, CA).  
 
Cell Culture 
 Mouse N1E-115 and Phoenix packaging cells 
were cultured in DMEM supplemented with 10% 
fetal calf serum, penicillin and streptomycin and 
kept in a humidified CO2 incubator. Stable cell 
lines were generated by retroviral transduction as 
previously described (Clark et al., 2006). Cells 
were selected by the addition of 0.8 mg/ml G418 
to the media and the selection was complete within 
7 days. Cells were passaged twice a week and 
seeded on glass cover slips for experiments.  
 
Generation of Antibodies 
 To generate anti-TRPM7 antibodies, a GST-
fusion protein encoding amino acids 1748 to 1862 
was expressed in Escherichia coli BL21 and 
purified on a glutathione-sepharose column. 
Rabbits were injected with the antigen mixed with 
Freund’s adjuvant and serum was collected 10 
days after every vaccination. Serum collected 
before immunization (preimmune) was used as a 
control in all experiments (Clark et al., 2006).  
 
In Vitro Kinase Assay 
 Cells were lysed in RIPA buffer (50 mM Tris 
pH 7.5, 150 mM NaCl, 0.1% SDS, 0.5% sodium 
deoxycholate, 1% triton X-100 supplemented with 
protease inhibitors), incubated on ice for 20 min, 
and lysates were cleared by centrifugation. Lysates 
were incubated with anti-TRPM7 antibodies for 3 
h at 4oC and immunocomplexes were isolated by 
the addition of protG-sepharose. The beads were 
washed 3 times with lysis buffer and subsequently 
twice with kinase buffer without ATP (50 mM 
HEPES pH 7.0, 3.5 mM MnCl2, 5 mM DTT). The 
kinase reaction was initiated by adding 0.1 mM 
ATP in combination with 5 μCi γ-32P-ATP and 
proceeded for 30 min at 30oC. The products of the 
kinase reaction were resolved by SDS-PAGE on a 





 Cells grown for 24 hours on glass coverslips 
were fixed for 10 minutes at room temperature in 
phosphate-buffered saline and 4% 
paraformaldehyde. Subsequently, cells were 
permeabilized with 0.1% triton X-100 in 
phosphate-buffered saline. Cells were incubated 
with rabbit anti-TRPM7 sera (1:200) followed by 
horse-radish peroxidase-conjugated anti-rabbit Ig 
(1:1000). Amplification of the signal was by 
tyramide-conjugated FITC (PerkinElmer, Boston, 





 For Ca2+ recordings, cells on glass coverslips 
were incubated for 30 min with dyes, followed by 
further incubation in medium for at least 15 min. 
For pseudoratiometrical determinations (van der 
Wal et al., 2001; Jalink et al., 1990), a mixture of 1 
μg Oregon Green 488 BAPTA-AM and 4 μg Fura 
Red-AM in 100 μl medium was used. Coverslips 
were mounted on the inverted microscope and 
recordings were made at 37°C in HEPES-buffered 
saline, composed of (in mM): NaCl (140), KCl (5), 
MgCl2 (1), CaCl2 (1), HEPES (10) and glucose 
(10), pH 7.2. Single-cell fluorescence recordings 
were collected with a Nikon inverted microscope 
fitted with a Biorad MRC600 scanhead (Biorad, 
Herts, England). Excitation of Oregon Green and 
Fura-Red was at 488 nm and emission was 
detected at 522 +/- 16 nm and at >585 nm. All 
traces were calibrated with respect to maximal 
ratio (after ionomycin treatment) and minimal ratio 
(in the presence of excess BAPTA). Calculation of 
Ca2+ concentrations were performed as published 
(Grynkiewicz et al., 1985). Ca2+ experiments were 
also repeated in large series of ratiometric Indo-1 
experiments, as well as using the FRET Ca2+ 
sensor Yellow Cameleon 2.1 (Miyawaki et al., 
1997) essentially as published (van der Wal et al., 
2001). For Ca2+ uncaging experiments, oNP-
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EGTA (0.5 μg per 100 μl) was co-loaded with 
Ca2+ dyes into cells. Uncaging of oNP-EGTA was 
achieved by a sub-second flash of UV light (355 ± 
25 nM) from a mercury arc lamp. 
 
Indo‐1 Quenching Experiments 
 N1E-115/TRPM7 cells on rectangular 
coverslips were grown to near-confluency. Cells 
were loaded with Indo-1 AM (1.5 μg/100μl) for 30 
min and further incubated in fresh medium for at 
least 30 min. Coverslips were introduced into a 
photon-counting spectrofluorometer (Quanta-
Master, PTI Inc., Lawrenceville, NJ) controlled by 
the vendors Felix software. Experiments were 
performed in HEPES-buffered saline; excitation 
was at 338 nm and emission was detected at 410 
nm. Following recording of basal fluorescence 
changes for ~10 min, 200 μM Mn2+ was added and 
fluorescence was recorded for 10 more min. 
Autofluorescence, as determined by maximal 
quenching of Indo-1 with ionomycin + excess 
Mn2+, was usually less than 10 %. Both the 
baseline and the initial part of the response after 
Mn2+ addition were fitted linearly, and the Mn2+-
induced quench rate was calculated by subtracting 
the former from the latter. The quench rate is 




 Cells grown on coverslips were transfected 
with FRET constructs (1μg/coverslip) using 
FuGene 6 according to manufactures’ guidelines, 
and experiments were performed as described 
previously (van der Wal et al., 2001; Ponsioen et 
al., 2004). In brief, coverslips were placed on an 
inverted Nikon microscope and excited at 425nm 
using an ND3 filter. CFP- and YFP emission were 
collected simultaneously through 470 ± 20 and 530 
± 25 nm bandpass filters. Data were acquired at 4 
samples per second and FRET was expressed as 
ratio of CFP to YFP signals. This ratio was set to 
1.0 at the onset of the experiments, and changes 




 Electrophysiological recordings were 
collected using an EPC9 amplifier (HEKA 
electronics, Lambrecht, Germany), connected to a 
personal computer and controlled by HEKA pulse 
software. Voltage-clamp protocols were generated 
using HEKA pulse software, and current 
recordings were digitized at 100 kHz (ramp and 
block pulse protocols) or 10 Hz (steady-state 
whole-cell currents). Borosilicate glass pipettes 
were pulled on a p-2000 pipette puller (Sutter 
instruments, Novato, CA) and fire-polished 
(Narishige Microforge, Tokyo, Japan) to 2-4 MΩ. 
After establishment of the GΩ seal, the patched 
membrane was ruptured by gentle suction to obtain 
whole-cell configuration, or amphotericin B (240 
μg/ml) was used to obtain the perforated-patch 
configuration with typical access resistance of 3-10 
MΩ.  
 Solutions were as follows (in mM): whole-
cell pipette solution: K-Glutamate (120), KCl (30), 
MgCl2 (1), CaCl2 (0.2), EGTA (1), HEPES pH.7.2 
(10) and MgATP (1); external solution: NaCl 
(140), KCl (5), MgCl2 (0-1), CaCl2 (0-10), HEPES 
(10) and glucose (10), adjusted to pH 7.3 with 
NaOH; for perforated-patch recordings, the pipette 
solution was complemented with 240 μg/ml 
Amphotericin B and MgATP was omitted. For 
MIC/MagNuM recordings (Fig. 1c & d) the pipette 
solution contained CsCl (120), HEPES (10), 
MgATP (1) and MgCl2 (0-3), pH adjusted to 7.2 
with CsOH, and cells were kept in a solution 
containing TEACl (100), CsCl (5), CaCl2 (2), 
MgCl2 (1), HEPES (15), Glucose (10), pH adjusted 





Consistent with observations by others 
(Nadler et al., 2001) we observed that transient 
overexpression of TRPM7 channels was lethal 
within 1 to 3 days in N1E-115 cells and all other 
cell lines tested (data not shown). Furthermore, at 
early time points after transfection, the protein 
located primarily to the biosynthetic pathway, with 
little or no expression detectable at the plasma 
membrane. To circumvent these problems, we 
introduced TRPM7 in N1E-115 cells at low 
expression levels by retroviral transduction. These 
cells, termed N1E-115/TRPM7 cells, were viable, 
divided normally and could be routinely kept in 
culture for several months. Using a TRPM7-
specific antibody, the expression level in N1E-
115/TRPM7 cells was found to be 2-3 times that of 




majority of TRPM7 labeling localized to the 
plasma membrane. 
 Initially we analyzed whether TRPM7 
overexpression caused in increased MIC/MagNum 
currents. In whole-cell patch clamp experiments, 
[Mg2+]i was lowered by omission of the ion from 
the pipette solution. With a fluorescent dye in the 
pipette it was verified by confocal microscopy that 
intracellular perfusion was near-complete within a 
few minutes (data not shown). Concomitantly, 
both in parental and in N1E-115/TRPM7 cells, 
MIC/MagNuM currents developed. In parental 
cells, the current density at –60 mV averaged -0.33 
+/- 0.08 pA/pF, N = 14 (Fig. 1c, upper panel; 
quantification in Fig. 1d). In N1E-115/TRPM7 
cells, MIC/MagNuM current density averaged -
0.80 +/- 0.18 pA/pF, N = 9 (Figs. 1c, middle panel,  
1d), in good agreement with the expression data 
(Fig. 1a). In both cell lines, currents had all the 
characteristic hallmarks of MIC/MagNuM 
currents: first, they were strongly blocked by 
including 1-3 mM of free Mg2+ in the pipette 
solution (Fig. 1c, lower panel). Second, whole-cell 
currents showed an outward-rectifying I/V 
relationship in divalent-containing media (Fig. 1e) 
that became linear upon removal of divalents 
(Mg2+ and Ca2+) from the medium (data not 
shown). Third, in line with the results from 
Runnels (Runnels et al., 2001), responses evoked 
by voltage-step protocols lacked voltage- or time-
dependent characteristics (Fig 1e, right panel). 
Furthermore, sensitivity of MIC/MagNuM currents 
to inhibitors of TRPM7 matches with that reported 
in the literature (Table 1).  
Fig. 1. Expression of TRPM7 in N1E-115 cells by
retroviral transduction. (a) Retroviral transduction 
causes moderate overexpression of the TRPM7
channel-kinase as assayed by autophosphorylation of its
kinase domain after immunoprecipitation by TRPM7-
specific antibodies. (b) Confocal image of N1E-115 cell 
showing localization of the protein to the plasma
membrane. TRPM7 was detected using anti-TRPM7 
antibodies, followed by tyramide signal amplification.
Scale bar, 10 μm. (c) Upper panel, MIC/MagNuM
detected in whole-cell configuration. MIC/MagNuM
currents start to develop immediately after break-in, 
peak at ~5-10 minutes and then gradually run down.
Spikes represent current excursions induced by 1 s
pulses to +60 mV from a holding potential of –60 mV. 
Solutions were chosen so that outward currents are
mainly Cs+, and inward currents are mainly Ca2+ by 
substituting tetraethyl ammonium (TEA+) for Na+ in the 
medium. Middle panel, MIC/MagNuM currents in
N1E-115/TRPM7 cells are 2- to 3-fold larger in
amplitude but display the same kinetics. Lower panel, 
inclusion of 3 mM Mg2+ in the pipette completely
blocks MIC/MagNuM currents in N1E-115/TRPM7
cell. (d) Quantification of MIC/MagNuM currents for
N1E-115/TRPM7 and parental cells, detected at –60 
mV and at +60 mV. *: p < 0.01. (e) Left panel, I/V plots
of MIC currents measured in N1E-115/TRPM7 cells by
ramps (-100 to +100 mV, grey line) from at 0 mV
holding potential and from instantaneous V-steps (20
mV-steps from –80 mV to 80 mV, black squares),
corrected for background. Note complete overlap of
I/V-plots obtained by these two methods. Right panel, 
individual, uncorrected traces from step-response
currents at onset of the experiment (top panel) and at 
maximal activation (lower panel) show lack of time-
dependent activation. Shown are representative traces
from 10 individual experiments.  
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Whole cell Perforated 
Patch 
La3+ / Gd3+ + (200uM) + (5mM) n.t. 
2-APB (100μM) + + + 
SKF 96365 (30μM) + + + 
Spermin (50μM) n.a. + n.t. 
Niflumic acid (100μM) + + + 
 
N1E-115/TRPM7 cells were challenged with 1 μM bradykinin and the sensitivity of the ensuing sustained responses to 
the indicated blockers was tested. +, response is sensitive to blocker; n.a., not applicable (i.e. spermin works only in 




 Next we analyzed [Ca2+]i in parental and 
N1E-115/TRPM7 cells by ratiometrical Ca2+ 
imaging (see Methods). Intracellular Ca2+ was 
elevated significantly in N1E-115/TRPM7 cells 
(108.9 +/- 6.0 nM, N = 50) as compared to parental 
cells (85.3 +/- 2.5 nM, N = 50; p < 0.05; Fig. 2a, 
quantification in Fig. 2b). As it has been reported 
that TRPM7 channels are partly pre-activated 
(Schmitz et al., 2003; Kozak and Cahalan, 2003; 
Hanano et al., 2004; Matsushita et al., 2005; 
Demeuse et al., 2006), this suggests that in N1E-
115/TRPM7 cells too, a part of the TRPM7 
channel population is open under resting 
conditions. Thus, low-level overexpression of 
TRPM7 is well tolerated and contributes to Ca2+ 
homeostasis. 
 Because cell-biological and biochemical data 
(Clark et al., 2006) indicate that TRPM7 channels 
are activated by the GPCR agonist BK, we next 
monitored the effect of addition of BK on TRPM7-
mediated Ca2+ influx by comparing N1E-
115/TRPM7 to parental cells. In N1E-115 cells, 
stimulation of endogenous B2 receptors with 
bradykinin (BK) strongly activates PLC through 
the Gq pathway (Coggan and Thompson, 1995; 
Chapter II). In parental cells, 1 μM BK induced a 
cytosolic Ca2+ increase (765.9 +/- 9.7 nM, N = 80) 
that peaked within seconds and subsequently 
returned to values close to resting levels (92.9 +/- 
2.9 nM) within 60s (Fig. 2a, left panel). This 
corresponds to a mean increase of 7.6 nM from 
basal levels, which was not statistically significant. 
In contrast, in N1E-115/TRPM7 cells the BK-
induced transient Ca2+ increase (peak 843.3 +/- 
12.7 nM) was followed by a prominent sustained 
Ca2+ elevation (141.0 +/- 7.0 nM, N = 120) that 
lasted for several minutes before returning to 
resting levels rather abruptly (Fig. 2a, right panel; 
quantification in Fig. 2b). Note that, in comparison 
with wt cells, the magnitude of the mean increase 
in sustained Ca2+ levels in N1E-115/TRPM7 cells 
(32.1 nM; p < 0.001, paired t-test) corresponds 
reasonably well with the 2 to 3-fold higher TRPM7 
expression levels. Thus, expression of TRPM7 at 
the plasma membrane elicits a sustained phase in 
the Ca2+ response to BK, in good agreement with 
Fig. 2. Sustained Ca2+ influx in N1E-115/TRPM7 
cells after stimulation of PLC. (a) Pseudo-ratiometric 
single-cell Ca2+ traces showing effect of addition of 
bradykinin (BK, 1 μM) in parental (left panel) and 
TRPM7 transduced cells (right panel). Note the 
characteristic abrupt end of the sustained phase after 
~3-5 minutes. Shown are representative traces from 
hundreds of experiments. Similar results were obtained 
with Indo-1 as well as with the FRET Ca2+ sensor 
Yellow Cameleon 2.1 (see Methods). (b) Effects of 
retroviral TRPM7 expression on basal (B) and agonist-
induced peak (P) and sustained (S, taken 2 minutes after 
addition of BK) calcium levels. [Ca2+]i concentrations 
were calibrated with ionomycin and BAPTA, and data 
of hundreds of cells were averaged. Shown are mean + 
s.e.mean of values of the initial Ca2+ peak and of the 
sustained phase, taken 2 minutes after addition of BK. 








 To address whether the sustained Ca2+ phase 
is due to entry through TRPM7 channels, we 
investigated several alternatives. First, it is 
conceivable that expression of TRPM7 could 
burden the cells with excess Ca2+ entry, thereby 
compromising intracellular Ca2+ buffering 
mechanisms. Therefore we assayed cytosolic Ca2+ 
buffering by quantitating the rate of clearance of 
UV-released caged Ca2+. Native N1E-115 and 
N1E-115/TRPM7 cell were loaded with o-
nitrophenyl-EGTA and Ca2+ dyes (see Methods) 
and exposed to ~0.2s flashes of UV light (Fig. 3a, 
left and middle panels). In wt cells, this caused an 
instantaneous increase in [Ca2+]i, which was 
cleared from the cytosol with a time course well 
fitted by a single exponential. Ca2+ drop rates in 
both cell lines were indistinguishable (21.77 +/- 
2.00, N = 15 versus 21.75 +/- 1.76, N = 15, Fig. 
3a, right panel), ruling out different cytosolic 
buffering as the responsible mechanism. Note that 
the shape of the BK-induced Ca2+ increase, with a 
prolonged sustained phase that ends rather abruptly 
after several minutes (Fig. 2a, right panel), also 
argues against flawed Ca2+ buffering as the 
responsible mechanism. Rather, sustained elevated 
Ca2+i levels are due to influx since they were 
absent in cells acutely pre-treated with the calcium 
chelator BAPTA at 3 mM (Fig. 3b, left panel). 
Addition of  BAPTA during the sustained Ca2+ 
elevation also caused a rapid drop which often 
proceeded to values below basal level (Fig. 3b, 
right panel; 59.9 +/- 8.2 nM), an observation that 
is in line with the reported pre-activation of 
TRPM7 channels. Thus, the sustained phase in 
BK-stimulated N1E-115 cells reflects Ca2+ influx 
over the plasma membrane.  
 We further ruled out that addition of BK 
caused depolarization of the cell membrane with 
consequent Ca2+ influx through voltage-sensitive 
Ca2+ channels. Whereas this has been described for 
N1E-115 cells that were induced to adopt a 
differentiated neuronal phenotype (Bolsover, 
1986) by 2-4 day serum starvation, in non-starved 
cells Ca2+i levels were completely insensitive to 
depolarization by 50-100 mM extracellular K+ 
(Fig. 3c). Furthermore, resting membrane 
potentials of non-starved native and TRPM7 
overexpressing cells did not differ (-29.9 +/- 3.4 
mV and -32.8 +/- 5.3 mV, resp.) and BK 
stimulation evoked only minor depolarization of 
the plasma membrane (wt: 10.0 +/- 4.0 mV, N=6; 
N1E-115/TRPM7: 11.8 +/- 0.9 mV, N=5). These 
results rule out activation of a voltage-sensitive 
Ca2+ channel as the responsible mechanism and are 
in line with the reported lack of voltage sensitivity 
of TRPM7 at physiological membrane voltage. 
 Finally, we tested sensitivity of the sustained 
phase of Ca2+ influx to a panel of inhibitors for 
TRPM7 channels (Table 1). When administered 
during the sustained Ca2+ phase, 2-aminoethoxy-
Fig. 3. Sustained Ca2+ levels in N1E-115/TRPM7 
cells are due to increased membrane permeability. 
(a) Left and middle panel, typical traces showing 
similar Ca2+ clearance of caged Ca2+ spikes in parental 
and N1E-115/TRPM7 cells. Right panel, quantification 
(mean + s.e.mean of τ; N = 15) of Ca2+ clearance from 
single-exponential fits. (b) Left panel, sustained Ca2+
elevation after BK stimulation in N1E-115/TRPM7 
cells is abolished by brief pre-treatment with 
extracellular BAPTA. Right panel, addition of BAPTA 
during the sustained Ca2+ phase lowers [Ca2+] to values 
below baseline. (c) Depolarization of N1E-115/TRPM7 
cells by adding extracellular KCl (50mM) does no
i
t 
cause Ca2+ influx; iono indicates addition of the Ca2+
ionophore ionomycin as a positive control. Note the 
break in the Y-axis. (d) BK (1 μM) stimulation causes 
increased permeability for Mn2+ in N1E-115/TRPM7 
cells as measured by an Indo-1 quenching assay (mean 
+ s.e.mean; N = 6; *: p < 0.025, single-sided t-test).  
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diphenyl-borate (2-APB, 50μM) (Jiang et al., 
2003) completely blocked BK-induced Ca2+ influx. 
In line with the observation that TRPM7 
expression also contributes to basal Ca2+i levels, 
the 2-APB-induced drop in Ca2+ levels often 
proceeded to values below baseline (data not 
shown). Furthermore, we tested SKF 96365 
(30μM) (Kozak et al., 2002), and the polyvalent 
cations Gd3+ and La3+ (both at 200μM) (Runnels et 
al., 2001). In all cases, the BK-induced sustained 
phase, but not the initial Ca2+ peak, was strongly 
inhibited. Note that none of these inhibitors are 
truly selective for TRPM7, and that this 
pharmacological profile also fits ICRAC. However, 
unlike ICRAC (Hoth and Penner, 1992) TRPM7 
permeates Mn2+ ions well (Monteilh-Zoller et al., 
2003). When tested by Indo-1 quenching assays 
(see Methods), N1E-115/TRPM7 cells challenged 
with BK were significantly more permeable to 
Mn2+ than unstimulated cells (Fig. 3d). Taken 
together, these data strongly suggest that the BK-
induced sustained Ca2+ elevation in N1E-
115/TRPM7 cells is mediated by influx through 





 In whole-cell patch clamp experiments on 
HEK-293 cells overexpressing M1 muscarinic 
receptors, TRPM7 channels were shown to be 
inhibited by carbachol-induced PIP2 breakdown 
(Runnels et al., 2002), and this inhibition was 
reverted by intracellular perfusion with a water-
soluble PIP2 analogue. This result was 
subsequently challenged by Takezawa and 
colleagues (Takezawa et al., 2004) who found that 
activating PLC through endogenously expressed 
M1 receptors had little effect on TRPM7 currents, 
and used the lack of effect of the inhibitor U-
73122 to underscore this point of view. Instead, 
they reported that whole-cell TRPM7 currents 
were enhanced or attenuated, respectively, by 
agonists to receptors that couple to stimulatory 
(Gs) or inhibitory (Gi) G proteins to raise or lower 
intracellular cAMP levels.   
Fig. 4. Activation of TRPM7 by GPCRs: 
involvement of the Gq / PLC signalling pathway. (a) 
Representative FRET traces showing PIP2 hydrolysis 
(upper panel) induced by BK, LPA and thrombin 
receptor activating peptide (TRP), and the ensuing 
sustained Ca2+ elevations in N1E-115/TRPM7 cells 
(lower panel). Prostaglandin E1 (PGE-1), a potent 
activator of cAMP production, does not activate PLC 
and it fails to evoke sustained Ca2+ entry (rightmost 
traces). (b) BK receptor activation does not alter cAMP 
levels in N1E-115/TRPM7 cells as detected by a PKA-
based FRET probe (left panel). Addition of the adenylyl 
cyclase activator forskolin together with the 
phosphodiesterase inhibitor IBMX serve as a positive 
control. Conversely, PGE-1 potently activates the Gs / 
cAMP pathway through its cognate GPCR (middle 
panel) but fails to elicit the sustained Ca2+ elevation 
(right panel) that is typically seen after Gq / PLC 
activation. (c) In N1E-115/TRPM7 cells BK fails to 
alter cGMP levels, whereas the NO-donor nitroprusside 
readily activates this pathway, as assessed using 
Cygnet, a FRET sensor for cGMP (Honda et al., 2001). 
Addition of nitroprusside had no effect on [Ca2+]i in 
these cells (right panel). 
 We made use of the endogenously expressed 
B2 bradykinin receptors that couple predominantly 
to the Gq/PLC pathway, but some scattered reports 
suggest that depending on the cell type the B2 
receptor may sometimes either inhibit (Hanke et 
al., 2001) or stimulate (Albert et al., 1999) 




the signaling route responsible for BK-induced 
activation of TRPM7 in intact N1E-115/TRPM7 
cells by correlating Ca2+ fluorometry with 
activation of intracellular signaling pathways, as 
detected by various FRET assays.  
 We and others have previously reported that 
stimulation of endogenous B2 receptors with BK 
causes rapid breakdown of a significant fraction 
(60-80%) of the membrane PIP2 pool in N1E-115 
cells (van der Wal et al., 2001; Xu et al., 2003). 
Similarly, addition of BK to N1E-115/TRPM7 
cells caused near-complete breakdown of PIP2, as 
detected by a FRET assay that reports membrane 
PIP2 content (Fig. 4a, upper  panel, first trace (van 
der Wal et al., 2001)). In these cells, the Gq-
coupled agonists lysophosphatidic acid (LPA) and 
thrombin receptor activating peptide also activate 
PLC, albeit to a lesser extent (~20-30% of BK 
values; N > 200; Fig. 4a, upper panel, second and 
third trace (van der Wal et al., 2001)). Similar to 
BK, the initial Ca2+ peak induced by these agonists 
was followed by sustained Ca2+ influx in N1E-
115/TRPM7 cells, although responses were a bit 
more variable than those to BK (Fig. 4a, lower 
panel). In contrast, sustained Ca2+ influx was not 
seen when cells were stimulated with agonists to 
receptors that do not couple to PLC (Fig. 4a, right 
panel, and data not shown). Thus, TRPM7 
activation correlates well with PLC activation / 
Ca2+ signaling but it does not require near-
complete breakdown of the PIP2 pool. 
Fig. 5. MIC/MagNuM currents in N1E-115/TRPM7 
cells are inhibited by BK. (a) TRPM7 currents, 
evoked with Mg2+-free pipette solution in a N1E-
115/TRPM7 cell, are strongly inhibited after activation 
of PLC. Currents evoked by ±100 mV ramps (b) from a 
holding potential of 0 mV are quantified at –80 mV 
(circles) and +80 mV (squares). Note that the small 
inward currents are due to divalent-block in Mg2+- and 
Ca2+-containing extracellular medium. Shown is a 
representative trace from 10 individual experiments. 
 To address possible involvement of cAMP in 
the BK-induced opening of TRPM7, we monitored 
cAMP levels in intact N1E-115/TRPM7 cells 
using a genetically encoded sensor for cAMP 
(Zaccolo et al., 2000). Of the available FRET 
sensors for cAMP, this sensor has the highest 
affinity (Kd of 300 nM (Bacskai et al., 1993)) and 
it is well suited to reveal small changes from 
baseline levels. Addition of BK to N1E-
115/TRPM7 cells had absolutely no effect on 
cAMP levels (N = 8), whereas forskolin (25μM) 
readily raised cAMP levels in these cells (Fig. 4b, 
left panel). Furthermore, we tested the effects of 
pre-treatment of cells with pertussis toxin, which 
specifically inhibits Gi and thereby blocks 
receptor-induced decreases in cAMP levels, on the 
response to BK. No effects on kinetics or 
amplitude of the BK-induced Ca2+ influx were 
observed in N1E-115/TRPM7 cells (data not 
shown). Thus, we find no evidence that cAMP 
may mediate BK-induced opening of TRPM7. 
Conversely, we tested the effect of agonists that do 
signal potently through Gs and Gi, respectively. 
Prostaglandin E1 (PGE1) potently activates Gs to 
cause a rapid and sustained increase in [cAMP]i 
(Fig. 4b, middle panel) that was not paralleled by 
sustained Ca2+ influx (Fig. 4b, right panel). 
Similarly, activation of Gi by Sphingosine-1-
phosphate (S1P) was ineffective. We conclude that 
there is no evidence for a role of cAMP in BK-
mediated Ca2+ influx in N1E-115/TRPM7 cells.  
 We also investigated the role of other well-
delineated signaling pathways in N1E-115 cells. In 
these cells, stimulation with agonists that couple to 
G13 leads to strong activation of the small GTPase 
Rho, resulting in rapid contraction of the actin 
cytoskeleton (Postma et al., 1996b). S1P potently 
activates this signaling cascade (Postma et al., 
1996b) but it does not couple to Gq (KJ, 
unpublished results). In N1E-115/TRPM7 cells, 
S1P caused rapid cytoskeletal contraction but it 
had no detectable effect on Ca2+ (data not shown). 
Finally we tested the effects of addition of the NO-
donor nitroprusside since NO was reported to 
activate TRPM7-mediated Ca2+ influx in cultured 
cortical neurons (Aarts et al., 2003). In intact 
parental and N1E-115/TRPM7 cells, nitroprusside 
potently triggered production of cGMP (Methods; 
Fig. 4c, left panel (Ponsioen et al., 2004)) but no 
effect on [Ca2+]i was observed (Fig. 4c, right 
panel). In conclusion, TRPM7 opening correlates 
well with Gq / PLC but not with other G-protein 







 In whole-cell patch clamp experiments on 
HEK-293 cells overexpressing M1 muscarinic 
receptors, TRPM7 channels were shown to be 
inhibited by carbachol-induced PIP2 breakdown 
(Runnels et al., 2002), and this inhibition was 
reverted by intracellular perfusion with a water-
soluble PIP2 analogue. This result contrasts with 
our cell-biological, biochemical and Ca2+-data (see 
above, and (Clark et al., 2006)) that show that PLC 
activation causes opening rather than closure of 
TRPM7 channels. We therefore tested whether 
TRPM7 currents recorded in whole cells with 
Mg2+-free pipette solution were similarly 
suppressed in our cells. Upon break-in, channel 
activation was monitored from outward-rectifying 
(MIC/MagNuM) currents evoked with voltage 
ramps. Indeed, challenging the cells with BK after 
full activation of TRPM7 caused currents to 
rapidly decrease in both native N1E-115 cells (data 
not shown) and N1E-115/TRPM7 cells (99.7 % ± 
1.0, N=9, Fig. 5a). Whereas inward currents were 
completely abolished, small outward currents were 
still observed at high depolarizing potentials (Fig. 
5b, trace 3). Other PLC-coupled agonists, 
including TRP and LPA, also inhibited the 
currents, though to a lesser extent. Therefore, it 
appears that the original observations on PIP2-
dependency of whole-cell TRPM7 currents hold 




 The above observations leave us with a 
paradox: PLC activation inhibits TRPM7 currents 
in whole-cell experiments, whereas it opens the 
channels when assayed by Ca2+ fluorometry. What 
causes this difference? Immediately after breaking 
the patch membrane to whole-cell, perfusion will 
start to dilute diffusible signaling molecules, which 
could influence gating properties. To test this 
possibility, we analyzed the electrophysiological 
effects of PLC activation in intact cells using the 
perforated patch configuration (Rae et al., 1991; 
Postma et al., 1996a). In this configuration, 
conventional GΩ seals are obtained, but electrical 
access to the cell is gained by including selective 
Na+/K+ ionophores in the pipette solution, which 
incorporate in the patch membrane. Using 
amphotericin B, we routinely obtained access 
resistances well below 10 MΩ, allowing reliable 
recording of total membrane currents without 
disturbing the cytosolic composition. 
 Voltage clamped perforated patches were held 
at –70 mV, and conductance of the membrane was 
monitored by measuring currents evoked by a 
biphasic block-pulse protocol (+ 10 and –10 mV 
from resting potential; Fig. 6a). In unstimulated 
cells, evoked currents were small (0.46 +/- 0.16 
pA/pF, N=10), corresponding to a membrane 
conductance of 23 pS/pF. Note that since Mg2+ 
levels are intact in the perforated-patch 
configuration, the magnitude of the detected 
currents should match those of whole-cell 
experiments with Mg2+ included in the pipette 
(Fig. 1c, lower panel). Indeed, the currents induced 
by 120 mV voltage steps in unstimulated whole-
cells measured 3.1 +/- 0.4 pA/pF (N=5), which 
corresponds to ~26 pS/pF, in close agreement with 
the perforated-patch data. As to be expected, 
spontaneously developing currents were never 
observed in perforated patches (Data not shown). 
Strikingly, stimulation with bradykinin 
significantly increased the membrane conductance 
Fig. 6. TRPM7 currents detected using perforated-
patch clamping. N1E-115 wt (a) and N1E-
115/TRPM7 cells (a) were kept at a holding potential of
–70 mV and membrane conductance changes were 
determined from current responses to biphasic +10 and
–10 mV block pulses. Note the BK-induced sustained
activation of an additional conductance (BK, 1 μM). To 
verify that the small BK-evoked current would suffice
to increase [Ca2+]i significantly, we point out that an
influx of just 10 pA of current carried by Ca2+ equals 10
x 10-12 / F.z = 5 x 10-17 mole (F, faraday constant; z,
valence of ion), which in a cell of 1 pl volume would
raise [Ca2+] by 5 x  10-5 M (50 μM) in 1 second, if no
buffer systems are in place. Weakly rectifying currents 
induced by BK in wt (Fig. 6a, left panel) and N1E-
115/TRPM7 (Fig. 6b, left panel) cells obtained by




(~250 +/- 53pS, N=6, Fig. 6b, left panel) in N1E-
115/TRPM7 cells. In all cases, currents were 
transient, reverting to baseline with somewhat 
variable kinetics (range, 2-8 minutes). Note that 
whereas these conductance changes are quite 
small, the magnitude of inward currents, which are 
carried predominantly by Ca2+ (Nadler et al., 
2001), is adequate to explain the sustained Ca2+ 
phase observed in fluorometric experiments (for 
analysis, see legend to Fig. 6). As wildtype N1E-
115 cells express some endogenous TRPM7 
channels, we next examined whether these are 
similarly activated after activation of PLC. Indeed, 
addition of BK increased the membrane 
conductance slightly, but significantly (Fig 6a, left 
panel). In addition, the same panel of inhibitors 
blocked the BK-induced currents (see Table 1). I/V 
plots of BK-induced currents in wt and N1E-
115/TRPM7 cells revealed almost linear currents 
(Fig. 6a and b, right panels), the magnitude of 
which correlated with the expression levels. We 
conclude that bradykinin can activate TRPM7 
channels in both native and TRPM7-transduced 
N1E-115 cells. 
 We next verified these results in HEK-293 
cells. Cells were transiently transfected with 
TRPM7 (in a GFP-tagged zeocin vector) and the 
NK2-receptor, a G protein-coupled receptor 
(GPCR) for neurokinin A (Mau et al., 1990) that 
signals predominantly through Gq. One day after 
transfection, healthy cells expressing GFP at low 
levels were selected. When assayed by whole-cell 
patch clamping with Mg2+-free pipette solutions, 
these cells displayed outwardly rectifying currents 
with all the hallmarks of TRPM7, including 
spontaneous activation and subsequent run-down 
(data not shown). In perforated-patch experiments, 
HEK-293 cells showed small, near-linear currents 
and no spontaneous developing outward rectifying 
currents were observed. Challenging HEK-293 
cells with neurokinin A (NKA) caused a marked 
increase in membrane conductance (ΔG 0.79 +/- 
0.33 nS; N = 3; Fig.7a). Again, conductance 
increases were transient, reverting to baseline 
within minutes. Note however, that in HEK-293 
cells responses were quite variable, perhaps 
reflecting more widely diverging TRPM7 
expression levels or impaired viability of 
transiently transfected cells. The inhibitor 2-APB 
(100 μM) consistently lowered the conductance to 
below initial values, in line with the notion that 
part of the channel population is opened under 
resting conditions (data not shown). Thus, the 
perforated-patch data obtained from HEK-293 
cells transiently expressing TRPM7 match those 
obtained from N1E-115/TRPM7 cells, demon-
strating that the phenotype does not depend on 
long-term viral transduction. We conclude that the 
stimulatory effect of PLC on TRPM7 currents in 
minimally perturbed cells parallels the Ca2+ 
imaging data, but contrasts with the data from 
Mg2+i-free whole-cell patch clamping. 
Fig. 7. TRPM7 current activation by NKA in
HEK293 overexpressing TRPM7. (a) HEK-293 cells
transiently expressing TRPM7 as well as NK2 receptors
show increased membrane conductance upon
stimulation of PLC with NKA (4 μM) in perforated-
patch experiments. (b) In whole-cells with 1 mM of
Mg2+ in the pipette solution, addition of NKA
stimulates, rather than inhibits, TRPM7 currents. (c) left 
panel, I/V-plots from NK2-induced TRPM7 activation
in HEK293 cells during whole-cell configuration. I/V-
plots obtained before (1) and after (2) NKA stimulation.
Black line, NKA-induced increase in currents (i.e., 1 –
2). Individual current responses to voltage steps (right 
panel) show all the hallmarks of TRPM7 currents. 
 The above observations suggest that in whole-
cells, loss of [Mg2+]i or possibly other signaling 
cofactors is sufficient to cause TRPM7 to become 
inhibited, rather than activated, by PLC activating 
agonists. To study this, HEK-293 cells transiently 
expressing TRPM7 were whole-cell patch-clamped 
with 1 mM free Mg2+ in the pipette. Under these 
conditions, NKA stimulation (Fig. 7b) also caused 
activation of TRPM7, as observed by the increase 
in membrane conductance. The I/V-plots obtained 
are slightly outward-rectifying, suggesting that 
internal Mg2+ partly prevents outward rectification 
by blocking/obstructing the pore of TRPM7 (Fig. 
7c, left panel). Again, no voltage- or time-
dependent components were observed in the 
current responses to voltage steps (Fig. 7c, right 
panel). Thus, stimulatory effects of PLC-activating 





 In this study we addressed the regulation of 
TRPM7 channels in intact cells using low-level (2- 
to 3-fold) overexpression. Transient over-
expression of the protein was avoided because this 
caused mislocalisation of TRPM7 to endo-
membranes and cell death within a few days most 
likely because TRPM7 is to some extent 
constitutively active. Furthermore, transient 
overexpression is also more likely to titrate out 
essential binding partners and thereby influence 
signaling events. Indeed, Takezawa et al. noted 
that TRPM7 expression abolished activation of 
PLC by carbachol receptors (Takezawa et al., 
2004). Strikingly, in a very recent study by Kim 
and colleagues (Kim et al., 2005) also concluded 
that regulation of native TRPM7 channels by PLC 
appeared different from results published 
previously from transiently transfected HEK293 
cells (Runnels 2002). We furthermore chose to use 
perforated-patch clamping and Ca2+ imaging to 
avoid disturbing cell signaling due to intracellular 
perfusion in whole-cell configuration. 
 Our results revealed that retroviral 
transduction resulted in the appearance of a 
conductance with all the properties of TRPM7. 
The evidence can be summarized as follows. (i) 
The TRPM7 protein is expressed (Fig. 1a) and it 
resides at the plasma membrane (Fig. 1b). (ii) Its 
expression increases membrane permeability to 
Ca2+, evident from increased basal Ca2+ levels (Fig. 
2a & b,). (iii) Whole-cell currents in these cells 
have all the hallmarks of TRPM7 (Fig. 1d & e), i.e. 
activation by omitting Mg2+i from the pipette 
solution with subsequent run-down, reversal 
potential about 0 mV, and outward rectification 
that becomes linear when extracellular divalents 
are removed. Moreover, these currents are 
inhibited upon PLC activation as originally 
reported. (iv) The sensitivity of sustained Ca2+ 
influx and whole-cell currents to a panel of 
inhibitors (Table 1) corresponds to that reported 
earlier for TRPM7. Whereas ICRAC is blocked by 
the same panel of inhibitors, it differs from 
TRPM7 in that it is hardly permeable to Mn2+ ions 
(Fig. 3d), and shows fast desensitization in 
divalent-free solutions. (v) The basal currents 
observed in perforated-patches (which are small 
due to intracellular Mg2+, data not shown) have the 
same magnitude as the whole-cell currents in the 
presence of intracellular Mg2+ (Fig. 1c, lower 
panel), and BK-evoked additional currents, which 
are transient and revert to baseline levels within 
several minutes, have the same properties. (vi) In 
addition, we can rule out obvious other candidates 
such as  compromised cytosolic Ca2+ buffering 
(Fig. 3a) and TRPM2 (which is also widely 
expressed, and was detected in N1E-115 by RT-
PCR) that display linear I/V-relationship and are 
more Ca2+ selective (Perraud et al., 2001). 
 Of course the phenotype of TRPM7 in Ca2+ 
experiments strongly reminisces of Store-Operated 
Calcium Entry (SOCE, ICRAC). SOCE is likewise 
manifested as a sustained plateau phase that 
depends on Ca2+ influx to follow an initial large 
Ca2+ peak from IP3-sensitive internal stores. Unlike 
SOCE, however, TRPM7 opening was not evoked 
by depletion of stores with thapsigargin (Prakriya 
and Lewis, 2002; Hermosura et al., 2002) and data 
not shown). Moreover, under divalent-free 
conditions ICRAC inactivates within seconds, 
whereas MIC/MagNum currents showed no decay 
for at least a few minutes. Furthermore, the relative 
permeability of TRPM7 channels to different ions 
does not fit with ICRAC: TRPM7 channels are 
permeable to Mg2+, Mn2+ (Fig. 3d) and Cs+ (Fig. 
1b & c) whereas ICRAC is characterized as non-
permeable for these ions (Hoth and Penner, 1992; 
Zweifach and Lewis, 1993; Lepple-Wienhues and 
Cahalan, 1996). We thus arrive at the same 
conclusion as previous studies that point out that 
TRPM7 is not the channel responsible for 
conducting ICRAC (Kozak et al., 2002; Prakriya 
and Lewis, 2002; Hermosura et al., 2002). 
 Two very recent reports strongly support the 
view that PLC activity augments, rather than 
inhibits, TRPM7 channels. Kim and colleagues 
showed that in clusters of interstitial cells of Cajal, 
which control pacemaking activity in the intestine, 
pacemaker frequency is determined by endogenous 
TRPM7 channels. Strikingly, addition of stem cell 
factor, a stimulus that causes PIP2 breakdown, 
positively influenced pacemaking, indicative of 
increased TRPM7 conductance in these cells (Kim 
et al., 2005). In a second report, we analyzed the 
role of TRPM7 in regulating actomyosin 
contractility (Clark et al., 2006). This report 
showed that upon stimulation of cells with PLC 
activating agonists such as bradykinin, the TRPM7 
kinase domain associates with the actomyosin 
cytoskeleton in a Ca2+ and kinase-dependent 
manner. Within this complex, TRPM7 inhibits 
myosin-II function resulting in the transformation 
of focal adhesions into podosomes. These 
biochemical and cell biological data unequivocally 
demonstrate activation of native TRPM7 protein 





 Strikingly, and at odds with previous reports, 
we observed that stimulation of PLC-activating 
receptors caused TRPM7 channel opening rather 
than closure. This discrepancy is not cell type 
dependent because similar observations were made 
in N1E-115 and HEK-293 cells, nor does it depend 
on TRPM7 expression levels. Rather, it was found 
that in intact, minimally perturbed cells (Ca2+ 
imaging and perforated-patch) PLC-coupled 
agonists activated the channel, whereas upon prior 
channel opening by Mg2+i depletion (whole-cell) 
PLC activation potently inhibited MIC/MagNuM 
currents. Conceivably, Mg2+i levels act on the 
TRPM7 protein itself, because it was reported that 
mutations in the kinase domain altered the 
channels setpoint for Mg2+ inhibition (Schmitz et 
al., 2003). Alternatively, Mg2+ depletion might act 
by altering interaction with adenosine nucleotides 
(ATP, cAMP) or by influencing (Nadler et al., 
2001; Demeuse et al., 2006) phosphoinositide 
metabolism, especially since both PIPkinases and 
PIP2 phosphatases are strongly Mg2+ dependent 
(Ling et al., 1989). Analysis of the kinetics of BK-
mediated stimulatory and inhibitory effects on 
TRPM7 shows that activation proceeds faster than 
inactivation. We speculate that this reflects 
fundamentally different modes of regulation 
mediating stimulation and inhibition, as opposed to 
a model whereby Mg2+i would modulate (flip) the 
effects of PLC activation on the channel. Rescue 
of agonist-induced channel inactivation by 
replenishment of membrane PIP2 in Mg2+-free 
inside-out patches (Runnels et al., 2002) shows 
that PIP2 is an essential cofactor for channel 
opening. The precise mechanism of the activation 
pathway remains elusive, although we can exclude 
the involvement of the PIP2-derived messengers 
DAG (since addition of membrane-permeable 
analogues did not activate TRPM7, data not 
shown) and cytosolic Ca2+ (Fig. 3a). In any case, 
we find that in unperturbed cells TRPM7 increases 
Ca2+i levels upon PLC activation and therefore we 
propose that this must be the more physiological 
mode of action.  
 Takezawa and colleagues recently reported 
that activation of PLC through endogenous M1-
muscarinic receptors had little effect on 
MIC/MagNuM currents in TRPM7-overexpressing 
HEK-293 cells (Takezawa et al., 2004). Perhaps 
the discrepancy between Runnels’ and our study 
on the one hand, and that of Takezawa and 
colleagues on the other hand, is a difference in 
potency of the PLC-activating receptors involved 
as in their (and our) hands endogenous M1 
receptors cause only minor PIP2 breakdown. 
Furthermore, unlike in our low-level retroviral 
overexpression studies, in HEK-293 cells TRPM7 
overexpression inhibited carbachol-induced PLC 
signaling (Takezawa et al., 2004). Their study 
furthermore relied on the use of the ‘PLC 
inhibitor’ U-73122, a compound with many known 
side effects (Balla, 2001; Horowitz et al., 2005). 
Rather, Takezawa and colleagues suggested that 
the modulatory effects of carbachol are mediated 
by cAMP, as lowering [cAMP]i attenuated whole-
cell TRPM7 currents in HEK-293 cells. However, 
in N1E-115 cells bradykinin had no effect on 
cAMP levels, and conversely, potent cAMP-
raising agonists did not trigger TRPM7 currents or 
sustained Ca2+ influx.  
 .Superficially, it could be disturbing that 
perforated-patch currents reported here are 
relatively small and lack strong outward 
rectification, a feature that has been termed 
‘TRPM7 signature’. However, small amplitude 
basal and evoked currents are to be expected from 
the experimental conditions used in this study: 
first, we expressed the channels at low levels and 
secondly, we detected currents at negative voltages 
to assess the inward conductance properties and 
allow comparison with the Ca2+ data. TRPM7 
inward currents consist mainly of Ca2+ and Mg2+ 
ions that both have low permeation rate (Runnels 
et al., 2001; Nadler et al., 2001) and in HEK-293 
overexpression studies inward currents are also 
minor. Strong outward rectification is seen under 
conditions of low [Mg2+]i . Interestingly, like the 
perforated-patch currents, the currents evoked by 
PLC activation in TRPM7-transfected HEK-293 
cells with 1 mM Mg2+ in the pipette show only 
weak outward rectification (Fig. 6b). Perhaps this 
reflects an anomalous mole fraction effect, 
whereby Mg2+i attenuates outward monovalent 
currents. However, separation of this effect from 
the inhibitory effect of Mg2+i on channel gating 
would require systematic analysis (preferably in 
inside-out patches) that to our knowledge have not 
been performed thusfar. 
 In summary, our experiments reveal a second 
mode of activation for TRPM7: not only can the 
channel be activated by depletion of intracellular 
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 The channel-kinase TRPM7 is of vital 
importance for cell function, reportedly because 
it regulates intracellular magnesium 
homeostasis. TRPM7 channels constitute a 
Mg2+ entry pathway, and their gating is 
regulated by the free intracellular Mg2+ 
concentration: in whole-cell patch clamp 
experiments, depletion of Mg2+i strongly 
activates TRPM7. Here we show that TRPM7 
can also be activated in perforated-patch 
experiments by treatment with the membrane-
permeable Mg2+ chelator EDTA-AM. We 
observed that whereas in whole-cell 
experiments TRPM7 currents spontaneous 
inactivate (run-down), in perforated-patch 
recordings the channel does not inactivate in 
time. Monitoring of PIP2 at the plasma-
membrane by confocal GFP-PHδ1 imaging 
reveals that  PIP2 homeostasis is compromised 
in whole-cell conditions, as a result of 
translocation of PI(4)P 5-kinase from the 
plasma-membrane into the cytosol. This effect 
is not dependent on intracellular Mg2+ since in 
whole-cells complementation of Mg2+ did not 
prevent translocation, while EDTA-AM loading 
of intact N1E-115/TRPM7 cells neither caused 
translocation of PI(4)P 5-kinase nor 
significantly lowered the PIP2 concentration 
significantly. Our experiments suggest that 
whereas depletion of intracellular Mg2+ is 
sufficient to open TRPM7 channels, its activity 
critically depends on the presence of 




 Magnesium is an essential ion involved in 
many biochemical and physiological processes 
(Fleig and Penner, 2004; Perraud et al., 2004; 
Rubin, 2005). Until recently it was remained 
illusive how Mg2+ is taken up by cells, but recently 
two closely related ion channels were identified 
that play a vital role in the homeostasis of Mg2+ in 
living cells. These belong to the melastatin 
subfamily of the transient receptor potential (TRP) 
channel family (Clapham, 2003) and both channels 
are known as TRPM6 and TRPM7 respectively. 
TRPM6 expression is restricted to intestinal 
epithelial cells and kidney tubules, and this 
channel was found to be the main ion channel for 
Mg2+ reabsorbtion in these cells (Walder et al., 
2002; Schlingmann et al., 2002). On the other 
hand, TRPM7 is expressed ubiquitously and was 
the first ion channel to be identified that permeates 
Mg2+ (Runnels et al., 2001; Nadler et al., 2001) 
and therefore implicated in cellular Mg2+ 
homeostasis (Schmitz et al., 2003). Conditional 
knock-out of TRPM7 in cells leads to growth 
arrest and cell death within 48-72 hours (Nadler et 
al., 2001), reportedly due to deficiency of 
intracellular Mg2+ (Schmitz et al., 2003). Knock-
out mice die at a very early stage during 
embryonic development (E6.5), consistent with a 
keyrole for TRPM7 during development (Kim et 
al., 2005).  
 As both TRPM6 and TRPM7 contribute to the 
cellular Mg2+ homeostasis, it is not surprising that 
their regulation depends on the concentration of 
intracellular Mg2+ (Kozak and Cahalan, 2003) and 
Mg2+-nucleotides (Nadler et al., 2001; Demeuse et 
al., 2006). Free cytosolic Mg2+ ions and Mg2+-
nucleotides keep the channels in a closed state, but 
the precise mechanism of this inhibition has not 
been solved at this time (Nadler et al., 2001; 
Prakriya and Lewis, 2002; Kozak and Cahalan, 
2003; Demeuse et al., 2006). In whole-cell patch-
clamp experiments, lowering of intracellular 
Mg2+/Mg-nucleotides releases this inhibition and 
consequently currents develop with a strong 
outward-rectifying IV-relationship. These currents 
reverse at a membrane potential of about 0 mV 
(Runnels et al., 2001; Nadler et al., 2001; Kozak 
and Cahalan, 2003), reflecting little specificity of 
the pore for cations. TRPM7 inward currents are 
predominantly carried by the divalent ions Mg2+ 
and Ca2+ at negative voltages (Runnels et al., 2001; 
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Nadler et al., 2001), but rare divalents  ions like 
Zn2+, Co2+, Mn2+ and Ni2+ are also conducted 
(Monteilh-Zoller et al., 2003). At positive voltages 
and in the absence of internal divalent ions, the 
outward current is mainly carried by monovalent 
ions, in particular K+ (Runnels et al., 2001). 
Following activation, TRPM7 currents gradually 
and spontaneously decrease in time (Runnels et al., 
2001). This phenomenon is known as channel 
rundown and it is observed in whole-cell or inside-
out experiments with many other ion channels.  
 Remarkably, rundown of ion channels can be 
often rescued by application of PIP2. For example, 
plasma-membrane PIP2 stabilizes the open state of 
KNCQ1/KCNE1 K+ channels (Loussouarn et al., 
2003). Also, rundown of other K+ channels is 
under control of PIP2, eg. M-type K+ channels 
(Ford et al., 2004), ATP-sensitive K+ channels 
(Baukrowitz and Fakler, 2000) and inward 
rectifying K+ channels (Huang et al., 1998; Zhang 
et al., 1999; Logothetis and Zhang, 1999). 
Furthermore, the inactivation of other ion channels 
is modulated by PIP2. For Example, the activity of 
Cystic Fibrosis Transmembrane conductance 
Regulator (CFTR) is regulated by PIP2 and 
removal of PIP2 in excised patches results in 
current decay of CFTR (Himmel and Nagel, 2004). 
The voltage-gated P/Q- and N-type Ca2+ channels 
are regulated by PIP2 as well. These authors show 
that the time-dependent decrease in current activity 
(rundown) of P/Q and N-type calcium channels 
following membrane patch excision could be 
slowed down and partially reversed by the addition 
of PIP2, and accelerated with antibodies against 
PIP2 (Wu et al., 2002). Note that in all these cases 
channel activity is inhibited when PIP2 is 
hydrolyzed. 
 Regulation of TRP channels also depends on 
membrane phospholipids or their metabolites, in 
particular PIP2 (Hardie et al., 2001; Su et al., 
2006). Of particular interest is PIP2 that regulates 
several TRP ion channels. In general, PIP2 levels 
are maintained at the plasma-membrane through a 
metabolic pathway including kinases and 
phosphatases (Anderson et al., 1999; Tolias and 
Cantley, 1999). The final step in PIP2 synthesis is 
the phosphorylation of phosphatidylinositol 4-
phosphate (PI(4)P) by phosphatidylinosistol 4-
phosphate 5-kinase (PI(4)P 5-kinase). On the other 
hand, PIP2 can be dephosphorylated by inositol 
phosphatases (Majerus et al., 1999) or hydrolyzed 
by phospholipases (Rhee, 2001). PIP2 levels at the 
plasma-membrane maintain the TRP channels 
TRPL and TRPV1 in a closed state, whereas 
TRPM5 and TRPM8 are active in the presence of 
PIP2. With regard to TRPM7, PIP2 has an 
ambiguous effect on its’ activity. In whole-cell 
patch-clamp experiments, activated TRPM7 
currents are inhibited by Gq-protein coupled 
receptor stimulation, which is preceded by 
translocation of the PIP2-sensor GFP-PHδ1 
(Runnels et al., 2002). Under physiological 
conditions, when Mg2+i is undisturbed, TRPM7 
channels are mainly in a closed (Kozak and 
Cahalan, 2003; Schmitz et al., 2003; Hanano et al., 
2004; Matsushita et al., 2005; Chapter II). Unlike 
whole-cell experiments, in perforated-patch and 
Ca2+ imaging experiments PLC activation leads to 
TRPM7 opening, observed as increased membrane 
conductance and Ca2+ influx (Chapter II). 
 Here we show that whereas rundown of 
TRPM7 ion channels occurs spontaneously in the 
whole-cell patch clamp configuration, EDTA-AM 
activated TRPM7 currents display no channel 
rundown. As PIP2 levels regulate TRPM7 activity, 
we therefore investigated PIP2 kinetics in both 
patch configurations. By combining confocal 
microscopy and patch-clamp we show that loss of 
PIP2 at the plasma-membrane is preceded by 
translocation of GFP-tagged PI(4)P 5-kinase into 
the cytosol in whole-cell. As a result, inhibition of 
TRPM7 currents by PLC activity in whole-cell 
configuration is irreversible. In perforated patches 
GFP-tagged PI(4)P 5-kinase remains located at the 
plasma-membrane and therefore EDTA-AM 
activated currents are transiently inhibited by PLC 




 Amphotericin B, MgATP, bradykinin, 
lysophosphatidic acid and myo-inositol were from 
Sigma-Aldrich Co. (St. Louis, MO). EDTA-AM 
was from Molecular Probes Inc. (Eugene, OR). 
Ionomycin, U73122 was from Calbiochem-
Novabiochem Corp. (La Jolla, CA). Salts were 
from Merck (Darmstadt, Germany). Dulbecco’s 
MEM, foetal calf serum, penicillin and 
streptomycin were obtained from Gibco BRL 
(Paisley, Scotland). FuGene 6 transfection reagent 
was from Roche Diagnostics B.V. (Penzbreg, 
Germany). DiC8 was purchased from 






 The PIP2 sensor (eCFP-PHδ1 and eYFP-
PHδ1) was previously generated in our lab as 
described (van der Wal et al., 2001). PI(4)P 5-
kinase-GFP was a kind gift from Dr. N. Divecha 
(NKI, Amsterdam, the Netherlands)  
 
Cell Culture 
 Mouse N1E-115/TRPM7 cells were cultured 
in DMEM supplemented with 10% fetal calf 
serum, penicillin and streptomycin and kept in a 
humidified CO2 incubator. Cells were passaged 
twice a week and seeded on glass cover slips for 
experiments. Transfection of constructs with 
FuGene6 (1μg DNA/coverslip of each individual 
construct) was performed according to 
manufacturers’ guidelines (Roche). 
 
Dynamic FRET Essays 
 Cells grown on coverslips were transfected 
with FRET constructs (1μg/coverslip) using 
FuGene 6 according to manufactures’ guidelines, 
and experiments were performed as described 
previously (van der Wal et al., 2001); (Ponsioen et 
al., 2004). In brief, coverslips were placed on an 
inverted Nikon microscope and excited at 425nm 
using an ND3 filter. CFP- and YFP emission were 
collected simultaneously through 470 ± 20 and 530 
± 25 nm bandpass filters. Data were acquired at 4 
samples per second and FRET was expressed as 
ratio of CFP to YFP signals. This ratio was set to 
1.0 at the onset of the experiments, and changes 




 Electrophysiological recordings were 
collected using an EPC9 amplifier (HEKA 
electronics, Lambrecht, Germany), connected to a 
personal computer and controlled by HEKA pulse 
software. Voltage-clamp protocols were generated 
using HEKA pulse software, and current 
recordings were digitized at 100 kHz (ramp and 
block pulse protocols) or 10 Hz (steady-state 
whole-cell currents). Borosilicate glass pipettes 
were pulled on a p-2000 pipette puller (Sutter 
instruments, Novato, CA) and fire-polished 
(Narishige Microforge, Tokyo, Japan) to 2-4 MΩ. 
After establishment of the GΩ seal, the patched 
membrane was ruptured by gentle suction to obtain 
whole-cell configuration, or amphotericin B (240 
μg/ml) was used to obtain the perforated-patch 
configuration with typical access resistance of 3-10 
MΩ.  
 Solutions were as follows (in mM): whole-
cell pipette solution: K-Glutamate (120), KCl (30), 
MgCl2 (1), CaCl2 (0.2), EGTA (1), HEPES pH.7.2 
(10) and MgATP (1); external solution: NaCl 
(140), KCl (5), MgCl2 (0-1), CaCl2 (0-10), HEPES 
(10) and glucose (10), adjusted to pH 7.3 with 
NaOH; for perforated-patch recordings, the pipette 
solution was complemented with 240 μg/ml 
Amphotericin B and MgATP was omitted.  
 For Ca2+ recordings, cells on glass coverslips 
were incubated for 30 min with dyes, followed by 
further incubation in medium for at least 15 min. 
For pseudoratiometrical determinations (Lipp and 
Niggli, 1993; Rasmussen et al., 1986), a mixture of 
1 μg Oregon Green 488 BAPTA-AM and 4 μg 
Fura Red-AM in 100 μl medium was used. 
Coverslips were mounted on the inverted 
microscope and recordings were made at 37°C in 
HEPES-buffered saline, composed of (in mM): 
NaCl (140), KCl (5), MgCl2 (1), CaCl2 (1), HEPES 
(10) and glucose (10), pH 7.2. Single-cell 
fluorescence recordings were collected with a 
Nikon inverted microscope fitted with a Biorad 
MRC600 scanhead (Biorad, Herts, England). 
Excitation of Oregon Green and Fura-Red was at 
488 nm and emission was detected at 522 +/- 16 
nm and at >585 nm. Excitation of eGFP was at 488 
nm and emission was detected at 522 +/- 16 nm. 
All Ca2+ recordings were normalized at maximal 
ratio change after ionomycin treatment. All 
experiments were calibrated with respect to 
maximal translocation of eGFP-PHδ1 and eGFP-








 To study TRPM7 channels we retrovirally 
introduced TRPM7 in N1E-115 (N1E-
115/TRPM7) cells. Overexpression levels were 
estimated to be 2-3 times the endogenous TRPM7 
channel levels (Chapter II, Clark 2006). TRPM7 
currents are activated in whole-cell patch-clamp by 
depletion of intracellular Mg2+ using Mg2+-free 
pipette solutions (Figure 1A, Kozak and Cahalan, 
2003; Chapter II). After full activation of the 
currents, TRPM7 channels start to inactivate in 
time with a t½ of 643 +/- 62 s, N = 3. In contrast, 
when N1E-115/TRPM7 cells are monitored by 
perforated-patch clamping, no spontaneous 
currents are observed (Figure 1B). To activate 
TRPM7 currents in perforated patches, we sought 
to lower Mg2+i by loading the cells with EDTA-
AM, a membrane-permeable Mg2+ chelator that 
becomes trapped in the cell. Strikingly, after a 
short lag-time this treatment caused currents to 
develop that have all the hallmarks of whole-cell 
TRPM7 currents, i.e., the IV-plot of the activated 
currents is outward rectifying and reversal is 
around 0mV (Figure 1C, left panel, trace 1); the 
IV-plots of these currents become linear when 
cells are challenged with divalent-free media, and 
under these circumstances inward currents are 
completely inhibited by spermin, whereas outward 
currents are partially blocked (Figure 1C). EDTA-
AM activated currents are also blocked by 2-APB, 
La3+ and SKF 96365 (data not shown). All these 
results are in line with previously reported 
characteristics of TRPM7 currents (Prakriya and 
Lewis, 2002; Kozak and Cahalan, 2003; Chapter 
II). In contrast to whole-cell, perforated-patch 
recordings of TRPM7 currents in N1E-
115/TRPM7 cells never exhibited rundown, even 
not after 1 hour (Figure 1B). Thus, in perforated 
patches Mg2+-depletion activates TRPM7 currents 
with properties similar to whole-cell currents, with 
the exception that they do not show rundown. This 
suggests that in the whole-cell configuration, but 
not in perforated-patch, a factor necessary to keep 
TRPM7 open is lost over time. 
Figure 1: TRPM7 currents measured by 2
different patch clamp techniques. (A) TRPM7
currents measured in whole-cell mode by depletion of
intracellular Mg2+ depletion show time-dependent
inactivation (rundown). (B) N1E-115/TRPM7 cells do
not display TRPM7 current activation when recorded
by perforated-patch unless intracellular [Mg2+] is
chelated by loading the cells with 10μM EDTA-AM.
(C) EDTA-AM evoked currents linearize in divalent-
free media. Note the inhibition by spermin (50 μM).
Open circles depict currents determined at -80mV and





 In whole-cell experiments in HEK-293, it has 
been documented that activation of PLC by 
carbachol inactivates TRPM7 through loss of PIP2 
(Runnels et al., 2002). Similarly, in N115/TRPM7 
cells endogenous BK2 receptors (for which we 
recently showed that they couple exclusively to 
Gq/PLC; Chapter II) also irreversibly inhibit 
TRPM7 currents (Figure 2A, upper panel). 
Remarkably, when TRPM7 currents were evoked 
by EDTA-AM in perforated patches, application of 
BK resulted in a fast but transient inhibition of the 
current (Figure 2A, lower panel). As compared to 
the complete inhibition by BK in whole-cell 
recordings (99.7 +/- 1.0%, N=9), inhibition in 
perforated-patch is only partial (65.9 +/- 18.7%, 
N=8, Figure 2A & B). In perforated patches, 
TRPM7 currents usually fully restored within a 
few minutes after BK application. Thus, BK 




it transiently inhibits EDTA-AM-evoked TRPM7 




 To further address the role of PLC in TRPM7 
gating, we used the PLC inhibitor U73122. 
Pretreatment with U73122 for 15 minutes 
completely blocked Mg2+i depletion-induced 
TRPM7 activation in whole-cell recordings (data 
not shown), even though PLC is not thought to 
play a role in this mode of activation. This 
suggests that U73122 may have side-effects 
preventing TRPM7 activation by Mg2+ depletion. 
Furthermore, when TRPM7 channels were pre-
activated by Mg2+ depletion in whole-cell and 
subsequently challenged with U73122 we 
observed that the compound caused inactivation of 
the channels (Figure 3A), reminiscent of that 
evoked by BK, although the onset was slower  
 A part of the TRPM7 channel population is 
already open under resting conditions, resulting in 
increased basal Ca2+ levels as compared to native 
N1E-115 cells (Chapter II). We therefore tested if 
U73122 has the same effect on cytosolic Ca2+ by 
fluorometry. Indeed, in  N1E-115/TRPM7 cells 
basal Ca2+ levels declined upon addition of 
U73122. As expected, subsequent BK stimulation 
could not trigger any Ca2+ release from internal 
stores (Figure 3B), but remarkably, BK-induced 
Ca2+ influx was also blocked. These results suggest 
that, in addition to blocking PLC-mediated IP3 
production, U73122 causes TRPM7 channels to 
close by an unknown mechanism.  
 To verify that U73122 inhibits PLC activity, 
we transfected N1E-115/TRPM7 with a PIP2 
FRET sensor (van der Wal et al., 2001). Strikingly, 
application of U73122 caused a complete 
translocation of PIP2 sensor within 5 minutes, 
observed as loss of FRET (Figure 3C). Stimulation 
with BK and ionomycin/Ca2+ did not lower the 
FRET signal any further. Similar results were 
obtained with native N1E-115 and HEK-293 cells. 
Thus, to our surprise, U73122 elicits complete 
breakdown of plasma-membrane PIP2 levels by an 
unknown mechanism. Therefore we conclude that 
closure of TRPM7 channels mediated by U73122 
correlates with loss of PIP2 at the plasma-




 As TRPM7 channel inhibition by both BK 
and U73122 correlates with loss of PIP2, we 
combined patch-clamping and confocal imaging of 
GFP-PHδ1 (Varnai and Balla, 1998) to study 
rundown of TRPM7 currents and PIP2 kinetics 
simultaneously. During activation of TRPM7 
currents in whole-cell, GFP-PHδ1 localized to the 
plasma-membrane. After a few minutes, GFP-
PHδ1 started to gradually translocate into the 
cytosol (t½ = 983 +/- 131s, N=3), and concurrently 
TRPM7 currents ran down (t½ = 643 +/- 62, N=3, 
Figure 4A, arrowhead).  
Figure 3: U73122 affects TRPM7 channel functioning 
and PIP2 homeostasis. (A) U73122 causes decay of 
TRPM7 currents in whole-cell patch-clamp. The 
currents measured at -80mV are depicted by open circles 
and at +80mV by open squares, dashed line represents 0 
pA. (B) U73122 decreased the elevated basal Ca2+ levels 
at resting conditions. (C) The PIP2 levels at the plasma-
membrane, detected by the PIP2 FRET sensor (van der 
Wal et al., 2001), decreased upon treatment with 
U73122. Bradykinin and ionomycin are unable to lower 
the FRET signal any further . 
Figure 2: Effects of bradykinin receptor activation
on TRPM7 currents. (A) Upper panel, TRPM7
currents measured in whole-cell are irreversibly closed
after BK2-R receptor activation. Perforated-patch 
induced TRPM7 currents are transiently inhibited and
in time full TRPM7 activity is restored (lower panel).
Open circles depict currents determined at -80mV and
open triangles at +80mV. dashed line: 0 pA. (B)
Quantification of the degree of inhibition in whole cells
(black bar) and perforated-patch (white bar). Data are




 What happens with PIP2 levels when TRPM7 
is activated by EDTA-AM-mediated depletion of 
Mg2+ in intact cells? In confocal time-lapse 
experiments, GFP-PHδ1 was retained at the 
plasma-membrane during accumulation of EDTA-
AM in the cytosol (Figure 4B, upper panels). 
Subsequent stimulation with BK results in a fast 
translocation of the PIP2-sensor into the cytosol 
(Figure 4B, lower left panel). GFP-PHδ1 relocated 
towards the plasma-membrane within several 
minutes (Figure 4B lower right panel & 4C).  
 In conclusion, rundown of TRPM7 currents 




 Since breakdown of PIP2, both spontaneous or 
resulting from PLC activation, correlates with 
irreversible TRPM7 channel inactivation, we 
sought to determine which aspect of PIP2 
homeostasis is impaired. In whole-cell 
configuration, diffusable cytosolic components, 
including proteins of PIP2 homeostasis and PIP2 
precursors, will be washed out in time. The first 
step in phospho-inostide synthesis is attachment of 
free inositol to cystidine diphosphate 
diacylglycerol. As free inositol diffuses rapidly, we 
complemented the intracellular pipette solution 
with 5 mM inositol in an attempt to prevent loss of 
plasma-membrane PIP2. In the presence of free 
inositol, TRPM7 currents activated normally. 
However, in 3 independent experiments inositol 
supplementation could not prevent TRPM7 
channel rundown (Figure 5A).  We also included 
the water-soluble PIP2 analogue DiC8-PIP2 
(24μM) in the pipette solution to directly 
compensate for the loss of PIP2. Unexpectedly, this 
also did not rescue spontaneous rundown in whole-
cell configuration (Figure 5B). Perhaps the PIP2 
hydrolysis rate exceeds the diffusion of DiC8-PIP2 
from the pipette. We therefore raised the DiC8-
PIP2 concentration to 200μM, but unfortunately 
this prevented GΩ seal formation. 
 In another attempt to counteract PIP2 
hydrolysis in whole-cell patch clamp, we 
transfected GFP-PIP(5)-kinase into N1E-
115/TRPM7 cells. We combined recordings of 
GFP-PIP(5)-kinase membrane localization with 
whole-cell patch-clamping of TRPM7 currents. 
Remarkably, shortly after breaking the patched 
membrane, PIP(5)-kinase commences to 
translocate to the cytosol of N1E-115/TRPM7 
cells. The translocation of PIP(5)-kinase preceeds 
TRPM7 channel inactivation (t½PIP(5)-kinase = 421 
+/- 61s vs. t½TRPM7 = 643 +/- 62, N=3, Figure 5C). 
As PIP(5)-kinases are heavily dependent on 
intracellular Mg2+ concentration, we repeated the 
experiment with 3mM of free Mg2+ included in the 
pipette solution. Even under these conditions, 
PIP(5)-kinases fall off the membrane during 
whole-cell patch-clamping (Figure 5C), although 
TRPM7 currents are not activated under these 
conditions (Chapter II).  
 May the translocation of PIP(5)-kinases in 
whole-cell explain the difference observed in 
TRPM7 current kinetics between whole-cells and 
perforated patches? GFP-PIP(5)-kinase expressing 
N1E-115/TRPM7 cells were challenged with 
EDTA-AM, comparable to perforated-patch 
recordings of TRPM7 channel activation. Imaging 
of GFP-PIP(5)-kinase showed that it remained at 
the plasma-membrane even after 1 hour of loading 
with EDTA-AM. Furthermore, the PIP2 
concentration also remained stable, as judged from 
GFP-PHδ1 experiments. Thus, our experiments 
suggest that in whole-cell recordings loss of 
PIP(5)-kinase membrane localization underlies  
TRPM7 channel rundown, whereas in perforated-
patch conditions PIP(5)-kinases are unaffected.. 
The mechanism of this PIP(5)-kinase translocation 
remains to be addressed. 
Figure 4: TRPM7 channel inactivation follows PIP2
depletion in whole-cell. (A) Simultaneous recording of
GFP-PHδ1 membrane localization and whole-cell 
TRPM7 currents reveals that loss of TRPM7 currents
and PIP2 coincide. (B) PIP2 kinetics in N1E-
115/TRPM7 cells loaded with EDTA-AM. BK
stimulation caused a transient translocation of GFP-
PHδ1 to the cytosol (left panel). Right panel shows a
typical trace of GFP-PHδ1 translocation. Note that the
BK-mediated PIP2 kinetics in EDTA-AM treated cells
resemble the BK-mediated inhibition of TRPM7





Figure 5: Impaired PIP2 homeostatis due to PIP(5)-kinase translocation in whole-cell, but not in perforated patch
Neither complementation of 5mM free inositol in the pipette solution (A) nor DiC8-PIP2 (B) is able to rescue TRPM7 
rundown in whole-cell patch clamping. (C) TRPM7 current decrease is preceeded by GFP-PI(4)P 5-Kinase translocation 
from the plasma-membrane. Note that GFP-PIP(4) 5-kinase translocation is independent of the presence of intracellular 
Mg2+. (D) Mg2+ depletion by EDTA-AM does not cause translocation of PIP(5)-kinase. All data are depicted as mean + 
SEM, N = 3, bar equals 10μM 
Discussion 
 In this study we compared TRPM7 channel 
activation and rundown occurring in whole-cell 
patch clamp experiments and perforated-patch 
mode. In close agreement with results published 
previously for HEK-293 cells {Runnels, 2002 20 
/id}, we show that in N1E-115/TRPM7 cells 
depletion of intracellular Mg2+ evokes TRPM7 
currents that subsequently gradually decrease and 
return to resting levels (Figure 1A). Furthermore, 
activation of PLC-coupled GPCRs inhibited 
TRPM7 currents permanently in whole cells 
(Runnels 2002, chapter II). Using a new 
experimental paradigm to evoke TRPM7 currents 
in perforated patches, we show that TRPM7 
channels do not rundown in this configuration. 
Moreover, in this configuration bradykinin caused 
transient, rather than sustained, inhibition of 
TRPM7 currents (Figure 2A, lower panel) 
 We also show that spontaneous TRPM7 
rundown coincides with loss of PIP2, as detected 
as translocation of GFP-PHδ1 from the plasma-
membrane into the cytosol (Figure 4A). Similarly, 
in HEK-293 cells carbachol-induced loss of PIP2 
accompanied TRPM7 inactivation (Runnels et al., 
2002). In this study, too, stimulation with 
bradykinin, which results in massive breakdown of 
PIP2 at the plasma-membrane (Chapter II), 
irreversibly closed TRPM7 channels in whole-cell. 
In contrast, in perforated-patch experiments 
spontaneously PIP2 depletion does not occur. 
Furthermore, the effects of BK on PIP2 are 
transient (Figure 4B). This is in line with an earlier 
report of Runnels et al., showing that inactivated 
TRPM7 channels could be reactivated by 
application of a water-soluble PIP2 analogue, 
recorded at single channel level (Runnels et al., 
2002). Therefore, it appears that TRPM7 channel 
function requires the presence of PIP2 at the 
plasma-membrane. We here propose that the PLC-
mediated inhibition of TRPM7 channels in whole-
cell is best interpreted as accelerated rundown, and 
as such an artifact of whole-cell recording.  
 In contrast, Takezawa et al. reported that not 
PLC/PIP2 activity but rather the level of cytosolic 
cyclic AMP, is the major regulator of TRPM7 
activity, (Takezawa et al., 2004). However, this 
notion was rejected in Chaper II. Perhaps the 
discrepancy between Runnels’ and our study on 
the one hand, and that of Takezawa and colleagues 
on the other hand, is a difference in potency of the 
PLC-activating receptors used. In their hands and 
also in our hands, endogenous M1 receptors cause 
only minor PIP2 breakdown.. Their study 
furthermore relied on the use of the ‘PLC 
inhibitor’ U-73122, a compound that we here show 
to have side effects opposite to that of PLC 
inhibition. For example, we noted that, in addition 
to blocking PLC, freshly prepared U73122 
completely depleted intracellular PIP2 levels, 
whereas the compound rapidly lost its’ potency in 
solution (KJ, unpublished observation). Horowitz 
and Hille very recently reported similar findings 
for this compound {Horowitz, 2005 322 /id}. 
Furthermore, various side-effects of U73122 on 
phospho-inositide homeostasis (Vickers, 1993), on 
G-protein mediated signaling and various 
phospholipases (A, C and D) activity  had been 
noted before (Balla, 2001). 
 What causes spontaneous PIP2 breakdown 
during studies performed in whole-cell and inside-
out experiments? Recent studies on the role of PIP2 
in TRPM8 function pointed out that inhibition of 




(Rohacs et al., 2005; Liu and Qin, 2005). This 
indicates that synthesis of PIP2 in whole-cell and 
inside-out patch clamping is impaired. In this study 
we show that PIP(5)-kinases translocate from the 
plasma-membrane in whole-cell configuration, 
resulting in loss off PIP2. It is well known that PIP-
kinases are strongly dependent on free Mg2+ and 
MgATP to function properly (Ling et al., 1989). 
However, we show that translocation of PIP(5)-
kinases is not caused by depletion of intracellular 
Mg2+ (Figure 5C). This may explain why other 
PIP2-dependent ion channels inactivate in time, 
even in the presence of Mg2+ and MgATP. In 
contrast, when  intracellular Mg2+ is depleted by 
loading of EDTA-AM, PIP(5)-kinases remain at 
the plasma-membrane and the PIP2 homeostasis 
remains in balance. Hence, whole-cell experiments 
result in translocation of PIP(5)-kinases by an 
unknown mechanism. Thus, the same mechanism 
underlies TRPM7 channel rundown and 
irreversible inactivation by receptor-mediated PLC 
activation. This is not observed during perforated-
patch experiments.  
 Does the TRPM7 sequence reveal any 
indication of PLC and/or PIP2-binding sites? 
TRPM7 was identified as an interactor with PLC 
isozymes, which bind to its kinase domain 
(Runnels et al., 2001). Recently it has been shown 
that a C-terminal “split PH-domain” of PLCγ1 can 
recombine with a split PH-domain found in 
TRPC3 to form a functional PH-domain (Van 
Rossum et al., 2005). Therefore, we analyzed the 
TRPM7 sequence for the presence of split PH-
domain by a home-written algorithm (Van Rossum 
et al., 2005). We identified a complementary split 
PH-domain located in the kinase-domain of 
TRPM7 (1643 to 1658). Future biochemical 
studies are needed to demonstrate this interaction 
and assess how it may affect TRPM7 regulation. 
Additionally, there may be direct binding of PIP2 
to TRPM7 channels analogous to other PIP2-
regulated TRP channels. For example, the TRP-
domain of TRPM8 interacts with PIP2, and this 
controls channel function (Rohacs et al., 2005). 
Based on sequence homology between the TRPM 
subfamily members, this may also be valid for 
TRPM7. Sequence analysis of TRPM7 further 
reveals other potential PIP2-binding sites. 
Downstream of the TRP-domain, a positive stretch 
of aminoacids (1111 to 1115, Figure 6) may bind 
to the negatively charged inositol group of PIP2. 
Furthermore, a modular PIP2-binding domain is 
predicted at 1147-1218 (T. Balla, Bethesda, 
personal communication), similar to the capsaicin 
sensitive TRPV1 channels (Prescott and Julius, 
2003). While the TRPM7 protein sequence 
suggests the presence of PIP2 and PLC binding 
motifs, experiments to validate these putative 
binding sites are needed. 
Figure 6: Schematic representation of possible
PLC/PIP2 interaction sites in TRPM7. A split PH-
domain (dark grey) complementary to a C-terminal split
PH-domain of PLCγ1 was predicted in the kinase-
domain of TRPM7. Further putative PIP2 interaction
sites in TRPM7 are the TRP-domain, a stretch of
positively charged amino-acids (light grey) and
modular PIP2-binding site, similar that of TRPV1. 
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 Actomyosin contractility regulates various 
cell biological processes including cytokinesis, 
adhesion and migration. While in lower 
eukaryotes α-kinases control actomyosin 
relaxation, a similar role for mammalian α-
kinases has yet to be established. Here, we 
examined whether TRPM7, a cation channel 
fused to an α-kinase, can affect actomyosin 
function. We demonstrate that activation of 
TRPM7 by bradykinin leads to a Ca2+- and 
kinase-dependent interaction with the 
actomyosin cytoskeleton. Moreover, TRPM7 
phosphorylates the myosin IIA heavy chain. 
Accordingly, low overexpression of TRPM7 
increases intracellular Ca2+ levels accompanied 
by cell spreading, adhesion and the formation 
of focal adhesions. Activation of TRPM7 
induces the transformation of these focal 
adhesions into podosomes by a kinase-
dependent mechanism, an effect that can be 
mimicked by pharmacological inhibition of 
myosin II. Collectively, our results demonstrate 
that regulation of cell adhesion by TRPM7 is 
the combined effect of kinase-dependent and -




 Actomyosin contractility in nonmuscle cells 
plays a fundamental role in regulating basic 
cellular functions such as cell shape, cytokinesis, 
adhesion and migration (Burridge and 
Wennerberg, 2004; De la Roche et al, 2002; 
Geiger and Bershadsky, 2002). Myosin II is the 
major motor protein driving contractility. 
Regulators of myosin II-based contractile 
responses include the Rho GTPase family and their 
effectors, myosin light chain (MLC) kinases and 
phosphatases as well as myosin heavy chain 
(MHC) kinases (Burridge and Wennerberg, 2004; 
De la Roche et al, 2002). The Dictyostelium 
genome encodes several MHC kinases, which are 
essential for proper localization and assembly of 
myosin II during cell division and migration (Heid 
et al, 2004; Kolman et al, 1996; Rico and 
Egelhoff, 2003). Myosin II assembles into bipolar 
thick filaments that generate cortical tension by 
pulling together oppositely oriented actin 
filaments. MHC kinases inhibit myosin II function 
by phosphorylating the MHC tail on threonine 
residues leading to filament disassembly and 
consequently, a release in cortical tension 
(Egelhoff et al, 1993). The cell biological effects 
of overexpression or knockout of these MHC 
kinases are consistent with this paradigm. Defects 
in cytokinesis due to overexpression of MHC 
kinases are reversed by expressing a MHC mutant 
that cannot be phosphorylated and therefore forms 
stable myosin filaments (Rico and Egelhoff, 2003). 
Thus, MHC kinases play a key role in actomyosin 
remodeling in Dictyostelium. 
 Dictyostelium MHC kinases belong to a rare 
and novel class of kinases known as α-kinases 
that, with the exception of the ATP-binding site, 
show only limited sequence similarity with other 
members of the protein kinase superfamily 
(Ryazanov, 2002). Based on in vivo substrates 
identified to date, these kinases preferentially 
phosphorylate threonine residues presented within 
the context of an α-helix, hence the name α-
kinases (Ryazanov, 2002). Whether mammalian α-
kinases also regulate actomyosin contractility has 
yet to be established. 
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 The mammalian genome encodes several α-
kinases whose function, with the exception of 
elongation factor kinase, is unknown (Drennan and 
Ryazanov, 2004). Notably, TRPM6 and TRPM7 
are two bifunctional proteins encoding a TRP 
cationic channel fused to a COOH-terminal α-
kinase domain. Electrophysiological charac-
terization of TRPM7 has suggested that it forms 
part of the channel responsible for the Magnesium 
Inhibited Current (MIC) and is implicated in 
cellular Mg2+ homeostasis (Kozak and Cahalan, 
2003; Nadler et al, 2001; Schmitz et al, 2003). 
However, TRPM7 may also relay signals by 
phosphorylating downstream effector molecules. 
In line with a hypothesized role for TRPM7 as an 
active component in receptor mediated signal 
transduction, it was reported that TRPM7 channels 
are highly permeable to Ca2+, that the TRPM7 
COOH-terminus associates with phospholipase C 
(PLC) isoforms and that PLC activation regulates 
TRPM7 channel opening (Runnels et al, 2001; 
Runnels et al, 2002; Langeslag et al., manuscript 
in preparation). We have previously found that 
bradykinin, a Gq-PLC coupled receptor agonist, 
induces Ca2+-dependent phosphorylation of the 
MHC and disassembly of myosin IIA at the cell 
periphery, which correlates with cell spreading and 
adhesion in mammalian cells (van Leeuwen et al, 
1999). Thus, we hypothesized that the coupling of 
a cation channel to an α-kinase in a single 
polypeptide could explain the close relationship 
between Ca2+ signaling and Ca2+-dependent 
actomyosin remodeling. Here, we investigated 
whether TRPM7 could link receptor-mediated 






 To examine a role for TRPM7 in the 
regulation of actomyosin contractility, an HA-
tagged TRPM7 cDNA encoding wild-type 
(TRPM7-WT) or a kinase-dead mutant (TRPM7-
D1775A) were introduced into N1E-115 
neuroblastoma cells by retroviral transduction (a 
technique that allows low, near physiological 
expression of recombinant proteins; supplementary 
Fig. S1). Both TRPM7-WT and TRPM7-D1775A 
were equally expressed at 2-3 times over 
endogenous TRPM7 levels (Fig. 1A, 
supplementary S2; Langeslag et al., manuscript in 
preparation). Both TRPM7-WT and TRPM7-
D1775A run as doublets at 216 kDa due to 
differential glycosylation (supplementary Fig. S3). 
Moreover, proper localization of TRPM7-WT and 
TRPM7-D1775A to the plasma membrane was 
confirmed by fluorescence microscopy 
(supplementary Fig. S3; see also Fig. 4).  
Figure 1 TRPM7 enhances receptor-operated 
calcium influx. (A) Expression of TRPM7-WT and 
TRPM7-D1775A in N1E-115 neuroblastoma cells was 
detected by IP-Western blot using antibodies against 
the HA-tag. Cells containing the empty vector were 
used as control in all experiments. (B) TRPM7 
expression causes sustained Ca2+ influx following BK 
stimulation independently of kinase activity. Left panel, 
typical time course of BK-induced Ca2+ changes in 
control N1E-115 cells; other panels, BK-induced Ca2+
mobilizations in N1E-115/TRPM7 cells. The sustained 
influx depends on Ca2+ influx since it is acutely blocked 
by extracellular La3+ and Gd3+ (data not shown). (C) 
Quantification of Ca2+ data for control and TRPM7-
overexpressing cells (mean ± SEM from at least 20 
experiments for each condition). Significant differences 
(*) are P < 0.01 from values obtained in control N1E-
115 cells.  
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 Initially, we investigated by Ca2+ 
fluorometry whether TRPM7 is activated 
following stimulation with bradykinin (BK), a 
peptide agonist that promotes actomyosin 
relaxation in N1E-115 cells (van Leeuwen et 
al, 1999). Low overexpression of TRPM7 in 
N1E-115 cells resulted in a moderate elevation 
of the resting Ca2+ levels (109 ± 9 nM vs. 85 ± 
4 nM). The addition of BK triggered a rapid 
increase in cytosolic Ca2+ from internal stores 
in both parental and TRPM7 transduced cells. 
Strikingly in N1E-115/TRPM7 cells, this 
initial Ca2+ transient was followed by a 
sustained phase of elevated Ca2+ that lasted for 
several minutes before returning to basal 
levels and was not observed in the parental 
cells (Fig. 1B). Removal of extracellular Ca2+ 
by BAPTA immediately terminated the 
plateau phase (data not shown). Patch-clamp 
studies and inhibitor profiling identified 
TRPM7 as the channel responsible for the 
Ca2+ influx (a detailed analysis of TRPM7 
channel function will be published elsewhere; 
Langeslag et al., manuscript in preparation).  
Finally, channel activation of kinase-dead 
TRPM7-D1775A by BK was not altered in 
comparison to TRPM7-WT (Fig. 1B,C), 
demonstrating that TRPM7 kinase activity is 
not required for BK-induced Ca2+ influx. From 
these results, we conclude that TRPM7 






 Mouse N1E-115 neuroblastoma cells are an 
excellent model system to study the regulation of 
actomyosin contractility since signals that either 
activate contraction or promote relaxation are 
rapidly translated into cell rounding or cell 
spreading responses, respectively (Jalink et al, 
1994; van Leeuwen et al, 1997; van Leeuwen et al, 
1999). Consistent with a role for TRPM7 in 
actomyosin regulation, N1E-115/TRPM7 cells 
showed enhanced spreading when compared to the 
parental cells (Fig. 2A,B). In addition to effects on 
cell spreading, low overexpression of TRPM7 
increased cell-matrix adhesion of N1E-115 cells 
(Fig. 2A,C). Both effects of TRPM7 were 
independent of kinase activity, suggesting that 
Ca2+-dependent mechanisms account for the 
morphological differences between parental and 
TRPM7-transduced cells.  
Figure 2 TRPM7 overexpression induces cell
spreading and increases cell adhesion. (A) Phase 
contrast images of control, TRPM7-WT and TRPM7-
D1775A expressing N1E-115 cells. Scale bar = 50 μm. 
(B) Cell surface area covered by N1E-115 cells
expressing WT and kinase-dead TRPM7. Cells were
stained for F-actin and cell surface area was calculated
by quantifying the amount of pixels that exceeded a
threshold (n>5). (C) Quantification of cell adhesion of
N1E-115 cells expressing WT and kinase-dead TRPM7
(n=3). Significant differences (*) are P < 0.01 from




 In light of the effects of TRPM7 on cell 
morphology and adhesion, we further investigated 
the effect of low TRPM7 overexpression and 
activation on the subcellular distribution of F-
actin, myosin IIA and vinculin by confocal 
microscopy (Fig. 3A). Control N1E-115 cells 
displayed a predominantly cortical distribution of 
F-actin and myosin IIA, with little or no focal 
adhesions nor stress fibers. Following BK-induced 
cell spreading, a part of this peripheral actomyosin 
was lost while small focal adhesions could now be  
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Figure 3 Activation of TRPM7 induces actomyosin reorganization in conjunction with podosome formation. (A)
TRPM7 activation induces actomyosin reorganization and formation of podosomes in N1E-115/TRPM7 cells. Cells 
were either serum starved (0.1% FCS) or stimulated with BK (10 nM; 30 min) and stained for actin (red), myosin IIA
heavy chain (green) and vinculin (blue). Cells were analyzed by confocal microscopy. Scale bar = 20 μm. (B) Increase in 
cell surface area and production of podosomes occurs within minutes of BK stimulation in N1E-115/TRPM7 cells. N1E-
115/TRPM7 cells expressing GFP-β-actin were followed by confocal microscopy before and after BK stimulation. Cell
surface area was measured as described in Materials and Methods. Grayvalues are displayed using the Fire 
LookUpTable (LUT) of the public domain software Image J (National Institutes of Health, Bethesda, USA).  Left panel,
a resting cell; middle panel, the same cell 12 min post-BK stimulation; right panel, kinetics of BK-induced cell 
spreading. A movie is provided as supplementary data. Scale bar =15 μm. (C) High magnification of myosin lattices 
found in N1E-115/TRPM7 cells following BK stimulation. N1E-115/TRPM7 cells were transfected with GFP-myosin, 
stimulated with BK and stained for actin. Scale bar = 2 μm.  
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observed at the cell periphery by vinculin staining. 
In N1E-115/TRPM7 cells, a profound 
redistribution of actomyosin was observed. In 
contrast to the parental cells, focal adhesions were 
already present in unstimulated cells, whereas 
myosin IIA was dispersedly staining the 
cytoplasm. BK stimulation caused further cell 
spreading and increased the number and size of 
adhesion complexes. These responses were  
noticeable within 2 min and peaked at  
approximately 10 min after BK stimulation (Fig. 
3B and supplementary movie 1). The architecture 
and size (~1 μm) of these adhesion structures were 
remarkably different from the focal adhesions 
observed in unstimulated cells and resembled that 
of podosomes (Linder and Aepfelbacher, 2003). 
Similar to podosomes, the TRPM7-induced 
adhesions, found at the interface of the cell and 
matrix, had a diameter of approximately 1 μm. 
Moreover, they consisted of an actin core 
surrounded by vinculin and conspicuous myosin 
lattices that were no longer associated with actin 
stress fibers (Fig. 3C). We conclude therefore, that 





 To examine whether TRPM7 may affect cell 
adhesion locally, we investigated the cellular 
distribution of TRPM7 by immunofluorescence. 
TRPM7 was clearly present within membrane 
ruffles indicating that the protein is localized at the 
cell surface (Fig. 4A). In addition, TRPM7 is 
enriched in cell adhesions where it is found in the 
podosome ring structure, together with myosin IIA 
(Fig. 4B,C). Our results suggest that TRPM7 
regulates cell adhesion by directly affecting 
components within these structures.  
 
Figure 4 TRPM7 is present at the cell surface and
localizes to cell adhesion structures. N1E-
115/TRPM7-WT cell were stimulated with BK (10 nM;
30 min). Subsequently, TRPM7 was detected using
anti-HA (3F10) antibody followed by alexa 488-
conjugated anti-rat IgG. The actin cytoskeleton was
visualized using phalloidin-texas red. (A) TRPM7 is
found in membrane ruffles. Scale bar = 10 μm. (B) 
TRPM7 forms a ring surrounding the actin dense core
of podosomes. Scale bar = 10 μm.  (C) High
magnification of TRPM7 rings within podosomes.
Scale bar = 5 μm. A rat IgG control antibody did not




 Although the global effects of TRPM7 on cell 
spreading and adhesion appear to be independent 
of kinase activity, we tested whether the TRPM7 
kinase domain affects the subcellular organisation 
of the actomyosin cytoskeleton. By confocal 
microscopy, we compared N1E-115 cells 
expressing TRPM7-WT with cells expressing the 
kinase-dead TRPM7-D1775A mutant. No clear 
differences were noticed between unstimulated 
cells (data not shown). However to our surprise, 
cells expressing kinase-dead TRPM7 failed to 
induce podosomes in response to BK stimulation 
(Fig. 5). We conclude that TRPM7 activation  
Figure 5 Regulation of podosome formation by 
TRPM7 is kinase-dependent. N1E-115/TRPM7-WT 
and N1E-115/TRPM7-D1775A cells were stimulated 
with BK (10 nM; 30 min) and stained for actin (red), 
myosin IIA heavy chain (green) and vinculin (blue). 
Cells were analyzed by confocal microscopy. Scale bar 
= 20 μm.   
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Figure 6 Inhibition of myosin II function in N1E-115 cells expressing TRPM7-WT and TRPM7-D1775A leads to 
podosome formation. (A) N1E-115/TRPM7-WT and N1E-115/TRPM7-D1775A cells were incubated in the presence 
of vehicle control or 50 μM blebbistatin for 30 min. Cells were stained for actin (red), myosin (green) and vinculin (blue)
and visualized by confocal microscopy. Scale bar = 15 μm. (B) High magnification view shows that the adhesion 
complexes induced by BK and blebbistatin in N1E-115/TRPM7-WT cells are architecturally similar since they consist of 




results in a kinase-dependent remodeling of the 







 Actomyosin contractility plays a central role 
in regulating the assembly and dissasembly of 
adhesive contacts (Geiger and Bershadsky, 2002). 
Notably, the formation of podosomes requires a 
local inhibition of actomyosin contractility 
suggesting that TRPM7 may regulate podosome 
assembly by promoting relaxation of the 
actomyosin cytoskeleton (Burgstaller and Gimona, 
2004). To further test this model, we investigated 
the effect of directly inhibiting myosin II function 
on cell adhesion in N1E-115 cells expressing 
TRPM7-WT and TRPM7-D1775A. Treatment of 
cells with blebbistatin (a selective inhibitor of 
myosin II ATPase activity) led to the 
transformation of focal adhesions into podosomes 
independently of TRPM7 kinase activity (Fig. 6A). 
These effects of blebbistatin do not require 
exogenous TRPM7 as parental N1E-115 cells also 
produce podosomes in response to myosin II 
inhibition (supplementary Fig. S4). Notably, the 
adhesive structures formed upon blebbistatin 
treatment are remarkably similar to those formed 
after BK stimulation of N1E-115/TRPM7-WT 
cells (Fig. 6B). These findings indicate that the 
transformation of normal focal adhesions into 
podosomes by BK-mediated activation of TRPM7 
is due to a kinase-dependent inhibition of myosin 




 Since TRPM7 is a member of the α-kinase 
family, we hypothesized that it may affect 
actomyosin remodeling and podosome assembly 
by directly coupling to and potentially 
phosphorylating components present within the 
actomyosin cytoskeleton. Therefore, we 
precipitated TRPM7 complexes with anti-HA 
antibodies and detected the presence of associated 
proteins by Western blotting. Both β-actin and the 
myosin IIA heavy chain were present in a complex 
with TRPM7 (Fig. 7A). Importantly, endogenous 
TRPM7 also associates with the actomyosin 
cytoskeleton (Fig. 7B). This interaction indeed 
suggests that TRPM7 can affect actomyosin 
function through a direct association with 




 Since TRPM7 activation by BK results in 
Ca2+ -influx and a kinase-dependent remodeling of 
the actomyosin cytoskeleton, we investigated 
whether the interaction between TRPM7 and the 
actomyosin cytoskeleton is subject to regulation. 
BK stimulation of N1E-115/TRPM7 cells led to a 
transient increase in the amount of TRPM7-
associated myosin IIA (Fig. 7C,D). Its kinetics 
closely correlate with those of calcium influx in 
response to TRPM7 activation (refer to Fig. 1) 
with maximal association observed at about 2 min 
after agonist addition.  Moreover, chelation of 
Ca2+, using BAPTA or EDTA, abrogated the 
association between TRPM7 and myosin IIA (Fig. 
7E). These results indicate that the interaction 
between TRPM7 and myosin IIA is strictly Ca2+-
dependent, and suggest that TRPM7-mediated 
Ca2+ influx enhances the TRPM7/myosin IIA 
interaction. However, in addition to Ca2+, the 
association of TRPM7 with the cytoskeleton 
requires an active kinase domain since the kinase-
dead TRPM7-D1775A mutant did not interact with 
myosin IIA (Fig. 7F). A soluble COOH-terminus 
variant containing the kinase domain of TRPM7 
also interacted with myosin IIA (Fig. 7G). We 
conclude therefore that the interaction between 
TRPM7 and myosin IIA is mediated by the 
COOH-terminus and requires an active kinase 
domain.  
Figure 5 Regulation of podosome formation by
TRPM7 is kinase-dependent. N1E-115/TRPM7-WT 
and N1E-115/TRPM7-D1775A cells were stimulated
with BK (10 nM; 30 min) and stained for actin (red),
myosin IIA heavy chain (green) and vinculin (blue).
Cells were analyzed by confocal microscopy. Scale bar




 Hitherto, we have shown that TRPM7 
associates with myosin IIA in a regulated manner 
and that both activation of TRPM7-WT (but not 
TRPM7-D1775A) and inhibition of myosin II  
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Figure 7 TRPM7 activation promotes its association via the COOH-terminus with the actomyosin 
cytoskeleton in a calcium- and kinase-dependent manner. In all experiments (except panel B), N1E-115 control 
or TRPM7-transduced cells were lysed and incubated with anti-HA-coupled protein G beads for 3 h at 4oC. Proteins 
in the complex were detected by Western blotting. (A) Coimmunoprecipitation of TRPM7 with β-actin and myosin 
IIA. Top, detection of TRPM7 with anti-HA antibodies; middle and bottom, detection of myosin IIA and β-actin, 
respectively, in the immune complexes (IP, left) and total lysates to control for protein levels (TL, right). (B) 
Endogenous TRPM7 associates with the actomyosin cytoskeleton. PC12 lysates were incubated with pre-immune 
serum or anti-TRPM7 serum and protein complexes were isolated using protein G-sepharose. The presence of 
myosin IIA was detected by Western blotting. Top, detection of associated myosin IIA heavy chain in 
immunoprecipitates; and Bottom, in total lysates. (C) Coimmunoprecipitation of TRPM7 with myosin IIA heavy 
chain in the pre- and post-BK stimulation (10 nM, 1 min). Top, detection of coimmunoprecipitated myosin IIA. 
Middle, detection of TRPM7 with anti-HA antibodies. Bottom, detection of myosin IIA heavy chain in total lysates
to control for protein levels. (D) Kinetics of BK induced TRPM7 association with myosin IIA heavy chain. Cells
were stimulated with BK (10 nM) for the indicated times and TRPM7 was immunoprecipitated using anti-HA 
antibodies. Top, Western blot showing coimmunoprecipitated myosin IIA heavy chain. Bottom, detection of myosin
IIA heavy chain in total lysates. (E) Interaction between TRPM7 and myosin IIA heavy chain is Ca2+-dependent. 
N1E-115/TRPM7 cells were pre-incubated with 10 mM BAPTA or EDTA for 1 min prior to cell lysis and TRPM7
was immunoprecipitated using anti-HA antibodies. (F) TRPM7-D1775A does not interact with myosin IIA heavy 
chain. TRPM7-WT and –D1775A were immunoprecipitated with anti-HA antibodies and associating myosin IIA 
heavy chain was detected by Western blotting. (G) The COOH-terminus of TRPM7 interacts with myosin IIA. The 
soluble COOH-terminus of TRPM7 (a.a. 1158-1864) was immunoprecipitated from N1E-115/TRPM7-C cells with 
anti-HA antibodies and associated myosin IIA was detected by Western blotting. Top, detection of associated
myosin IIA heavy chain; bottom, detection of TRPM7-C using anti-HA antibodies in immunoprecipitation (IP, left) 
and in total lysates (TL, right).  
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function produce podosomes suggesting that 
TRPM7 activation promotes actomyosin 
relaxation. How does TRPM7 mediate the 
inhibition of myosin II function? By analogy to 
regulation of Dictyostelium myosin II function, we 
have previously proposed that Ca2+-dependent 
MHC phosphorylation contributes to cytoskeletal 
relaxation (van Leeuwen et al, 1999). The finding 
that TRPM7 coprecipitates with myosin IIA, 
particularly after BK stimulation, enabled us to test 
whether TRPM7 can phosphorylate myosin IIA 
heavy chain. Since TRPM7 and myosin IIA heavy 
chain co-migrate on SDS-PAGE gels, TRPM7 was  
 
immunoprecipitated both under conditions that 
favor association and dissociation (low vs. high 
stringency) of the cytoskeletal complex allowing 
us to distinguish between TRPM7 
autophosphorylation and myosin phosphorylation. 
By in vitro kinase assays, TRPM7 underwent 
autophosphorylation in agreement with earlier 
findings (Runnels et al, 2001; Ryazanova et al, 
2004; Schmitz et al, 2003) (Fig. 8A; bottom 
panel). Strikingly, clear phosphorylation of 
associated myosin IIA heavy chain (which runs 
slightly faster than TRPM7) was also observed in 
these kinase reactions (Fig. 8A; bottom panel). In 
contrast, actin was not phosphorylated (data not 
shown).  
 To demonstrate that TRPM7 directly 
phosphorylates myosin IIA heavy chain, a myosin 
tail fragment was expressed as a GST-fusion 
protein in E. coli to serve as substrate whereas 
TRPM7 was immunoaffinity purified from 
Figure 8 TRPM7 phosphorylates myosin IIA heavy 
chain. (A)  In vitro kinase assay detecting the 
phosphorylation of associated myosin IIA heavy chain 
by TRPM7. TRPM7/myosin IIA heavy chain 
complexes were isolated before and after stimulation of 
N1E-115 control and N1E-115/TRPM7 cells with BK 
(10 nM, 2 min) under low (1% triton X-100) and high 
(1% triton X-100/ 0.5% deoxycholate/ 0.1% SDS) 
stringency conditions. Substrates of TRPM7 were 
detected by labeling proteins with γ-32P-ATP, 
separating products of the in vitro kinase assay by SDS-
PAGE (6% gel) followed by autoradiography. Top, 
Coomassie staining of precipitated proteins. Bottom, 
autoradiogram of phosphorylated proteins. Note that 
myosin association is lost under high stringency 
conditions (1% triton X-100/ 0.5% deoxycholate/ 0.1% 
SDS) whereas TRPM7 autophosphorylation is 
unaffected. (B) TRPM7 phosphorylates recombinant 
myosin IIA. TRPM7-WT and –D1775A were 
immunoaffinity purified from HEK293 cells using anti-
HA antibodies under high stringency and mixed with 2 
μg of GST or GST-myosin IIA in kinase buffer. To 
detect phosphorylated myosin IIA, the proteins were 
separated by SDS-PAGE (12 % gel) followed by 
autoradiography. Top, Coomassie staining of GST-
fusion proteins. Note that GST co-migrates with the 
antibody light chain (Ig LC). Middle, autoradiogram of 
phosphorylated GST-fusion proteins.  Bottom, 
autoradiogram showing autophosphorylation of WT but 
not kinase-dead TRPM7. (C) Recombinant TRPM7 
kinase phosphorylates myosin IIA. The TRPM7 kinase 
domain (1403-1864 aa) was produced in E. coli as a 
fusion with maltose binding protein and purified on an 
amylose column. The purified kinase was incubated 
with 2 μg of GST or GST-myosin IIA in kinase buffer. 
The proteins were resolved on a 12% SDS-PAGE gel 
and detected by coomassie. Phosphorylated proteins 
were visualized by autoradiography. Left, coomassie 
staining of gel; right, autoradiogram.  
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mammalian cells or the COOH-terminus of 
TRPM7 was purified from E. coli. In in vitro 
kinase assays, immunoaffinity purified WT but not 
kinase-dead TRPM7 efficiently phosphorylated 
recombinant myosin IIA (Fig. 8B). Notably, GST 
was not phosphorylated by TRPM7 (Fig. 8B). 
Similar results were obtained when using the 
soluble COOH-terminus of TRPM7 (data not 
shown). Importantly, contaminating actin in the 
purified TRPM7 fractions is below detection levels 
and disruption of the actin cytoskeleton prior to 
TRPM7 purification had no effect on the level of 
myosin II phosphorylation arguing against the 
presence of contaminating kinases (supplementary 
Fig. S5). Finally, recombinant TRPM7 purified 
from E. coli lysates also efficiently phosphorylated 
myosin IIA, in the absence of other sources of 
eukaryotic proteins (Fig. 8C). Thus, TRPM7 itself 
and not an associated kinase is responsible for 
myosin IIA heavy chain phosphorylation. 
Collectively, our results demonstrate that TRPM7 
associates with the actomyosin cytoskeleton in a 
Ca2+- and kinase-dependent manner to regulate 
myosin II activity and consequently, actomyosin 
contractility. Moreover, our in vitro kinase data 
suggest that phosphorylation of the myosin IIA 




 In this study, we have tested the 
hypothesis that TRPM7, by analogy to its α-
kinase family members from Dictyostelium, 
affects actomyosin contractility. We provide 
evidence that TRPM7 promotes relaxation of 
the actomyosin cytoskeleton via a kinase-
dependent inhibition of myosin II, potentially 
involving myosin IIA heavy chain 
phosphorylation. The evidence includes: i) 
electrophysiological measurement of TRPM7 
channel opening after BK stimulation; ii) 
biochemical analyses of the TRPM7 complex 
showing that TRPM7 interacts in a Ca2+- and 
kinase-dependent manner with an actomyosin 
protein complex; iii) in vitro kinase reactions 
demonstrating that TRPM7 phosphorylates 
myosin IIA heavy chain; and iv) cell 
biological studies revealing that TRPM7 
promotes a loss of cortical tension leading to 
podosome formation by a kinase-dependent 
mechanism. Collectively, our data indicate 
that TRPM7 plays a role in linking receptor-
mediated signals to actomyosin remodeling 
and cell adhesion. Furthermore, our 
observations reveal for the first time that TRP 
channels affect the cytoskeleton by directly 
associating with cytoskeletal proteins in a 
highly regulated manner.  
 What is the relationship between channel 
opening and the kinase domain? Several 
studies have suggested that kinase activity 
regulates TRPM7 channel opening (Runnels et 
al, 2001; Schmitz et al, 2003). However, in 
our model system, TRPM7 channel opening 
was independent of kinase activity, since the 
responses to BK stimulation were identical 
between cells expressing WT and kinase-dead 
TRPM7. While TRPM7 kinase activity does 
not directly affect channel opening, it cannot 
be excluded that actomyosin remodeling 
serves to regulate TRPM7 function in an 
indirect manner as reported for other TRP 
channels (Itagaki et al, 2004; Lockwich et al, 
2001). Based on our observations, rather than 
the kinase domain regulating TRPM7-channel 
function, the reverse relationship exists. In this 
model (Fig. 9), phosphorylation of 
downstream targets (myosin II, annexin I; 
(Dorovkov and Ryazanov, 2004)) by the 
TRPM7-kinase domain is tightly regulated by 
ion-influx (Ca2+, Mg2+) through the TRPM7-
channel. In support of this model, we observed 
that Ca2+ is strictly required for the association 
of TRPM7 with the cytoskeleton, that 
increased Ca2+-influx through TRPM7 upon 
agonist-induced activation enhances its 
association with myosin IIA and that MHC 
phosphorylation is strictly Ca2+-dependent 
(van Leeuwen et al, 1999). Recently, 
Dorovkov and Ryazanov (2004) showed that 
the kinase activity of TRPM7 is potentiated in 
vitro by the addition of Ca2+ and conversely, is 
inhibited by chelation of Ca2+. Therefore, we 
propose that ion influx through the channel 
pore regulates the TRPM7 kinase domain by 
activating the kinase and controlling the 
recruitment of its substrates.  
 Kinases are maintained in an active state 
by intramolecular and intermolecular protein-
protein or protein-lipid interactions (Roskoski, 
2004; Van Etten, 2003). Activation of kinases  
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generally involves autophosphorylation or 
transphosphorylation at regulatory sites 
inducing conformational remodeling to expose 
the catalytic domain to its substrate. We 
postulate that TRPM7 is similarly regulated, 
since its kinase activity appears to be essential 
for its association with the actomyosin 
cytoskeleton. Autophosphorylation of 
TRPM7, which occurs on serine and threonine 
residues (Ryazanova et al, 2004; Schmitz et 
al, 2003), may release a cryptic binding site 
for myosin IIA heavy chain (Fig. 9). Thus, 
autophosphorylation of TRPM7 may serve as 
an important regulatory mechanism to 
modulate the interactions between TRPM7 
and its substrates.  
 A functional consequence of TRPM7 
activation is an increase in cell adhesion and 
spreading, which involves both kinase-
dependent and -independent pathways. 
Expression of a TRPM7 kinase-dead mutant 
still promotes cell adhesion and spreading but 
does not lead to the formation of podosomes 
upon BK stimulation. The fact that the global 
effects of TRPM7 on cell morphology are 
independent of kinase activity or its 
association with the cytoskeleton may reflect 
the increase in cytosolic Ca2+ concentrations 
observed in TRPM7-transduced cells. Indeed, 
reducing the internal Ca2+ concentration with 
BAPTA-AM impaired cell spreading (data not 
shown). Ca2+ may act directly at the level of 
integrin activation or affect the actomyosin 
cytoskeleton. The activation of integrins can 
lead to the remodeling of the actomyosin 
cytoskeleton to promote cell spreading via 
outside-in signaling pathways (DeMali et al, 
2003). Alternatively, Ca2+ is an important 
second messenger in actin remodeling 
including polymerization, severing of 
filaments and F-actin-membrane interactions 
(Forscher, 1989; Sun et al, 1999). Moreover, 
since TRPM7 can directly interact with PLC-
isoforms, it may influence local concentrations 
of PIP2, and thus affect actin polymerization 
(van Rheenen and Jalink, 2002). 
 The kinase-dependent effects of TRPM7 on 
cell adhesion are consistent with a role in 
regulating myosin IIA-dependent contractile 
responses. Notably, both BK stimulation and 
myosin II inhibition of N1E-115/TRPM7 cells 
induces the formation of large podosomes. Spatial 
and temporal regulation of actomyosin 
contractility is central to modulating the assembly 
and disassembly of focal adhesions and podosomes 
(Burgstaller and Gimona, 2004; Burridge and 
Wennerberg, 2004; DeMali et al, 2003; Geiger and 
Bershadsky, 2002; Linder and Aepfelbacher, 
2003). While local regulation of contractility 
appears to be controlled by Rho GTPases 
(Burgstaller and Gimona, 2004), α-kinases may 
also fulfill a role in spatial and temporal regulation 
of myosin II activity. Indeed, TRPM7, which is 
expressed at the cell surface, was found enriched 
in cell adhesion structures. By similarity, 
Dictyostelium myosin II function is precisely 
regulated by a family of MHC kinases with each 
member possessing a unique spatial distribution 
(Liang et al, 2002). Therefore, we postulate that an 
increase in TRPM7-mediated MHC 
phosphorylation contributes to local relaxation of 
the cortical cytoskeleton causing the 
transformation of focal adhesions into podosomes. 
Ablation of TRPM7 kinase activity maintains 
myosin-based cytoskeletal contractility preventing 
the reorganization of focal adhesions. Hence, 
TRPM7 regulates cell adhesion by modulating 
actomyosin contractility in a kinase-dependent 
manner and it is tempting to speculate that this 
phenomenon operates through MHC 
phosphorylation.  
 How to reconcile the small increase in 
TRPM7 expression (2-fold) with dramatic changes 
in cell morphology and response to BK? Although 
the kinase activity of TRPM7 is a linear 
relationship with concentration in vitro, it is most 
likely not linear in vivo as the protein will be 
subject to regulation. In support of this hypothesis, 
we have found that TRPM7 channels have 
increased activity as measured by patch-clamp and 
Ca2+ fluorometric experiments in N1E-
115/TRPM7 cells. It should be noted that the basal 
Ca2+ levels in the cells are significantly higher 
upon TRPM7 overexpression, which could 
influence kinase activity as reported by Dorovkov 
and Ryazanov (2004). Moreover, TRPM7-
mediated Ca2+ influx affects the recruitment of 
substrates for the kinase, by associating with the 
actomyosin cytoskeleton. Therefore, it can be 
expected that the activity of the TRPM7 complex 
in the N1E-115/TRPM7 in vivo is significantly 
more than the two-fold increase in kinase activity 
that is observed in vitro. Finally, if TRPM7 is 
targeted to a particular part of the cytoskeleton 
including cell adhesion structures, it is likely that 
the local activity of TRPM7 kinase increases 
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significantly more than 2-fold in those areas of the 
cell.  
 Bradykinin stimulation of N1E-115 cells 
leads to cell spreading and focal adhesion 
formation whereas it promotes the transformation 
of focal adhesions into podosomes in N1E-
115/TRPM7 cells. Although N1E-115 cells 
express endogenous TRPM7, these cells do not 
produce podosomes in response to BK. We believe 
these results reflect the contractile state of the cell 
and that it is necessary to overexpress TRPM7 to 
achieve complete relaxation of the actomyosin 
cytoskeleton required for BK-mediated podosome 
formation (see supplementary Fig. S6). In parental 
N1E-115 cells, myosin II is very active leading to 
a contractile phenotype. BK stimulation of these 
cells relaxes the cytoskeleton but since focal 
adhesions are formed, myosin II must be at least 
partly active as tension is required for focal 
adhesion biogenesis (Geiger and Bershadsky, 
2002). Overexpression of TRPM7 mimics these 
effects and BK stimulation of these cells leads to 
further inhibition of myosin II and relaxation of the 
actomyosin cytoskeleton, which allows for the 
formation of podosomes (adhesion structures 
which require an inhibition of myosin II for their 
formation (Burgstaller and Gimona, 2004)). In 
support of this model, inhibition of myosin II by 
blebbistatin in parental N1E-115 cells similarly 
induces podosomes (supplementary Fig. S4). Thus, 
since TRPM7 has a basal activity, its expression 
levels dictate myosin II activity, and thereby 
cellular phenotype.  
 Although mammalian nonmuscle actomyosin 
contractility appears to be primarily regulated by 
phosphorylation of the myosin regulatory light 
chain, a role for myosin heavy chain 
phosphorylation is emerging. Several studies have 
demonstrated that the MHC tail is phosphorylated 
on threonine residues upon stimulation of 
mammalian cells (van Leeuwen et al, 1999; 
Wilson et al, 1998). Based on homology to 
Dictyostelium MHC kinases, we hypothesized that 
TRPM7 may regulate myosin II function by 
phosphorylating the MHC α-helical tail. Indeed, in 
vitro kinase assays demonstrated that WT but not 
kinase-dead TRPM7 directly phosphorylates the 
MHC tail indicating broad evolutionary 
conservation with respect to both substrate and 
function. An unexpected result since other α-
kinases, α-kinase 1 and EFK-2, regulate protein 
transport and protein synthesis, respectively (Heine 
et al, 2005; Ryazanov, 2002). 
Figure 9 Regulation of actomyosin contractility by 
TRPM7. (A) In the resting state, TRPM7 is not 
associated with the actomyosin cytoskeleton (1). (B) 
Stimulation of cells with PLC-activating agonists 
induces TRPM7-mediated Ca2+ influx (2) as well as 
TRPM7 kinase activity. Autophosphorylation (3) 
promotes a conformational change within TRPM7 
allowing for Ca2+-dependent association with myosin 
IIA (4). (C) Subsequently, TRPM7 phosphorylates the 
myosin IIA heavy chain, presumably leading to 
dissociation of myosin filaments and cytoskeletal 
remodeling (5). 
 Myosin II forms bipolar thick filaments 
through electrostatic interactions of the MHC tail 
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(Hostetter et al, 2004). In Dictyostelium, 
phosphorylation of the α-helical MHC tail leads to 
filament disassembly thereby releasing cortical 
tension (Egelhoff et al, 1993). Whether 
phosphorylation of mammalian myosin II heavy 
chain by TRPM7 will have a similar effect on 
filament assembly remains to be determined (Fig. 
9C). Importantly, the region of myosin II 
phosphorylated by TRPM7 corresponds to the 
domain responsible for regulating myosin filament 
assembly (Nakasawa et al, 2005). Moreover, 
phosphorylation by PKC and casein kinase as well 
as point mutations affecting electrostatic charges 
(E1841K) within this domain affect myosin II 
function (Dulyaninova et al, 2005; Franke et al, 
2005). Therefore, we propose that phosphorylation 
of this region of the myosin IIA tail affects 
filament formation rather than ATPase activity of 
myosin II. Future investigations aimed at mapping 
the TRPM7 target residues within the myosin IIA 
heavy chain and defining the physiological 
relevance of MHC phosphorylation will provide 
further insight into the mechanisms underlying 
actomyosin contractility in mammalian cells.    
 In conclusion, we identified TRPM7 as a 
novel regulator of actomyosin contractility and cell 
adhesion in response to agonist stimulation. 
Moreover, we have demonstrated that TRP 
channels can interact with the actomyosin 
cytoskeleton to affect cell adhesion. Future 
experiments will be aimed at defining the role of 
TRPM7-containing protein assemblies in 
regulating actomyosin function, and establishing 
how these cytoskeletal changes affect cell adhesion 




 Mouse TRPM7 in pTracer-CMV2, and GFP-
myosin IIA in pEGFP-C3 were kind gifts from 
David Clapham (Harvard, Boston, USA) and 
Robert Adelstein (NIH, Bethesda, USA), 
respectively. An HA-tag has been inserted at the 
COOH-terminus of TRPM7 (Runnels et al, 2001). 
To generate retroviral expression vectors, the 
TRPM7 cDNA was inserted as a XhoI- NotI 
fragment into the LZRS-ires-neomycin vector. The 
kinase-dead mutant TRPM7-D1775A was 
produced by site-directed mutagenesis using the 
Quickchange kit (Stratagene). The soluble TRPM7 
COOH-terminus construct encodes for amino acids 
1158-1864 and contains a HA-tag at the NH2-
terminus. The cDNA was amplified by PCR and 
inserted as a XhoI- NotI fragment into the LZRS-
ires-neomycin vector. GFP-β-actin cDNA was 
inserted as an EcoRI- NotI fragment into the 
LZRS-ires-neomycin vector. Mouse myosin IIA 
heavy chain tail (aa 1795-1960) was amplified by 
RT-PCR from N1E-115 cells and cloned in frame 
in pGEX-1N using BamHI- EcoRI sites. The 
TRPM7 kinase domain (aa 1403-1864) in pMAL-
p2x was described previously (Ryazanova et al, 




 Mouse N1E-115, HEK293 and Phoenix 
packaging cells were cultured in DMEM medium 
with 10% FCS while PC12 cells were grown in 
RPMI medium with 10% horse serum and 5% 
FCS. Stable cell lines expressing the various 
TRPM7 constructs and GFP-β-actin were 
generated by retroviral transduction (van Leeuwen 
et al, 1999). N1E-115 cells transduced with the 
empty vector served as a control for all 
experiments. Cells were selected by the addition of 
0.8 mg/ml G418 to the media and the selection was 
complete within 7 days. For transient expression, 
cells were transfected using Fugene 6 (Roche) 
according to the manufacturer’s recommendations.  
 
Intracellular Calcium Determinations 
 Calcium measurements were performed by 
confocal ratiometric imaging of cells loaded with 
Oregon Green 488 BAPTA-1 AM and Fura Red 
AM (Molecular Probes) essentially as described 
(Schild et al, 1994). Experiments were performed 
at 37ºC in a HEPES/bicarbonate-buffered saline 
under 5% CO2, pH 7.3  (140 mM NaCl, 23 mM 
NaHCO3, 5 mM KCl, 2 mM MgCl2, 1 mM CaCl2, 
10 mM HEPES and 10 mM glucose), and 
calibration was with ionomycin (Calbiochem). 
Shown are representative traces from experiments 
performed at least in 10-fold; data are presented as 
mean ± SEM. 
 
Adhesion Assay 
 Cells (5 x 105) were seeded in a T25 flask and 
allowed to adhere for 16 h. To quantitate cell 
adhesion, non-adherent cells were washed away 
with PBS. The adherent cells were fixed in 3.7% 
formaldehyde in PBS for 10 min, washed with 
PBS and subsequently stained with 2% crystal 
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violet for 50 min. Excess stain was removed by 
extensive washing in PBS. Cells were lysed in 
PBS containing 1% NP40 and the absorbance at 
570 nm of the lysate was measured. Maximal 
adhesion as measured on poly-L-lysine coated 
dishes was set to 100%. Values reported are 
representative of two independent experiments 
performed in triplicate. 
   
Microscopy  
 Cells seeded on glass coverslips, were serum 
starved (0.1% FCS) overnight prior to stimulation 
with BK or blebbistatin (Calbiochem). For fixed 
specimens, cells were stained as previously 
described (van Leeuwen et al, 1997). Antibodies 
used for immunofluorescence were rat anti-HA 
(3F10; 1:100; Roche), mouse anti-vinculin (1:400; 
Sigma), rabbit anti-myosin IIA (1:100; BTI), alexa 
488-conjugated anti-rabbit and anti-rat IgG, and 
alexa 647-conjugated anti-mouse IgG (1:200; 
Molecular Probes). F-actin was detected using 
either texas-red or alexa 546-labelled phalloidin 
(1:50; Molecular Probes). Cells were viewed using 
either a Zeiss-LSM 510-meta microscope equipped 
with a Plan-Apochromat 63X, 1.4 NA oil 
immersion lens or a Leica-DMRA microscope 
with a 63X, 1.32 NA oil immersion lens. For 
videomicroscopy, cells were transferred to a 
bicarbonate-buffered medium as described above 
and maintained at 37oC on a temperature- and 
CO2-controlled stage. Cells were imaged with a 
DM-IRE2 inverted microscope fitted with a TCS-
SP2 scanhead and a 63X, 1.32 NA oil immersion 
lens (Leica). Images were collected at a 30 s time 
interval and surface area was calculated by 
quantifying the amount of pixels under a digital 
mask constructed by using the binary-fill operation 
after a thresholding step.  
 
Generation of Anti‐TRPM7 Antibodies 
 To generate anti-TRPM7 antibodies, a GST-
fusion protein encoding amino acids 1447 to 1555 
of TRPM7 was expressed in E. coli and purified on 
a glutathione-sepharose column. Rabbits were 
injected with the antigen mixed with Freund’s 
adjuvant and serum was collected 10 days after 
every vaccination. Serum collected prior to 
immunization (pre-immune) was used as a 
negative control in all experiments.   
 
Immunoprecipitations 
 Cells were serum starved (0.1% FCS) 
overnight prior to stimulation as indicated in the 
figure legends. After stimulation, cells were lysed 
on ice for 20 min in lysis buffer (50 mM Tris pH 
7.5, 300 mM NaCl, 0.5 mM DTT, 1.5 mM MgCl2, 
0.2 mM EDTA, 1% triton x-100 supplemented 
with protease inhibitors) and the extract was 
cleared by centrifugation. For the 
immunoprecipitation of exogenously expressed 
TRPM7, protein G-sepharose beads, which were 
blocked with 0.5% BSA and pre-coupled with anti-
HA antibody (clone 12CA5), were added to the 
lysate of N1E-115/ empty vector (control) or N1E-
115/TRPM7 cells. The samples were incubated at 
4oC for 3 h.  Endogenous TRPM7 was 
immunoprecipitated by incubating cellular lysates 
with anti-TRPM7 antibodies at 4oC for 3 h 
followed by the addition of protein G-sepharose 
beads at 4oC for 15 min. Subsequently, the beads 
were washed 3 times with lysis buffer, protein 
complexes were solubilized in Laemmli sample 
buffer and separated by SDS-PAGE. Proteins were 
detected by immunoblotting using the following 
antibodies: anti-HA (clone 3F10; 1:1000), anti-
myosin IIA (1:500), anti-β actin (1:20000; Sigma).  
 
In Vitro Kinase Assays 
 Recombinant TRPM7 kinase domain (amino 
acids 1402-1864) and myosin tail fragment (amino 
acids 1795-1960) were expressed, respectively, as 
a maltose binding protein- and GST-fusion protein 
in Escherichia coli and purified by standard 
methods. Immunocomplexes containing TRPM7 
with or without associated myosin or TRPM7 
mixed with 2 μg of GST-myosin were solubilized 
in kinase buffer (50 mM HEPES pH 7.0, 4 mM 
MnCl2, 5 mM DTT) without ATP. The kinase 
reaction was initiated by adding 0.1 mM ATP in 
combination with 5 μCi γ-32P-ATP and proceeded 
for 30 min at 30oC. The products of the kinase 
reaction were resolved by SDS-PAGE and 
detected by autoradiography. 
 
Statistical Analysis 
 All data are representative of at least 3 
independent experiments. Quantitative data are 
presented as the mean ± SEM. Statistical 
significance of differences between experimental 
groups was assessed with Student's t test. 
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Differences in means were considered significant 
if p < 0.05. 
 
Supplemental Material 
 Fig. S1 shows that mutation of aspartate 1775 
to alanine abrogates the ability of TRPM7 to 
undergo autophosphorylation. Fig. S2 shows the 
relative TRPM7 kinase activity in the different 
N1E-115 cell lines. Fig. S3 shows that both 
TRPM7-WT and TRPM7-D1775A are 
glycosylated and properly localized to the plasma 
membrane. Fig. S4 depicts the induction of 
podosomes in parental N1E-115 cells upon 
blebbistatin treatment. Fig. S5 shows that depletion 
of actin from TRPM7 immunoprecipitation by 
latrunculin A treatment has no effect on myosin 
IIA phosphorylation. Fig. S6 provides a model 
explaining the correlation between cell phenotype, 
TRPM7 expression and myosin II activity. Movie 
1 depicts the dynamics of cell spreading and focal 
adhesion formation in N1E-115/TRPM7 cells in 
response to BK stimulation. 
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Figure S1 Characterization of TRPM7 kinase-dead mutant. Mutation of aspartate 1775 to alanine abrogates the 
ability of TRPM7 to undergo autophosphorylation. WT and kinase-dead TRPM7 constructs were transiently transfected 
into HEK293 cells and immuno-affinity purified complexes were subjected to in vitro kinase assays. Top, In vitro 
autophosphorylation of TRPM7 detected by 32P labeling and autoradiography. Bottom, expression levels of TRPM7 
constructs in HEK293 cells detected using anti-HA antibodies. 
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Figure S2 Quantification of TRPM7 kinase activity in the different N1E-115 cell lines. (A) Autoradiogram of 
TRPM7 autophosphorylation levels in the different N1E-115 cell lines. N1E- 115 cells transduced with either the empty 
vector, TRPM7-WT or TRPM7-D1775A were lysed in RIPA buffer. Protein concentration was determined using the 
BCA kit and equal amounts of protein (400 μg) were transferred to each tube. TRPM7 was immunoprecipitated using a 
rabbit polyclonal TRPM7 antibody or rabbit pre-immune serum as a negative control. To assess the level of kinase 
activity, TRPM7 was autophosphorylated in the presence of 5 μCi of γ-32P-ATP, separated on an 8% SDS-PAGE gel 
and detected by autoradiography. (B) Quantification of TRPM7 kinase activity. Autophosphorylation of TRPM7 was 
quantified using phospho-imager analysis. The level of kinase activity in control N1E-115 cells was set to 1 and the data 




Figure S3 TRPM7 is glycosylated. (A) Cells were treated with vehicle control or 2 μg/ml tunicamycin for 24 h. TRPM7 
was immunoprecipitated and detected by Western blotting using anti-HA antibodies. Note that while TRPM7 runs as a 
doublet at 216 kDa, only the fast migrating band is observed upon treatment with tunicamycin. (B) Glycosylation is 
independent of kinase activity. TRPM7-WT and TRPM7-D1775A were detected by immunoprecipitation followed by 
Western blotting using anti-HA antibodies. Note that both TRPM7-WT and TRPM7-D1775A migrate as doublets on 
SDS-PAGE gels indicative of glycosylation. (C) Expression of TRPM7-WT and TRPM7-D1775A at the cell surface. 
N1E-115 cells were transfected with YFP-TRPM7-WT or CFP-TRPM7-D1775A. Live cells were visualized by confocal 
microscopy 48 h post-transfection. Cell surface expression was also detected in N1E-115/TRPM7-WT and N1E-




Figure S4 Inhibition of myosin II function in N1E-115 cells leads to cell spreading and podosome formation. N1E-
115 cells were seeded on fibronectin-coated coverslips to increase their adherence. Cells were treated with 50 μM 
blebbistatin for 30 min, fixed and stained for vinculin (green) and F-actin (red). (A) Untreated N1E-115 cells. Note the 




Figure S5 Disruption of the actin cytoskeleton prior to TRPM7 purification does not affect the phosphorylation of 
myosin IIA. (A) Effect of latrunculin A on the phosphorylation of myosin IIA by TRPM7. TRPM7-C WT and KD were 
immunopurified using anti-HA antibodies under high stringency conditions before and after latrunculin A treatment (1 
μM; 30 min). The kinase was incubated with 2 μg of GST or GST-myosin IIA in kinase buffer. Phosphorylated proteins 
were detected by SDS-PAGE followed by autoradiography. Top, coomassie staining of GST-fusion proteins; Middle, 
autoradiogram showing that phosphorylation of GST-myosin IIA is unaffected by prior treament with latrunculin A; 
Bottom, autophosphorylation of TRPM7-C constructs. (B) Contaminating actin is below detection levels. An aliquot of 
the purified TRPM7-C WT and KD from experiment in section A was run on gel and probed for β-actin (Top) or HA-




Figure S6 Relationship between TRPM7 expression, myosin activity and cellular phenotype. Parental N1E-115 cells 
have high myosin II activity which is translated into a contractile phenotype where cells are round and poorly adherent. 
Stimulation of these cells with BK leads to a loss of contractility as observed by the spreading of cells. However, myosin 
II is not fully inhibited as focal adhesions form at the periphery of the cell. Overexpression of TRPM7 mimics the effect 
of BK on N1E-115 cells as it has basal activity. Stimulation of N1E-115/TRPM7 cells leads to a further inhibition of 
myosin II activity leading to the formation of podosomes. Directly inhibiting all myosin II activity leads to the formation 
of podosomes regardless of whether TRPM7 is present or not. Thus, the level of TRPM7 expression and activation 
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 Rac is activated in response to various 
stimuli including growth factors and by 
adhesion to the extracellular matrix. However, 
how these stimuli ultimately result in Rac 
activation is poorly understood. The increase in 
intracellular calcium [Ca2+]i represents a 
ubiquitous second messenger system in cells, 
linking receptor activation to downstream 
signaling pathways. Here we show that 
elevation of [Ca2+]i, either artificially or by 
thrombin receptor activation, potently induces 
Rac activation. Lamellipodia formation induced 
by artificial elevation of [Ca2+]i is blocked by 
inhibition of Rac signaling, indicating that 
calcium-induced cytoskeletal changes are 
controlled by the activation of Rac. Calcium-
dependent Rac activation was dependent on the 
activation of a conventional protein kinase C. 
Furthermore, both increased [Ca2+]i and 
protein kinase C activation induce 
phosphorylation of RhoGDIα and induce the 
translocation of cytosolic Rac to the plasma 
membrane. Intracellular calcium signaling may 
thus contribute to the intracellular localization 
and activation of Rac to regulate the 




The Rho family of small GTPases, including Rho, 
Rac, and Cdc42 isoforms, regulates different 
aspects of cytoskeletal organization, which are 
coordinated in the process of cell migration (1). Of 
these, Rac is involved in the protrusion of 
lamellipodia, which occur principally at the 
leading edge of migrating cells but also emerge 
from around newly adherent cells to mediate cell 
spreading (2, 3). Rac also regulates gene 
transcription, cell cycle progression, and 
transformation in vitro (4–6) and is implicated in 
tumor initiation and progression in vivo (7). Rac is 
activated in response to various stimuli, including 
growth factors and adhesion to the extracellular 
matrix. However, how these stimuli ultimately 
result in Rac activation is poorly understood. The 
principal regulators of Rac activation are the 
guanine nucleotide exchange factors (GEFs)1 and 
GTPase activating proteins. GEFs induce 
activation by exchanging GDP for GTP, whereas 
GTPase activating proteins enhance the intrinsic 
rate of hydrolysis of bound GTP to GDP, resulting 
in inactivation. In cells, Rac exists predominantly 
in its inactive GDP-bound form in a complex with 
RhoGDI (8). RhoGDI binds and masks the 
hydrophobic C-terminal region of Rac, the same 
region that is responsible for targeting Rac to the 
plasma membrane (9). Thus RhoGDI maintains 
Rac in the cytoplasm and must dissociate to allow 
Rac to translocate to the membrane and interact 
with membrane-associated activators (10–12). It 
was shown recently (13, 14) that integrin signals 
disrupt the Rac-RhoGDI interaction, enabling Rac 
to target to regions of cell-matrix interaction and 
activate an adhesion-dependent signaling pathway. 
Thus appropriate localization, as well as 
activation, is necessary for Rac to carry out its 
functions. Increased intracellular calcium [Ca2+]i 
represents a ubiquitous second messenger system 
in cells, linking receptor activation to downstream 
signaling pathways. Previous studies (15–18) have 
described relationships between intracellular 
calcium and the activation and function of Rho 
family GTPases in processes including muscle 
contraction and the exocytic response. Intracellular 
calcium is also required for thrombin- and 
collagen-induced Rac activation in platelets (19). 
In neutrophils, however, chemoattractant-induced 
Rac activation is independent of intracellular 
calcium (20), suggesting that the relationship 
between calcium and Rac signaling is dependent 
on the cell type and/or the growth factor receptor 
involved. Ras-GRF 1 and 2, exchange factors 
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specific for both Ras and Rac (21, 22), harbor a 
calcium-calmodulin binding site (23) whereas the 
Rac exchange factor, Tiam1, is phosphorylated by 
calcium-calmodulin-dependent protein kinase II, 
which leads to increased nucleotide exchange on 
Rac (24). These findings suggest that nucleotide 
exchange on Rac may be regulated by changes in 
intracellular calcium. Various studies have 
implicated protein kinase C (PKC) in the 
activation of Rac. In Swiss 3T3 cells, phorbol ester 
treatment induces membrane ruffling, which is 
indicative of Rac activation (2), whereas PKC is 
required for PDGF-induce Rac activation in NIH 
3T3 cells (25). However, how PKC affects Rac 
activity is unclear. Here we have examined the 
effect of intracellular calcium transients on Rac 
signaling. We find that intracellular calcium 
transients induce the membrane translocation and 
activation of Rac. We propose an additional 
mechanism of regulation of Rac by calcium 
whereby calcium induces a PKC-dependent 
disruption of the Rac-Rho GDI complex. This 
promotes the translocation of Rac to the plasma 
membrane where it can be activated by membrane-
associated or membrane-translocated guanine 




 To generate the biotinylated CRIB peptide the 
amino acid sequence n-KERPEISLPSDFEH-
TIHVGFDAVTGEFTGMPEQWARLLQTSNIT-c 
was used and biotinylated during synthesis at the 
N-terminus. The TAT-CRIB peptide contained the 
additional N-terminal sequence GCGYGRKK-
RRQRRR and was not biotinylated. Thrombin 
related peptide (TRP) was synthesized as described 
previously (26). Fura red, Oregon green, BAPTA-
AM, and Alexa 568-phalloidin were from 
Molecular Probes. Thapsigargin, ionomycin, 
GF109203X (Gö 6850), U73122, calmidazolium 
chloride, and KN-93 were from Calbiochem. 
Streptavidin-agarose and PMA were from Sigma, 





 PC3 human prostate carcinoma cells (27) 
were cultured in DMEM supplemented with 10% 
fetal calf serum in a humidified incubator at 37 °C 
and with 5% CO2. NIH 3T3-Tiam1 cells (28) were 
cultured in DMEM + 10% bovine calf serum. Cells 
were seeded in tissue culture dishes 24 h before 
use to obtain a final density of ~70% confluence. 
For microscopy, cells were seeded at lower density 
on glass coverslips and grown for 24 h. PC3 cells 
expressing EGFP-Rac1 were generated by 
infection with a retrovirus containing EGFP-Rac1 
(29, 30). Western blotting showed that EGFP-Rac1 
was expressed at approximately the same level as 
endogenous Rac (not shown). EGFP-Rac1 was 
also functionally active as determined by Rac 




 Rac activity was assayed essentially as 
described previously (28), with the exception that 
instead of GST-Pak-CRIB a biotinylated peptide 
corresponding to the CRIB domain of Pak (see 
above) was used to precipitate active Rac. Briefly, 
after treatment of cells with the relevant inhibitors 
and stimuli, cells were washed and then lysed with 
a 1% Nonidet P-40 buffer containing 2 μg/ml 
CRIB peptide. Cell lysates were cleared by 
centrifugation, and active Rac-CRIB complexes 
were precipitated with streptavidin-agarose and 
solubilized in SDS sample buffer. Rac was 
detected following Western blotting with anti-Rac 





 Changes in cytosolic Ca2+ in PC3 cells were 
monitored ratiometrically by simultaneous 
confocal imaging of the Ca2+ indicators Oregon 
green 488, BAPTA-1AM, and Fura red-AM (31). 
Cells were loaded for 30 min by incubation in 
DMEM with 10 μM of the AM-esters of these 
dyes in the presence of pluronic and incubated in 
fresh DMEM for 15 min prior to the experiment. 
Excitation was at 488 nm, and the emission was 
detected using a 522 ± 17-nm bandpass filter 
(green) and a 585-nm longpass filter (red). 
Measurements were performed at 37 °C in a buffer 
containing, in mM, 140 NaCl, 23 NaHCO3, 5 KCl, 
2 MgCl2, 1CaCl2, 10 HEPES, and 10 glucose 
under 5% CO2. All measurements were calibrated 
using ionomycin. For simultaneous detection of 
phospholipase C activation and [Ca2+]i, PC3 cells 
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were transfected overnight with pcDNA3-EGFP-
PH (32) and subsequently loaded with Fura red-
AM and imaged as described above. PLC 
activation was visualized as translocation of the 
GFP-tagged, phosphatidylinositol 4,5-biphosphate-
binding PH domain from the membrane to the 
cytosol and quantitated by taking the ratio of 
membrane to cytosolic fluorescence as described 
(32). To determine the membrane association of 
GFP-tagged Rac1, medial sections ~2 μm above 
the plane of the coverslip were imaged by confocal 
microscopy. These were captured at 10-s intervals 
and stored on disk for offline analysis. The mean 
fluorescence intensity at the membrane and at the 
cytosol was determined, and the ratio of those was 
plotted versus time, essentially as described (32). 
 
Immunofluorescence Microscopy 
 PC3 cells or NIH 3T3 cells expressing Tiam1 
were seeded on glass coverslips 24 h before use. 
Following treatment/stimulation, cells were fixed 
with 3.7% formaldehyde for 10 min and then 
permeabilized with 0.2% Triton X-100 for 5 min. 
Filamentous actin was labeled with 0.2 μM Alexa 
568-phalloidin (Molecular Probes) for 30 min. 
Tiam1 was visualized with a polyclonal antibody 
(33). Where cells were treated with TAT-CRIB 
peptide, peptide (0.2 mg/ml) was added for 15 min 




 To visualize calcium-dependent phosphor-
rylation of cellular proteins, PC3 cells were lysed 
in buffer containing 0.5% Nonidet P-40, and 
lysates cleared by centrifugation and resolved by 
SDS-PAGE. Cellular proteins were resolved by 
SDS-PAGE transferred to nitrocellulose and 
probed with Phospho(ser)-PKC substrate antibody 
(Cell Signaling Technology). GDI phosphorylation 
was detected as described previously (34). Briefly, 
PC3 cells were starved of phosphate for 2 h and 
then metabolically labeled with 0.5 mCi/ml 
[32P]orthophosphate for 2 h. Cells were treated 
with or without GF109203X and stimulated with 
thapsigargin (1 μM) or PMA (100 nM). Cells were 
washed in cold phosphate-buffered saline and 
lysed (0.5% Nonidet P-40, 20 mM Tris, pH 7.6, 
250 mM NaCl, 5 mM EDTA, 3 mM EGTA, 20 
mM NaPO4, 3 mM β-glycerophosphate, 1 mM 
NaVO4, 100 nM calyculin A, 10 mM NaF, and a 
protease inhibitor mixture). RhoGDI was 
precipitated with polyclonal anti-RhoGDIα (Santa 
Cruz Biotechnology, Inc.) and protein G-
Sepharose. Precipitated RhoGDI and RhoGDI 
from total cell lysates was resolved by SDS-PAGE 
and Western blots probed with a monoclonal anti-
RhoGDIα antibody (Transduction Laboratories). 
 
Cell Fractionation 
 After treatment/stimulation, PC3 cells in 2-cm 
dishes were washed once with ice-cold phosphate-
buffered saline and then washed again with 
permeabilization buffer (20 mM Na-PIPES, 137 
mM NaCl, 2mM MgCl2, 2.7mM KCl, 0.05% 
bovine serum albumin). Cells were then 
permeabilized with 25 μM digitonin in 
permeabilization buffer for 20 min to allow 
leakage of cytosolic proteins. Maximal leakage of 
Rac and complete leakage of the cytosolic markers 
mitogen-activated protein kinase and RhoGDIα 
was found to take place within 10 min. No E-
cadherin, chosen as a representative 
transmembrane protein, was extracted by digitonin 
treatment (not shown). The cytosol-depleted cells 
were then washed twice with digitonin-containing 
buffer and lysed with radioimmune precipitation 
assay buffer. Lysates were cleared by 
centrifugation at 4 °C for 5 min at 15,000 × g, and 
5× SDS sample buffer was added to the 
supernatants. Proteins were resolved on 4–20% 
gradient gels (Novex), and following Western 
blotting, membranes were cut and probed with 
antibodies against Rac, anti-PKCα (Transduction 
Laboratories), and anti-pan-cadherin (Sigma) for 





 To study the relationship between 
intracellular calcium signaling and Rac function, 
we stimulated PC3 cells with the thrombin 
receptor agonist TRP and measured the effects on 
intracellular calcium concentration ([Ca2+]i) and on 
activation of Rac. Stimulation of the thrombin 
receptor with TRP results in release of calcium 
from inositol 1,4,5-trisphosphate-sensitive 
intracellular stores. As expected, stimulation of 
PC3 cells with TRP induced a rapid and transient 
increase in intracellular calcium [Ca2+]i (Fig. 1A). 
To assay Rac activity, we used a modified Rac 
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pull-down assay, which utilizes a synthetic 
biotinylated peptide corresponding to a region of 
the Rac-interacting (CRIB) domain of the Rac 
effector, Pak (see “Experimental Procedures”). 
This region specifically binds to Rac when it is in 
its active conformation. The biotinylated CRIB 
peptide works equally efficiently as the GST-Pak 
fusion protein used in earlier studies (35, 36) but is 
more stable and less susceptible to batch-to-batch 
variation. Stimulating the thrombin receptor with 
TRP induced a rapid activation of Rac in PC3 cells 
(Fig. 1B). Rac activation was transient, returning to 
baseline levels after ~10 min (not shown). 
Treatment with TRP also induced extensive 
lamellipodia formation and membrane ruffling 
(Fig. 2A, upper panels), which is consistent with 
an increase in Rac-GTP levels. 
 To examine whether a causal relationship 
exists between increased [Ca2+]i and activation of 
Rac and lamellipodia formation by TRP, we first 
examined the effects of calcium chelation on TRP-
induced morphological changes. Pre-treatment of 
PC3 cells with the membrane-permeable calcium 
chelator, BAPTA-AM, strongly inhibited TRP-
induced extension of lamellipodia (Fig. 2A), 
suggesting that lamellipodia formation was 
calcium-dependent. BAPTA-AM also inhibited 
TRP-induced Rac activation (Fig. 2B), suggesting 
that increased [Ca2+]i was required for Rac 
activation. To ensure that the effects of BAPTA-
AM were not because of disrupted receptor 
signaling, we examined the effect of BAPTA-AM 
on TRP-induced PLC activation. For this, PC3 
cells were transfected with a GFP chimera of the 
PH domain of PLCδ1, which translocates from 
plasma membrane to cytosol upon activation with 
TRP (37). Confocal imaging of living cells showed 
that TRP induced the translocation of GFP-PH 
from membrane to cytosol, confirming previous 
findings that thrombin receptor activation leads to 
the activation of PLC. TRP induced GFP-PH 
translocation equally well in the presence or 
absence of BAPTA-AM (Fig. 2C, lower traces). 
However, concomitant measurement of [Ca2+]i 
confirmed that BAPTA-AM treatment effectively 
blocked TRP-induced calcium transients (upper 
traces). This demonstrates that thrombin receptor-
Gq-PLC signaling, which ultimately leads to 
release of intracellular calcium, is not disrupted by 
BAPTA-AM treatment. From these data we 
conclude that intracellular calcium is required for 
thrombin receptor-mediated Rac activation and 
lamellipodia formation. 
FIG. 1. Thrombin-related peptide induces Rac acti-
vation and increased intracellular calcium. A, TRP 
(12.5 μM) induces an increase in intracellular calcium
in PC3 cells. Intracellular calcium levels were detected
by ratiometric imaging of Oregon green and Fura red
calcium indicators. The trace represents an average of
six individual cells captured from one image field. A
representative trace from a single cell is shown and is
representative of at least 10 quantifications and three 
independent experiments. iono, ionomycin. B, Rac 
activation in PC3 cells following stimulation with 12.5
mM TRP. Active Rac was precipitated with biotin-
CRIB peptide and detected following Western blotting
with anti-Rac antibodies (as described under 
“Experimental Procedures”). Rac (both active and
inactive) present in whole cell lysates are shown in the
lower panel to demonstrate equal amounts of protein in
samples. -Fold induction of Rac activation after 1 min





 To examine further the dependence of Rac 
activation on calcium signaling, we used 
pharmacological modulators of [Ca2+]i. Treatment 
of PC3 cells with thapsigargin, which liberates 
calcium from intracellular stores by blocking re-
uptake from the cytosol by Ca2+-ATPases, led to a 
transient elevation of [Ca2+]i that remained 
somewhat above baseline levels (Fig. 3A). 
Analysis of the time course of Rac activation 
showed that thapsigargin treatment induced a 
strong activation of Rac that was maximal at ~5 
min (Fig. 3B). Similarly, treatment of cells with 
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ionomycin, which induces a rapid elevation of 
[Ca2+]i because of influx of extracellular calcium,  
also induced rapid activation of Rac (Fig. 3, C and 
D). Interestingly, we observed consistently that the 
kinetics of calcium elevation appeared to correlate 
with that of Rac activation; thus, the prolonged 
elevation of [Ca2+]i induced by thapsigargin and 
ionomycin correlated with prolonged elevation of 
Rac activity, whereas TRP stimulation produced 
more transient increases in [Ca2+]i and Rac 
activation. Activation of Rac was not because of 
calcium-induced changes in spreading or other 
actin-dependent changes, because thapsigargin-
induced Rac activity was not inhibited by 
cytochalasin treatment (not shown). From these 
results we conclude that elevation of intracellular 
calcium is sufficient to activate Rac in the absence 
of receptor stimulation. 
 Our results also suggest that intracellular 
calcium mediates TRP-induced activation of Rac 
via the classical Gq-PLC-inositol 1,4,5-
trisphosphate pathway. To test this hypothesis, we 
examined the effects of PLC inhibition, which is 
predicted to inhibit receptor-induced intracellular 
calcium increase but not calcium transients 
induced directly by thapsigargin. Pre-treatment of 
cells with the PLC inhibitor U73122 (38, 39) 
inhibited TRP-induced Rac activation but not 
thapsigargin-induced Rac activation (Fig. 3E). 
Although we can not exclude the possibility that 
U73122 inhibited TRP-induced Rac activation 
non-specifically, our results are consistent with the 
hypothesis that TRP-induced Rac activation is 
mediated by PLC-[Ca2+]i signaling and that direct 
elevation of [Ca2+]i can bypass the requirement for 
receptor-PLC signaling. 
FIG. 2. Intracellular calcium is required for thrombin
receptor dependent Rac activation. A, chelation of
calcium with BAPTA-AM inhibits TRP-induced 
lamellipodia formation. BAPTA-AM (15 μM) was added
to PC3 cells on glass coverslips for 10 min before
stimulation with TRP for 5 min. Cells were then fixed,
and F-actin was stained with rhodamine-phalloidin as
described under “Experimental Procedures.” B, calcium 
chelation inhibits thrombin peptide-induced Rac activity.
To chelate intracellular calcium, cells were treated with
15 μM BAPTA-AM for 10 min. Cells were then
stimulated with 12.5 μM TRP for 5 min, and Rac activity
was analyzed by pull-down assays. Average -fold 
induction of Rac activation +S.D. is also shown (n = 4, 
BAPTA-AM significantly inhibited TRP-induced Rac
activation; p = 0.04). C, calcium chelation does not
disrupt receptor-phospholipase C signaling. Cells
transiently expressing a GFP chimera of the PH domain
of phospholipase Cδ were pre-treated with and without
BAPTA-AM as above and stimulated with 12.5 μM TRP. 
Calcium traces (upper graphs) show the intracellular 
calcium concentration as reflected by changes in Fura-red 
intensity. GFP-PH relocalization from membrane to
cytosol (lower graphs) reflects activation of PLC and was
imaged simultaneously with calcium in the same cell.
BAPTA-AM abolishes the TRP-induced calcium transient
(upper right trace) but not translocation of GFP-PH 
(lower right trace). At the end of the experiment, 
ionomycin (iono) and excess extracellular calcium were
added to the medium to give maximal (100%) responses.
The scale bar indicates percent change of basal
fluorescence. 
 We also examined the effects of increased 
[Ca2+]i on Rac activation in other cell types. In 
addition to PC3 cells, thapsigargin also induced 
Rac activation in T47D mammary carcinoma cells 
and Madin-Darby canine kidney cells but not in 
NIH 3T3 fibroblasts or lymphocytes (data not 
shown). This suggests that Ca2+-dependent Rac 
activation is cell type-specific and may be 




 Plasmid-based expression of the CRIB 
domain of Pak has been used previously (3, 40) to 
inhibit the signaling of Rac to endogenous CRIB-
containing targets. To examine the role of Rac in 
cell responses, we inhibited Rac signaling using a 
peptide corresponding to the CRIB domain of Pak 
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combined with a TAT sequence to confer 
membrane permeability (see Ref. 41 and 
“Experimental Procedures”). We first tested the 
ability of the TAT-CRIB peptide to inhibit Rac 
signaling using NIH 3T3 cells overexpressing the 
Rac exchange factor Tiam1, which shows high 
levels of activated Rac and as a consequence 
extensive membrane ruffling (28). Addition of 
TAT-CRIB peptide to the medium for 30 min 
dramatically attenuated Tiam1-mediated 
membrane ruffling in these cells, indicating that 
the peptide inhibits Rac downstream signaling 
(Fig. 4A). Control TAT peptides did not inhibit 
membrane ruffling (not shown). Treatment of cells 
with TAT-CRIB peptide for 30 min prior to 
thapsigargin stimulation also completely inhibited 
the subsequent detection of active Rac in cells 
(Fig. 4B), most likely because the TAT-CRIB 
blocked the binding of the biotinylated CRIB 
peptide used in the pull-down assay. The TAT-
CRIB peptide can therefore be used as a tool to 
inhibit Rac function in living cells and avoids 
potential long-term effects of CRIB expression. 
 We then used the TAT-CRIB peptide to 
examine the role of Rac in calcium-induced effects 
in PC3 cells. Thapsigargin and TRP induced 
extensive membrane ruffling and lamellipodia 
formation at the cell cortex, which is indicative of 
Rac activation. This was strongly inhibited by pre-
treatment with TATCRIB. From these results we 
conclude that the induction of lamellipodia by 





 In considering the mechanism by which 
intracellular calcium transients could mediate Rac 
activation, we first examined the possible role of 
GEFs. The GEFs GRF and Tiam1 both promote 
nucleotide exchange on Rac and are potential 
targets for regulation by calmodulin and 
calmodulin-dependent protein kinase II. However, 
thapsigargin-induced Rac activity in PC3 cells was 
not blocked by calmidazolium chloride or KN-93, 
inhibitors of calmodulin and calmodulin-
dependent protein kinase II, respectively (data not 
shown). Furthermore, thapsigargin failed to induce 
Rac activation in BW5146 T-lymphoma cells, 
despite the very high level of Tiam1 in these cells 
but did induce Rac activation in Madin-Darby 
canine kidney-f3 cells, which have undetectable 
levels of Tiam1 (not shown). Apparently, these 
particular exchange factors are most likely not 
directly involved in calcium-induced Rac 
activation, and we therefore investigated other 
potential mechanisms. 
FIG. 3. Increased intracellular calcium induces Rac
activation. The effect of thapsigargin treatment (100 
nM) on intracellular calcium levels (A) and Rac activity
(B) in PC3 cells measured as described for Fig. 1 is
shown. The effect of ionomycin (iono) treatment (1
μM) on intracellular calcium levels (C) and Rac activity
(D) in PC3 cells is shown. D also shows Rac activity in
response to thapsigargin for comparison. E, effect of the
PLC inhibitor U73122 (2.5 μM for 1 h) on Rac
activation induced by activation of the thrombin
receptor with TRP or by direct elevation of calcium
with thapsigargin (Tg). PLC inhibition blocks TRP-
induced Rac activation but not Rac activation induced
by direct elevation of [Ca2+]i by thapsigargin.  
 Various PKC isoforms have been implicated 
in the activation of Rho family GTPases. A 
subclass of these, the conventional PKCs, are also 
regulated by calcium (42). To determine whether 
PKC mediates calcium-induced Rac activation, we 
first inhibited PKC, both by long-term treatment of 
cells with the phorbol ester PMA, which down-
regulates novel and conventional PKC proteins, 
and with the PKC inhibitor GF109203X, used at 
concentrations that preferentially inhibit 
conventional and novel PKCs (43). Both 
treatments potently inhibited thapsigargin-induced 
Rac activation (Fig. 5A). On the other hand, 
activation of PKC by short-term PMA treatment 
transiently activated Rac (Fig. 5B). To investigate 
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whether intracellular calcium transients are 
sufficient to induce PKC activation in PC3 cells, 
we used an antibody that recognizes 
phosphorylated substrates of PKC. Western blot 
analysis of cell lysates revealed multiple PKC-
phosphorylated proteins in response to 
thapsigargin treatment, which were reduced by 
GF109203X treatment (Fig. 5C). TRP stimulation 
induced a similar profile of phosphorylation that 
was also blocked by the PKC inhibitor. These 
results suggest that intracellular calcium activates a 
calcium-dependent PKC in PC3 cells, which leads 
to activation of Rac. Although we cannot exclude 
the possibility that activation of PKC by calcium is 
indirect, our data suggest that a conventional PKC 
mediates calcium-induced Rac activation. 
 RhoGDIα possesses several potential PKC 
phosphorylation sites and has been shown to be a 
substrate for PKCα in vitro. Furthermore, it was 
shown that that phosphorylation of RhoGDI 
induces translocation of RhoA to the plasma 
membrane (34). We therefore examined whether 
calcium induced the phosphorylation of RhoGDI 
and if so, whether this was PKC-dependent. To do 
this, [32P] metabolically labeled PC3 cells were 
stimulated with thapsigargin or PMA in the 
presence and absence of PKC inhibitor, and 
RhoGDI phosphorylation was analyzed. We found 
that both PMA and thapsigargin treatments 
induced the phosphorylation of RhoGDI and that 
this phosphorylation was inhibited by GF109203X 
(Fig. 5D). These results demonstrate that elevation 
of intracellular calcium induces the PKC-
dependent phosphorylation of RhoGDI. 
 
Membrane Translocation of Rac 
 To examine whether calcium and PKC 
regulate membrane translocation of Rac, we 
examined the localization of Rac in single living 
cells. For this we used real-time confocal imaging 
of PC3 cells stably expressing low levels of wild 
type eGFP-Rac1. Prior to stimulation, GFP-Rac 
was predominantly cytoplasmic, with some regions 
of enrichment at membrane protrusions. Following 
stimulation with thapsigargin, fluorescence images 
of medial sections and corresponding line scan 
analysis showed that GFP-Rac levels increased in 
most parts of the plasma membrane (Fig. 6A). 
Enrichment of GFP-Rac occurred in particular at 
regions of the membrane that were often sites of 
subsequent membrane protrusion. Quantitative 
analysis of membrane and cytosolic fluorescence 
over time showed that GFP-Rac translocation 
peaked at ~2 min and gradually returned to a 
baseline distribution over 10–30 min (Fig. 6B). In 
addition to an increase of GFP-Rac in the plasma 
membrane, following stimulation we observed a 
consistent decrease in cytosolic fluorescence of 10 
± 3% (+S.E.). Although increased labeling in 
membrane ruffles can sometimes be attributed to 
increased amounts of membrane (44), 
simultaneous imaging of GFP-Rac with the 
membrane dye DiI showed that there is very little 
increase in membrane in these medial sections 
(data not shown). Furthermore, a decrease in 
cytosolic fluorescence support the finding that 
FIG. 4. Calcium-induced lamellipodia formation is 
Rac-dependent. A, treatment of NIH 3T3 cells stably 
overexpressing Tiam1 with or without 0.2 mg/ml TAT-
CRIB peptide for 30 min. Cells were stained for Tiam1 
expression and F-actin distribution. Note, control cells 
expressing Tiam1 show extensive actin-rich membrane 
ruffles (arrows), which are absent in TAT-CRIB-
treated cells. B, treatment of PC3 cells with TAT-CRIB 
peptide (0.2 mg/ml) inhibits thapsigargin-induced 
detection of active Rac. C, fluorescence micrograph of 
actin staining of PC3 cells pre-treated with or without 
TAT-CRIB peptide and stimulated with thapsigargin or 
TRP. Unlike control cells, TAT-CRIBtreated cells do 
not extend broad lamellipodia upon stimulation. 
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translocation to the membrane occurs. Our 
findings therefore indicate that calcium transients 
induce a temporary increase in translocation of 
Rac to the plasma membrane, which precedes the 
formation of Rac-dependent membrane 
protrusions. A translocation of 10% of total Rac 
from cytoplasm to plasma membrane is highly 
significant in view of the fact that at most 5–10% 
of total Rac is activated in response to extracellular 
stimulation as determined by pull-down assays2. 
 To further support the live-cell imaging 
results, we quantified the cytosolic and membrane-
bound Rac using a rapid cell fractionation 
procedure based on cell permeabilization (see 
“Experimental Procedures”). We found that 
thapsigargin treatment increased the amount of 
Rac in the membrane-containing fraction (Fig. 6C, 
compare lanes 1 and 3). Densitometry analysis of 
films from several experiments showed that this 
represented a mean increase of 2.4-fold ± 0.8 (n = 
4, p = 0.05). To examine the requirement for PKC 
in calcium-induced translocation of Rac, we 
inhibited PKC by long-term PMA treatment prior 
to thapsigargin stimulation. This resulted in 
inhibition of thapsigargin-induced translocation 
and also of that induced by TRP (Fig. 6C, compare 
lanes 3–6). Moreover, activation of PKC by brief 
PMA treatment enhanced membrane translocation 
of Rac (Fig. 6C, lanes 7 and 8). These results 
confirm that calcium induces the translocation of 
Rac to the plasma membrane and further support 
our conclusion that PKC mediates the membrane 
translocation and activation of Rac by 
phosphorylation of RhoGDI. 
 
DISCUSSION 
 We report here that intracellular calcium 
transients regulate the activation of Rac. Rac 
activation could be induced artificially either by 
releasing calcium from intracellular stores or by 
inducing the influx of extracellular calcium and 
was thus not a consequence of store emptying per 
se. Rac activation induced by thrombin receptor 
stimulation was also calcium-dependent, because it 
could be blocked by chelation of intracellular 
calcium. Furthermore, thrombin receptor-mediated 
Rac activation required phospholipase C activity, 
whereas thapsigargin-induced Rac activity did not. 
These findings suggest that calcium transients 
induced by receptor activation of the canonical 
Gq-PLCinositol 1,4,5-trisphosphate pathway are 
sufficient and necessary to activate Rac. Increased 
[Ca2+]i was sufficient to induce Rac activation in 
several epithelial cell lines, including Madin-
Darby canine kidney cells and T47D mammary 
carcinoma cells, but did not activate Rac in NIH 
3T3 fibroblasts or lymphocytes (data not shown). 
It was reported previously (45, 46) that cell-cell 
adhesion can regulate Rac activity. However, the 
differences that we observed between cell types 
FIG. 5. PKC-dependent Rac activation and RhoGDI
phosphorylation. A, thapsigargin-induced Rac
activation is inhibited in a dose-dependent manner by
inhibition of PKC with either GF109203X (GF) or
overnight (16 h overnight (o/n)) treatment with PMA
(100 nm). The upper panel shows active Rac; the lower
panel shows both active and inactive Rac in original
cell lysates. Down-regulation of PKCα was confirmed
by Western blotting (not shown). B, Rac activation in
response to 1- and 5-min treatments with PMA (100
nM). C, phosphorylation of cellular proteins by PKC.
Cells were stimulated with thapsigargin (5 min; Tg) or
thrombin peptide (2 min) with or without treatment
with GF109203X (GF). As a positive control for PKC-
induced phosphorylation, cells were also stimulated
with PMA for 1 or 10 min. A Western blot of total cell
lysates probed with an antibody that recognizes proteins
phosphorylated on serine by PKC is shown. Longer
exposure of the film revealed multiple additional bands
(not shown). D, PKC-dependent phosphorylation of
RhoGDI. 32-P-labeled PC3 cells were stimulated with
thapsigargin (Tg) or PMA in the presence or absence of
GF109203X (GF). Endogenous RhoGDIα was
immunoprecipitated, and both 32-Pphosphorylated
RhoGDIα and total RhoGDIα were visualized (see
“Experimental Procedures”). Note that the PKC
inhibitor blocks thapsigargin-induced phosphorylation.
con, control.  
2 L. S. Price and J. G. Collard, unpublished results. 
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are unlikely to be because of the formation of 
adherens junctions in epithelial cells, because PC3 
cells do not form cadherin-mediated adhesions. In 
neutrophils, chemoattractant-induced Rac 
activation is completely independent of 
intracellular calcium (20). Cells in which Rac is 
not activated directly by increased [Ca2+]i may 
therefore utilize a calcium-independent mechanism 
to modulate Rac-RhoGDI interaction or may 
instead be critically dependent on other receptor-
mediated signals, such as those that regulate the 
activation of specific GEFs.  
 Intracellular calcium transients also led to 
increased cell spreading and the formation of 
lamellipodia, a hallmark of Rac activation. 
Lamellipodia were inhibited by calcium chelation 
and also by TAT-CRIB peptide, a membrane-
permeable Rac inhibitor, demonstrating that 
calcium-induced lamellipodia were mediated by 
Rac. Lamellipodia formation at the leading edge is 
an important component of the coordinated 
cytoskeletal reorganization that occurs during cell 
migration. Oscillations in [Ca2+]i have been 
observed during the migration of various cell types 
and are either essential for or contribute toward 
migration of cells (47, 48). Rac activation may 
therefore be coordinated by oscillations in [Ca2+]i 
that occur during the migratory process. Previous 
studies have demonstrated targeting of active Rac 
to membrane ruffles and the leading edge of 
migrating cells in response to growth factor and 
integrin signalling (14, 49). Increases in 
intracellular calcium can also be highly localized 
to sites of receptor activation and may therefore be 
an important factor in the spatial regulation of Rac 
activation. 
FIG. 6. Calcium- and PKC-dependent translocation 
of Rac. A, real-time confocal imaging of GFP-Rac 
localization (upper panel). Cells were stimulated with 
thapsigargin (Tg). Representative images 2 μM above 
the plane of the coverslip from the same cell were taken 
at different times after stimulation. The  lower panels 
show GFP-Rac fluorescence intensity across the cell at 
the line depicted in the upper left panel and 
demonstrate an increase in cortical fluorescence after 
stimulation. B, time course of the ratio of total 
cytosol/membrane fluorescence averaged over four 
representative cells ± S.D. The cytosol/membrane ratio 
for each cell at t = 0 was normalized to 1. C, Rac levels 
in membrane fractions of PC3 cells transiently 
stimulated with thapsigargin (Tg), TRP, or PMA. PKC 
down-regulation was by overnight PMA treatment. 
After stimulation, cells were permeabilized to remove 
cytosolic proteins (see “Experimental Procedures”) and 
then solubilized in radioimmune precipitation assay 
buffer. These lysates, which contain 
membraneassociated proteins, were then analyzed for 
the presence of Rac. -Fold induction of membrane Rac 
(determined by densitometry) is shown above the 
corresponding band. Total Rac content is also shown. 
Cadherin levels in the membrane fraction, determined 
using pan-cadherin antibodies, demonstrate equal gel 
loading. PKCα levels are shown to demonstrate 
efficient degradation of PKC by overnight PMA 
treatment. Results are representative of four separate 
experiments that gave essentially the same results. con, 
control. 
 In NIH 3T3 cells, PDGF-induced membrane 
translocation and phosphorylation of the GEF 
Tiam1 is regulated by calcium-calmodulin kinase 
II but is independent of PKC (25). However, the 
Rac activation that we observed in PC3 cells was 
calmodulin-calmodulin kinase II-independent and 
strongly dependent on PKC. Furthermore, the 
capacity of intracellular calcium to regulate Rac 
activity did not correlate with cellular Tiam1 
levels. We conclude therefore that the signaling 
pathway described in the present study represents 
an additional mechanism of activation of Rac that 
is independent of Tiam1 or other calmodulin-
regulated Rac exchange factors. Calcium-
dependent Rac activation was strongly inhibited by 
treatments that preferentially inhibit conventional 
and non-conventional PKCs, whereas stimulation 
of PKC by transient PMA treatment induced the 
activation of Rac. Thapsigargin treatment also 
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resulted in increased PKC kinase activity. From 
these results we conclude that PKC mediates 
calcium-induced Rac activation and suggest the 
involvement of a calcium-dependent conventional 
PKC isoform. Interestingly, the study by Buchanan 
et al. (25) concluded that PKC was involved in 
PDGF-induced activation of Rac although this was 
in a Tiam1-independent manner, which is 
consistent with our findings. However, increased 
[Ca2+]i was not sufficient to induce Rac activation 
in NIH 3T3 cells. Furthermore, BAPTA-AM did 
not inhibit PDGF-induced circular ruffle 
formation, structures that are also associated with 
Rac activation (data not shown) (50), suggesting 
that PDGF can induce Rac activation via a 
pathway that is not dependent on intracellular 
calcium. Both calcium-dependent and calcium-
independent PKCs have been implicated in 
signaling by Rho family GTPases (25, 43, 51, 52). 
It is tempting to speculate that calcium-
independent PKCs may perform an equivalent 
function in regulating Rac where intracellular 
calcium is not critical for activation.  
 Both increased intracellular calcium and PKC 
activity induced the translocation of Rac to the 
plasma membrane. Translocation of Rac has been 
shown to correlate with activation (53, 54). 
However, these two events can be uncoupled. 
Thus, the membrane translocation of a 
constitutively active Rac mutant (V12Rac) is still 
regulated by an extracellular stimulus (14), 
whereas membrane translocation and activation of 
Tiam1 is not sufficient to activate Rac (25). These 
findings are consistent with the view that the 
translocation and activation of Rac are 
independently regulated events. Our findings show 
that intracellular calcium- and PKC-dependent 
targeting of Rac to the plasma membrane may be 
sufficient to lead to activation of Rac by 
membrane-associated or membrane translocated 
exchange factors.  
 Elevation of [Ca2+]i resulted in the PKC-
dependent phosphorylation of numerous cellular 
proteins. One of these was RhoGDIα, a protein 
that binds to the hydrophobic C terminus of Rho 
family GTPases and maintains them in the 
cytoplasm (8, 55). These results suggest that 
calcium- and PKC-dependent phosphorylation of 
RhoGDI may promote the release of bound Rac 
and subsequent translocation to the plasma 
membrane. This hypothesis is supported by 
previous studies (34, 56), which demonstrated that 
a conventional PKC, PKCα, induces the 
phosphorylation of RhoGDI and induces the 
membrane translocation and activation of RhoA. 
RhoGDI preferentially associates with the inactive 
GDP-bound form of endogenous Rho family 
GTPases (8, 55, 57). Furthermore, it has been 
reported that the binding of RhoGDI and Tiam1 to 
Rac are mutually exclusive (11), a phenomenon 
that might also hold true for other exchange 
factors. Together these results suggest that release 
of Rac from RhoGDI is a prerequisite for the 
activation of Rac by exchange factors. It was 
shown recently (14) that integrin signals act on the 
Rac-RhoGDI interaction inducing release of Rac 
to sites of cell adhesion. Reduced affinity of 
RhoGDI for Rac may therefore be a common 
feature of receptor-mediated Rac activation.  
 In conclusion, intracellular calcium transients 
modulate Rac activity through different 
mechanisms. In addition to regulating guanine 
nucleotide exchange factors, we show here that 
calcium also regulates the membrane translocation 
of Rac. This is mediated by PKC, which we 
propose acts on the Rac-RhoGDI complex, 
resulting in translocation of Rac to the plasma 
membrane, where it is activated by exchange 
factors, which could be membrane-associated or 
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Ions play an important role in many cellular 
process. They may act as regulators of enzymes or 
as second messenger: changes in intracellular ion 
concentration are induced by stimuli (like 
hormones) from the outside of the cell. Therefore 
cells maintain a tightly regulated gradient of ions 
over the plasma-membrane. Sodium and potassium 
are the main ions that control the membrane 
potential of cells whereas calcium (Ca2+) and 
magnesium (Mg2+) regulate many enzymes and 
cellular processess. The plasma-membrane 
consists of various lipids through which ions can 
not pass. As a result, cells have adopted 
specialized transporters and channels to control the 
distribution ions over the plasma-membrane. 
TRPM7 channels are widely expressed and 
play a crucial role in the Mg2+ homeostasis of 
cells. This channel permeates divalent ions, such 
as Ca2+ and Mg2+. Above all, TRPM7 channels 
have an unique feature at their C-terminus: an α-
kinase domain.  
 It is well established that TRPM7 channels 
may be activated by depletion of internal Mg2+ or 
magnesium-nucleotides in “whole-cell” patch 
clamp experiments (a method for measuring ionic 
currents whereby the contents of the cell is 
dialyzed). Activation of TRPM7 currents by 
agonist-induced second messengers was still 
unknown. In Chapter II we describe a receptor-
mediated signaling pathway that mediates TRPM7 
channel activation in unperturbed cells. In wild-
type N1E-115 cells, stimulation of G-Protein 
Coupled Receptors that couple to PLC cause a 
single transient intracellular Ca2+ elevation through 
Ca2+ release from the endoplasmatic reticulum, 
meaured by fluorescent Ca2+ dyes. In TRPM7 
transduced N1E-115 cells, this single transient 
Ca2+ elevation is followed by a second, sustained 
Ca2+ increase as a result of Ca2+ influx through 
TRPM7 channels. The activation of TRPM7 by 
PLC activation was validated by perforated-patch 
experiments (a patch-clamp assay that leaves the 
contents of the cells unperturbed). Furthermore, in 
this chapter we show that opening of TRPM7 
channels is restricted to PLC-coupled stimuli: 
using various fluorescent indicators (“FRET 
assays”) we confirmed that TRPM7 opening 
correlates well with PLC activity, but not other 
GPCR-derived second messengers such as cyclic 
AMP and  cyclic GMP. 
 The above described PLC regulation of 
TRPM7 currents contradicts with results of other 
groups: they show that activation of PLC leads to 
closure of TRPM7 cells in “whole-cell” patch-
clamp configuration. In Chapter III we continued 
to examine this discrepancy. Here we show that 
this difference can be ascribed to the difference in 
the patch-clamp assays. We use minimal invasive 
techniques like Ca2+ experiments and the 
perforated-patch clamp technique, which both do 
not interfere with the functioning of the cell. We 
show that the inhibitory effect of PLC is only 
observed in “whole-cell” experiments where 
intracellular Mg2+ is artificially clamped at low 
concentrations. To convincingly proove this, we 
have developed a method to lower intracellular 
Mg2+ levels in perforated-patch: pretreatment of 
cells with a membrane-permeable Mg2+ buffer. De 
currents induced in this way are both biohysically 
and pharmacoligically identical to the TRPM7 
currents measured activated by Mg2+ depletion 
measured in whole-cell configuration. Moreover, 
the data described in this chapter show that a 
gradual loss of PIP2 at the plasma-membrane 
probably underlies the artificial whole-cell results. 
 Mild overexpression of the TRPM7 channel 
in neuroblastoma cells induces cell spreading, cell 
adhesion and formation of focal adhesions. In 
Chapter IV we show that all these features are 
enhanced after PLC-mediated TRPM7 activation. 
The underlying mechanism is a Ca2+- and kinase-
dependent association with the actomyosin 
cytoskeleton. This association of the kinase 
domain and the cytoskeleton results in phospho-
rylation of myosin IIA and releases the tension of 
the actomyosin cytoskeleton. Furthermore, 
podosomes are formed de novo or out of existing 
focal adhesions. Thus, TRPM7 regulates cell 
adhesion by changing actomyosin contractility. 
 In Chapter V we describe a second Ca2+ 
dependent signaling pathway that regulates the 
cytoskeleton. In prostate carcinoma cells elevation 
of intracellular Ca2+, either by receptor stimulation 
or pharmacologically, activates the small G-protein 
Rac. This activated protein causes lamellipodia 
formation: dynamic, flat structures of the plasma-
membrane that contain large amounts of actin. The 
experiments described in this chapter show that the 
Ca2+ increase activates a kinase (a so-called 
conventional protein kinase C) that phosphorylates 
an activator of Rac (RhoGDIα) and causes 
translocation of Rac to the plasma-membrane. 
 We conclude that TRPM7, which combines a 
ion channel with a kinase, affects the cytoskeleton 

























 Ionen spelen een belangrijke rol in tal van 
cellulaire processen. Ze fungeren o.a. als 
regulatoren van enzymen of als zogenaamde 
‘tweede boodschapper’: veranderingen in ion 
concentraties binnen de cel (intracellulair) worden 
geïnduceerd door stimulansen (zoals een hormoon) 
aan de buitenkant van de cel. Daarom houden 
cellen een strikt gereguleerde gradiënt van ionen 
over de plasma-membraan in stand. Natrium en 
kalium ionen zijn de belangrijkste ionen in het 
bepalen van de membraan potentiaal van cellen, 
terwijl calcium (Ca2+) en magnesium (Mg2+) ionen 
vele enzymen en cellulaire processen reguleren. 
De plasma-membraan is opgebouwd uit vetten en 
ionen kunnen deze barriëre niet passeren. 
Zodoende hebben cellen gespecialiseerde ion 
transporters en kanalen geevolueerd om de 
verdeling van ionen over de plasma-membraan te 
kunnen reguleren. 
 TRPM7 ion kanalen worden in elke type cel 
tot expressie gebracht en hebben een cruciale rol in 
de interne Mg2+ balans van cellen. Dit kanaal laat 
divalente ionen door, zoals Ca2+ en Mg2+. 
Bovendien heeft het TRPM7 kanaal een unieke 
eigenschap: het bezit een intrinsiek α-kinase 
domein aan de C-terminus. 
 Het is bekend dat TRPM7 kanalen 
geactiveerd kunnen worden door depletie van 
intern Mg2+ en/of magnesium-nucleotiden in 
“whole-cell” patch-clamp experimenten (een 
methode waarbij de inhoud van een cel wordt 
gedialyseerd). Activatie van TRPM7 stromen door 
agonist-geinduceerde ‘tweede boodschapper’ 
cascades was nog niet bekend. In Hoofdstuk II 
beschrijven we dat receptor gemedieerde signaal 
transductie in staat is om TRPM7 kanalen te 
activeren in intacte cellen. In wildtype N1E-115 
neuroblastoma cellen veroorzaakt stimulatie van 
G-eiwit gekoppelde receptoren die fosfolipase C 
activeren een enkelvoudige Ca2+ verhoging vanuit 
het endoplasmatisch reticulum, zoals gemeten met 
fluorescente Ca2+ indicatoren. In cellen 
geïnfecteerd door een virus met TRPM7 wordt 
deze Ca2+ transient gevolgd door een tweede, trage 
fase van Ca2+ verhoging die het resultaat is van 
Ca2+ influx door TRPM7 kanalen. Activatie van 
TRPM7 door PLC-activerende stimuli is ook te 
meten in “perforated-patch” experimenten (een 
meetmethode waarbij de inhoud van de cel intact 
blijft). In dit hoofdstuk laten we verder zien dat 
opening van TRPM7 specifiek is voor PLC-
gekoppelde stimuli: door gebruik te maken van een 
aantal verschillende fluorescente indicatoren 
(“FRET assays”) bepalen we dat er een zeer goede 
correlatie is tussen TRPM7 opening en PLC 
activatie, maar niet met andere boodschappers 
zoals cyclisch AMP en cyclisch GMP. 
 Het hierboven beschreven resultaat is in 
tegenstelling met resultaten van andere groepen die 
beschreven dat activatie van PLC juist leidt tot 
sluiting van TRPM7 in de zogeheten ‘whole-cell’ 
patch clamp configuratie. In Hoofdstuk III gaan 
we verder in op deze paradox. We tonen aan dat 
het verschil is terug te leiden tot een verschil in de 
meetmethode. Wij gebruiken minimaal invasieve 
methoden zoals Ca2+ metingen en perforated patch 
clamping, die het normale functioneren van de cel 
intact laten. We laten zien dat het remmend effect 
van PLC alleen gevonden wordt in whole-cell 
metingen waarbij de intracellulaire Mg2+ 
concentratie arteficieel laag wordt gehouden. Om 
dit overtuigend aan te tonen hebben we een 
methode ontwikkeld om ook in perforated patches 
de intracellulaire Mg2+ concentratie te kunnen 
verlagen: voorbehandeling met een membraan 
permeabele Mg2+ buffer. De aldus geinduceerde 
stromen zijn biofysisch en farmacologisch identiek 
aan de TRPM7 stromen in whole-cell geactiveerd 
door Mg2+ depletie. De data uit dat hoofdstuk laten 
verder zien dat het langzaam verloren gaan van het 
membraan lipide PIP2 waarschijnlijk ten grondslag 
ligt aan het arteficiële whole-cell resultaat. 
 De milde overexpressie van TRPM7 in 
neuroblastoma cellen induceert spreiding van 
cellen, versterkte adhesie van cellen en de formatie 
van focale adhesie structuren. In Hoofdstuk IV 
laten we zien dat al deze kenmerken worden 
versterkt na PLC gemedieerde TRPM7 activatie. 
Het onderliggende mechanisme is een Ca2+- en 
kinase-afhankelijke associatie met het actomyosine 
cytoskelet. Deze associatie van het kinase domein 
en het cytoskelet resulteert in fosforylering van 
Myosine IIA en verlaagd daardoor de spanning 
van het actomyosine cytoskelet. Bovendien 
worden er podosomen gevormd, zowel de novo als 
uit bestaande ‘focal adhesion’ structuren. TRPM7 
reguleert dus cel adhesie door de contractiliteit van 
het actomyosine cytoskelet te veranderen.  
 In Hoofdstuk V, ten slotte, beschrijven we 
een tweede, Ca2+-afhankelijk, signaal dat het actine 
cytoskelet beinvloedt. In prostaat carcinoma cellen 
leidt verhoging van de intracellulaire Ca2+ 
concentratie, hetzij door receptor stimulatie hetzij 
met farmacologische methoden, tot activatie van 
het kleine G-eiwit Rac. Dit eiwit veroorzaakt 
uitgroei van zogeheden lamellipodia: dynamische, 
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platte structuren in de membraan die veel actine 
bevatten. De experimenten beschreven in dit 
hoofdstuk laten zien dat Ca2+ verhoging een kinase 
(een zogeheten conventionele PKC) geactiveerdt 
dat een activator van RAC (RhoGDIα) fosforyleert 
waardoor Rac naar de plasma membraan 
transloceert. 
 We concluderen dat TRPM7, dat een ion 
kanaal en kinase combineert, het cytoskelet op 
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